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Executive summary
The National Centre for Education and Train-
ing on Addiction (NCETA) was commissioned 
by the Australian National Council on Drugs 
(ANCD) in March 2007 to undertake an in-
dependent, comprehensive and critical ex-
amination of all relevant issues involved in 
drug detection and screening in the school 
setting.
The results of the review are presented in 
this report.
Summary comments
Overall, the body of evidence examined indi-
cates a strong case to be made against drug 
detection and screening strategies being uti-
lised in the school setting. In essence, the 
key findings are:
Most drug tests are insufficiently reliable 1. 
for testing in a setting such as schools.
The cost of testing was found to be very 2. 
large and would represent a substan-
tial impost on any education system’s 
budget.
A wide range of moral and legal issues 3. 
act as serious concerns, if not impedi-
ments.
Prevalence of illicit drug use by school-4. 
children has been declining for over a 
decade; current levels of regular use are 
very low, making detection a technically 
challenging task.
Highest prevalence of drug use occurs 5. 
among high-risk and vulnerable groups 
of children, including the poorer aca-
demic performers and Indigenous stu-
dents, indicating that punitive and 
inquisitorial methods of deterrence are 
ill-advised.
Evidence indicates that drug testing is an 6. 
ineffective deterrence mechanism.
Two-thirds of submissions received from 7. 
professionals (n = 33) were opposed to 
drug testing in schools.
The majority of survey respondents 8. 
(n = 284) were opposed to testing in 
schools.
An effective array of school-based pre-9. 
vention interventions is now available 
to schools — interventions that focus on 
building positive relations and develop-
ing pupils’ sense of connectedness with 
the school.
Effective mechanisms exist to target and 10. 
intervene in appropriate ways with high-
risk students and/or their families.
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The approach taken
In undertaking this review, NCETA endeav-
oured to achieve a broad and comprehensive 
coverage of relevant issues related to (i) pre-
vention and school drug education, including 
the protective and enhancing roles schools 
can play; (ii) drug testing in various contexts; 
(iii) the efficacy of screening and detection 
tests; (iv) the cost of implementation; (v) 
ethical and legal matters; and (vi) preva-
lence of drug use by school-aged children. 
We have attempted to synthesise a diverse 
array of complex, conflicting and sensitive 
information in a balanced manner.
This report draws together input from all the 
above areas in an effort to ensure the most 
comprehensive coverage of relevant issues. 
In particular, we have: 
examined the available data on drug use •	
by school-aged children (Section 4.1.1) 
and, in particular, high-risk groups of chil-
dren (Section 4.1.2)
assessed the evidence of the effectiveness •	
of biometric and psychometric tests (Sec-
tions 4.2 and 4.3)
critiqued evidence on the effectiveness •	
of tests to deter or reduce drugs and any 
associated potential adverse outcomes 
(Sections 4.5, 4.6 and 4.7)
examined the cost implications of the •	
implementation of various forms of test-
ing (Section 4.2.5)
covered the ethical, legal and practical •	
implications of testing school-aged chil-
dren (Section 5)
incorporated the views and perspectives •	
of professionals, parents and community 
members through a submissions process 
(Section 6) and an online survey (Sec-
tion 7)
addressed the range of alternative strat-•	
egies available to tackle drug use among 
school-aged children and the evidence 
base of effectiveness (Section 8).
This review has been undertaken from a 
public health perspective. In doing so, we 
have applied a public health model as a 
useful tool to draw together and analyse 
factors associated with the development of 
drug problems among children, and iden-
tify potentially effective strategies to address 
them. The following basic steps in the pub-
lic health model have been applied in the 
present review and involve: 
assessing the epidemiology of a targeted •	
problem (i.e. patterns and prevalence of 
use)
identifying risk and protective factors •	
associated with the development of the 
problem
applying interventions known to reduce •	
these risk factors and enhance protective 
factors that buffer against the effects of 
risk
monitoring the impact of these interven-•	
tions on the incidence and prevalence 
of the targeted disease and disorder 
(Hawkins, Catalano & Arthur, 2002).
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Key findings
1. Patterns and prevalence of 
drug use among school-aged 
children
Drug use among school-aged children is 
declining according to data from the Aus-
tralian Secondary Schools Survey on Alcohol 
and Other Drugs (ASSAD). Lifetime, monthly 
and weekly prevalence of use of alcohol, 
tobacco and illicit drugs in 2005 was signifi-
cantly lower (p<.01) than in previous years. 
The overall pattern of drug use among teen-
agers indicates continual downward trends 
that are anticipated to continue into the 
future.
Cannabis is the illicit drug most commonly 
used by school-aged children on a regular 
basis (‘regular’ use is defined here as having 
used more than 10 times in the last year). 
Regular use of cannabis was reported by less 
than 4 per cent of the total school student 
population. Regular use of other illicit sub-
stances was below 1 per cent. Low levels of use 
present challenges for any detection devices 
and strategies and necessitate higher levels of 
testing sensitivity (see Section 4.2.1).
Students who fall into high-risk categories 
are more likely to use illicit substances. Illicit 
drug use is in the order of two to three times 
greater among below-average academic 
performers, compared to above-average stu-
dents. Indigenous school students also use 
all illicit substances at a significantly greater 
level than non-Indigenous students.
Available expendable income was also 
strongly associated with level of drug use. 
After controlling for age, gender and school 
type, disposable income remained a signifi-
cant predictor of drug use. Students with 
$21–$60 and with more than $60 per week 
to spend were respectively 1.6 and 1.9 times 
more likely to have used any drug in the last 
year than students with less than $20 to 
spend each week.
2. Aims/rationale for drug testing
Drug testing is sometimes viewed as an ap-
pealing strategy to deal with drug use among 
school-aged children as it is assumed to: 
deter initiation of drug use and encour-•	
age cessation
detect users in order to refer them to •	
treatment/counselling
reduce drug-related harm by improving •	
young people’s physical and psychological 
wellbeing, reduce truancy and behavioural 
problems, and improve educational out-
comes.
What drug testing does not purport to do, 
however, is to: 
provide a measure of intoxication or •	
impairment
determine the quantity, frequency or con-•	
text of drug use
distinguish between experimental, occa-•	
sional or one-off users and those with 
problematic drug use
distinguish between similar metabolites •	
found in over-the-counter or legally pre-
scribed medications and illicit drugs.
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3. Approaches to drug detection 
and screening
There are a number of different approaches 
that can be employed to address the use of 
drugs in a school environment. These include: 
biometric measures of drug use (e.g. bio-•	
logical assays of urine, saliva, sweat, hair)
psychometric measures of drug use (e.g. •	
self-report survey, questionnaires or inter-
views)
devices for detection of drugs or drug •	
paraphernalia (e.g. sniffer dogs, search of 
lockers or belongings).
4. Effectiveness of drug testing 
as a deterrent
The available evidence assessing the effec-
tiveness of drug testing programs for 
deterring drug use is limited, derived from 
United States studies only, and poor in qual-
ity. No studies were found that provided 
appropriate controls or baseline data to ade-
quately determine whether changes in the 
proportions of students who tested positive 
for drugs could be attributed to the presence 
of any drug testing program.
This report therefore concludes that there 
is insufficient evidence to support the use 
of drug testing as a deterrent for drug use 
in schools.
5. Effectiveness of drug testing 
for reducing drug-related harm
Only two studies were located that eval-
uated the effectiveness of a drug testing 
program and/or measured other outcomes 
that may be impacted by drug use, such as 
psychological wellbeing, or behavioural and 
educational outcomes. Of these studies, one 
qualitative study found that while the major-
ity of students were undisturbed by the drug 
testing experience, more than one-quarter 
were distressed or angered by it. The other 
study reported that drug-tested students had 
more negative attitudes and beliefs about 
drug testing, the school, and drug use out-
comes, compared to students who were not 
drug-tested.
No studies directly evaluated the safety or 
other adverse outcomes of implementing a 
drug testing program, but several potential 
harms were identified, including: 
damage to the child–school or child–•	
parent relationship and loss of school 
connectedness
truancy to avoid testing and school exclu-•	
sion for positive tests. This is particularly 
pertinent for students who are at risk and 
most in need of a supportive educational 
environment
reduced participation in healthy activities•	
conversion to other less detectable, but •	
potentially more harmful substances
diversion of school resources from educa-•	
tional programs to manage a drug testing 
program
psychological distress and embarrassment •	
due to unwarranted invasion of privacy
breach of confidentiality where students •	
may be required to declare use of pre-
scribed medication
false sense of a drug-free environment, •	
where children with problematic drug 
use evade tests or are not detected and, 
therefore, not referred to appropriate 
treatment.
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6. Cost of tests
Cost is an important consideration in the 
implementation of any school-wide program. 
Existing information about test costs is very 
limited. To establish a cost structure relevant 
to Australian schools, during August 2007 
NCETA canvassed information via telephone 
from 11 of the main Australian suppliers of 
drug testing products or services.
Costs of implementing drug detection 
and screening
To estimate the actual costs of implementing 
a drug testing program in a school setting, 
a series of cost estimates were undertaken 
based on information obtained through the 
survey of the 11 test providers. A series of 
detailed breakdowns were calculated, from 
the basic cost of purchasing tests to the full 
cost of actual implementation of different 
testing regimes.
Costs were calculated for a hypothetical school 
of 500 students, then calculated for all gov-
ernment and non-government schools sepa-
rately, and then combined across Australia 
using actual student enrolment figures for 
2006. The costings were based on four pos-
sible scenarios: testing a whole school popu-
lation once; a 10 per cent random sample 
three times; a 5 per cent targeted sample three 
times; and a 2 per cent ‘for cause’ sample.
To undertake annual drug testing for all 
schools nationally for each of the four possi-
ble testing regimes the likely cost range is:
$15.9 million – $355.2 million (for saliva 
tests) and
$11.7 million – $302.3 million (for urine 
tests).
Not included in the cost implementation 
assessment was the cost of the provision of 
counselling and other essential forms of sup-
ports required after detection of use.
7. Accuracy of tests and 
other limitations
The accuracy of any test can vary greatly 
according to conditions and circumstances. A 
generally acceptable level for different drug 
testing settings has been set as ≥ 90 per 
cent sensitivity, ≥ 90 per cent specificity, and 
≥ 95 per cent accuracy. However, many tests 
that would be potential candidates for use 
in school drug testing would have levels of 
accuracy well below these levels.
Even achieving the minimum acceptable 
accuracy levels of tests, concerns remain 
when these tests are used with children in 
school settings. For example, a specificity 
level of 90 per cent results in a false positive 
error rate of 10 per cent, or one in 10. Such 
common results would necessitate strategies 
to be in place to cope with the consequences 
of false positives. Falsely accusing a child of 
illicit drug use may have a range of negative 
legal, social and psychological sequelae.
8. Ethical and legal issues
A range of ethical and legal issues pertaining 
to drug detection and screening in schools 
were examined. Consideration was given to 
the issues of rights of the child, invasion 
of privacy, protection from assault, and the 
school’s duty of care.
Comparison was made between the Aus-
tralian and United States legal frameworks 
as drug testing and screening of school-
children has been employed as a drug 
prevention strategy in many schools within 
the United States, and the experience there 
is often cited as a basis for emulating such 
approaches in this country. Australia’s legal 
framework differs markedly from that of 
the United States in a number of impor-
tant respects. The United States applies a 
less stringent standard of privacy and rea-
sonableness which resulted in children and 
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teenagers being strip-searched, drug-tested 
and, in one school, the FBI raided the school 
with sniffer dogs and pointed guns at the 
children’s heads (Alexander et al. v Goose 
Creek Police Department et al., 2006).
Overall, it was identified that:
The Australian and United States legal 1. 
perspectives differ greatly in regard to a 
number of key issues pertinent to drug 
testing. Hence, legal determinations by 
United States courts cannot be readily 
transferred to the Australian context.
Duty of care in Australia is considera-2. 
bly more limited in its extent than in 
the United States. The duty of care of 
an Australian school does not normally 
extend to cover activities outside school 
hours. On these grounds, it is unlikely 
that a case could be made for drug test-
ing to be necessitated or justified as part 
of the school’s duty of care.
It is improbable that drug testing of a 3. 
child could occur without their consent, 
or that of their parents. Moreover, failure 
to offer consent would be unlikely to be 
deemed an admission of guilt within the 
current Australian legal framework.
The Australian legal perspective places 4. 
great(er) weight on the rights of the child 
(than does the United States) and affords 
the child greater rights to privacy and 
protection from interference, especially 
where it may negatively impact their rep-
utation. Australian law is also sensitive 
to the lack of avenues for redress and 
natural justice available to children.
Best practice in workplace drug testing 5. 
involves extensive consultation pro cesses 
with employees, management and unions 
to achieve consensus. Even then, it is 
considered reasonable only where specific 
workplaces are deemed safety-sensitive 
or special needs settings. Zero-tolerance 
random drug testing, in the absence of 
strong justification, has been judged as 
unreasonable.
9. Submissions
A total of 33 submissions were received as 
part of this review. The majority of respond-
ents (61%, n = 20) were not in favour of 
drug detection and screening measures in 
schools. The disadvantages of drug detec-
tion and screening in schools were seen to 
outweigh any potential advantages, and the 
lack of credible evidence on the effectiveness 
of such measures was highlighted.
The following comments were made about 
the relative advantages and disadvantages of 
school drug testing. Disadvantages included 
a range of social, economic, ethical and legal 
disadvantages of school drug detection and 
screening, such as:
potential stigmatisation, discrimination •	
and alienation of students who are sub-
ject to screening and detection
creation of mistrust, suspicion and loss •	
of respect between teachers and students 
and/or parents and their children
disengagement of young people from •	
schools.
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Most frequently cited advantages among 
the 27 per cent of stakeholders in favour 
of drug detection and screening in schools 
were that it would:
provide an opportunity for early detection •	
and intervention
act as a deterrent to drug use•	
provide a legitimate reason for young •	
people to refuse the offer of drugs and 
resist peer pressure.
Other advantages included the scope pro-
vided to identify young people at risk and 
thereby benefit parents and the community 
in general by reduced drug use.
10. Survey results
Results from a community survey (n = 284) 
conducted as part of the consultation com-
ponent of this project found that less than 
one-quarter (24%) of respondents supported 
drug testing in schools, while 71 per cent 
(n = 200) were opposed or strongly opposed 
to it. Approximately half the respondents 
(51%) felt there were no advantages to drug 
testing in schools, and most (96%) believed 
that ‘it would lead to mistrust between stu-
dents and school personnel’ and that ‘it 
would stigmatise students with drug prob-
lems’ (72%). Where testing was supported, it 
was more strongly endorsed for older school 
students, with respondents most commonly 
endorsing random drug testing (39%) for 
Years 7–9 (42%) and Years 10–12 (61%), and 
with virtually no support for testing among 
primary schoolchildren.
11. Alternatives to drug testing
Schools are one of the most important set-
tings for health promotion and preventive 
interventions among children and youth. 
There is considerable scope for the school 
to act as an agent for prevention of drug 
use and associated problems. Schools can be 
effectively engaged in this area in a number 
of different ways. This review has identi-
fied three very different, but complementary, 
approaches as potentially useful ways in 
which schools can implement evidence-
based strategies to prevent drug-related 
problems among their student populations. 
These are: 
support and develop connectedness be-•	
tween the child and their school
provide targeted early and brief interven-•	
tions for high-risk youth
offer family strengthening interventions.•	
Overall, the literature suggests that success-
ful, safe negotiation through the adolescent–
adult transition requires good regulatory 
capacity, including executive functioning 
and emotion regulation, and the opportu-
nity to draw on social capital, such as con-
nections or relationships with supportive 
adults, peers who have good regulatory ca-
pacity, and prosocial community organisa-
tions. There is a close association between 
the level of connectedness felt by students 
and behaviours such as drug use. Enhanc-
ing student bonding to schools has been 
found to decrease these behaviours among 
young people. Measures that encourage stu-
dents to bond with their schools as social 
institutions and to form trusting, nurturing 
relationships with staff and other students 
represent the most important and empirically 
validated drug prevention strategies avail-
able to schools.
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1. Background and rationale
Over recent years, numerous preventive strat-
egies have been explored as possible options 
to address drug use by young people. One 
set of prevention and early intervention 
options relates to drug detection and screen-
ing measures. Screening and detection allow 
for the advantages afforded by early and 
brief interventions. A strong evidence base 
exists to support the efficacy of the latter in 
particular contexts.
However, to date, little systematic atten-
tion has been directed to these options 
as they might be applied within a school 
setting. A comprehensive, impartial and criti-
cal analysis is provided in this document to 
assess the potential for their application in 
the school setting. Such an analysis neces-
sitated a careful and detailed examination 
of potential impacts and implications, and 
was undertaken with cognisance of the wider 
range of available options for school-based 
interventions.
Drug detection and screening take highly 
varied forms, and can include questionnaires 
(administered with pen and pencil screen-
ing forms, or completed online), interviews 
and clinical observation (such as used in a 
clinical interview assessment), or independ-
ent tests of body fluids (e.g. saliva, sweat, 
urine, breath or blood) or tissue (e.g. hair, 
skin, nails). Other forms of detection and 
screening do not involve assessment of an 
individual per se but assessment of their 
materials (clothes, bags, belongings) using 
techniques such as sniffer dogs, scanning 
equipment or other forms of non-invasive 
mechanical detection devices.
In undertaking this examination of drug 
detection and screening in schools, the 
National Centre for Education and Training 
on Addiction (NCETA) attempted to ensure 
that an independent, comprehensive and 
critical examination of all relevant issues 
involved in drug detection and screening in 
the school setting was achieved. NCETA has 
drawn on its background in relation to (i) pre-
vention and school drug education, including 
the protective and enhancing roles schools 
can play (Roche, 2006); (ii) drug testing in 
various contexts (Pidd & Roche, 2006); (iii) 
screening and early and brief interventions 
(Roche & Freeman, 2004; Roche, Freeman 
& Skinner, 2004); (iv) comprehensive litera-
ture reviews and critical appraisals (Bywood, 
2006; Bywood, Lunnay & Roche, 2006); (v) 
ethical and legal matters; (vi) experience in 
secondary data analysis; and (vii) expertise in 
synthesising complex, conflicting and sensi-
tive information in a balanced manner.
Our report therefore draws together input 
from all the above areas in an effort to ensure 
the most comprehensive coverage of relevant 
issues. In particular, we have addressed the 
following: 
views and perspectives of professionals, •	
parents and community members (see 
Sections 6 and 7)
available data on drug use by school-aged •	
children (see Section 4.1.1) and, in par-
ticular, high-risk groups of children (see 
Section 4.1.2)
evidence of the effectiveness of bio metric •	
and psychometric tests (see Sections 4.2 
and 4.3)
evidence of the effectiveness of tests to •	
deter or reduce drugs and any associated 
potential adverse outcomes (see Sections 
4.5, 4.6 and 4.7)
the ethical, legal and practical implica-•	
tions of testing school-aged children (see 
Section 5)
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finally, a separate section has been in-•	
cluded which addresses the range of alter-
native strategies available to tackle drug 
use among school-aged children and the 
evidence base of effectiveness (see Sec-
tion 8).
This report has been undertaken from a pub-
lic health perspective and, in doing so, we 
have applied a public health model as a use-
ful tool to draw together and analyse the 
factors associated with the development of 
drug problems among young people and 
identify potentially effective strategies to 
address them. These basic steps in the pub-
lic health model have been applied in the 
present review.
This model involves: 
assessing the epidemiology of a targeted •	
problem (i.e. patterns and prevalence of 
use)
identifying risk and protective factors •	
associated with the development of the 
problem
applying interventions known to reduce •	
these risk factors and enhance protective 
factors that buffer against the effects of 
risk
evaluating the safety and effectiveness of •	
interventions
monitoring the impact of these interven-•	
tions on the incidence and prevalence of 
the targeted disease and disorder (Hawkins 
et al., 2002).
First, a brief overview is presented of factors 
associated with the development of alco-
hol and other drug (AOD) problems among 
young people.
1.1 Factors influencing 
the development of AOD 
problems
A large research base now exists which iden-
tifies factors associated with drug use prob-
lems. Toumbourou (2005) has described four 
major motivations underlying the develop-
ment of drug use problems, as follows:
To escape developmental distress•	 . The 
most severe and harmful drug use prob-
lems are associated with childhood back-
grounds characterised by problems that 
undermine healthy development and 
that operate from prior to birth through 
childhood. This appears to translate into 
social marginalisation and emotional dis-
tress through social exclusion processes, 
which can operate in families, schools and 
communities. Moderating factors include 
healthy family, school and peer environ-
ments.
To self-manage body and spirit•	 . Substance 
misuse is often an intentional activity that 
has functional motives relevant to feeling 
good, enhancing the body or achieving 
spiritual connection.
To conform to social norms•	 . Conformity is 
a general motivation behind the majority 
of alcohol and other drug use. Conform-
ing to social norms includes a variety 
of more specific motivations including 
the desire to achieve social inclusion, to 
achieve normal adulthood acceptance 
within a valued social group. Moderating 
factors in this regard include the range of 
situational influences that determine the 
balance of social approval for a particular 
type of drug use.
Background and rationale
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To create individual identity•	 . Greater in-
dustrial and technological sophistication, 
coupled with increasingly individual istic 
values, leads young people to try and es-
tablish a distinctive individual and peer 
identity. Individuating may be a more 
prominent motive in the needs of young 
people in communities in which the more 
basic needs of life are taken care of. One 
way of expressing this identity is via the 
use of licit and, in particular, illicit drugs. 
Moderating influences on this behav-
iour include the policies and practices of 
schools, families and the wider society.
The development of potentially harmful pat-
terns of alcohol and other drug use is known 
to be associated with a range of risk and pro-
tective factors (Loxley, Toumbourou, Stock-
well, Haines, Scott, Godfrey et al., 2004). 
These risk and protective factors can be cat-
egorised according to their influence at dif-
ferent developmental stages of the human 
life span and the development of later be-
havioural and adjustment problems and sub-
sequent harms. The likelihood of health and 
behavioural problems occurring is substan-
tially greater among those exposed to mul-
tiple risk factors.
Risk factors include:
Pre-school
inherited vulnerability (for males)•	
maternal smoking and alcohol use•	
extreme social disadvantage•	
family breakdown•	
child abuse and neglect•	
At school entry
early school failure•	
childhood conduct disorder•	
aggression•	
favourable parental attitudes to drug use•	
Adolescence onwards
low involvement in activities with adults•	
the perceived and actual level of com-•	
munity drug use
availability of drugs in the community•	
parent–adolescent conflict•	
parental alcohol and drug problems•	
poor family management•	
school failure•	
deviant peer associations•	
delinquency•	
favourable attitudes to drugs•	
community disadvantage and disorgani-•	
sation
positive media portrayals of drug use•	
adult unemployment•	
mental health problems.•	
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In contrast, protective factors against drug 
use include:
being born outside Australia•	
having an easy temperament•	
social and emotional competence•	
a shy and cautious temperament•	
degree of family attachment•	
parental harmony•	
religious involvement (Loxley et al., 2004).•	
The key clusters of identified risk factors for 
AOD problems among school-aged children 
that are of particular relevance to the school 
setting and that provide scope for effective 
intervention (Hawkins, Catalano & Arthur, 
2002) include:
early and persistent anti-social behaviour•	
academic failure, beginning in late ele-•	
mentary school
lack of commitment to school.•	
These risk factors also impact on other areas 
of problematic behaviour. Risk factors associ-
ated with development of drug use problems 
by young people are also associated with 
development of adolescent delinquency, teen 
pregnancy, dropping out of school and vio-
lence (Hawkins et al., 2002). Hence, many 
interventions designed to address drug use in 
schools also have potential to impact across 
these other domains. Effective interventions 
can have the advantage of a ‘knock-on’ 
effect across a wide range of health and 
behavioural issues, thus representing a good 
return on investment.
The nature of these approaches, the prin-
ciples upon which they are predicated, and 
their respective evidence bases are detailed 
below.
1.2 The broad social context 
of drug use
It is also important that drug use is examined 
and understood in the broader social context 
in which use occurs. To view drug use from 
a predominantly individualistic perspective, 
without taking into consideration the broad 
range of factors that impact upon use, may 
result in simplistic and ineffective responses 
to problems that have complex aetiologies. 
The implementation of any drug prevention 
program in schools therefore requires consid-
eration of the full range of social influences 
on drug use.
There is general consensus that drug use prob-
lems should not be regarded as a behaviour 
that is wholly influenced by individual choices 
(Spooner, Hall & Lynskey, 2001); rather, they 
are problems shaped by a range of macro-
economic factors, including the economic, 
social and physical environment. Wilkinson 
and Marmot (2003) maintain that:
Trying to shift the whole responsibility 
on to the user is clearly an inadequate 
response. This blames the victim, rather 
than addressing the complexities of the 
social circumstances that generate drug 
use. Effective drug policy must therefore 
be supported by the broad framework of 
social and economic policy. (p.25)
Human beings go through a number of tran-
sition periods which are critical for human 
development, including infancy to early 
childhood, going to school, the transition 
from primary to high school, and the tran-
sition into the workforce (National Crime 
Prevention, 1999). These transition points are 
times when a range of different outcomes 
are possible. The nature of these outcomes 
is influenced by environmental factors, the 
way in which previous transitions were coped 
with, and the level of support available to 
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the individual. When these transition points 
are not successfully negotiated, it can lead to 
an accumulation of risk factors for the devel-
opment of problems, such as drug use, later 
in life. However, the effect of early develop-
mental disadvantage on the progression to 
harmful substance use is not inevitable, and 
can be moderated by reducing its translation 
into social marginalisation (Toumbourou, 
Stockwell, Neighbors, Marlatt, Sturge & 
Rehm, 2007).
Spooner, Hall and Lynskey (2001) identified 
three groups of macro-economic risk and 
protective factors that impact on the degree 
to which young people make these transi-
tions successfully. These are:
the economic environment and socio-•	
economic status
the social and cultural environment (in-•	
cluding the strength and cohesiveness 
of social, family, school and community 
networks)
the quality of the physical environment •	
(which influences the individual’s oppor-
tunities for leisure, recreation, social 
integration and mobility).
Spooner et al., in their examination of the 
structural determinants of drug use by young 
people in Australia, highlighted that drug use 
is but one of a range of problem behaviours 
and should not be viewed in isolation. They 
hold that it is important that strategies be 
developed to address the shared pathways to 
these problem behaviours, and responses to 
drug use problems should not be developed 
in isolation from responses to other risky 
adolescent behaviours.
One of the themes arising from the research 
on risk and protective factors for adolescent 
drug use is the degree of social support and 
connectedness experienced by young people. 
Indeed, this is consistent with the broader 
literature concerning the social determi-
nants of health. Social support, good social 
relations and social cohesion are important 
factors that make a significant contribution 
to health (Wilkinson & Marmot, 2003). It 
is now well established that levels of trust, 
networks, and norms of reciprocity in the 
community, in the school setting and among 
peer groups, all have far-reaching effects on 
young people’s opportunities, choices and 
overall health and wellbeing (Roche, 2006).
It is evident that there is a very wide variety 
of risk and protective factors that influence 
patterns of harmful drug use among young 
people. In the following section, school-
based programs that aim to reduce these 
risk factors and enhance protective factors 
among young people are examined.
Australia’s document on the Principles for 
School Drug Education (Australian Govern-
ment Department of Education, Science 
and Training, 2004) reflects the Australian 
National Drug Strategy’s policy approach and 
provides guidance on the core concepts and 
values needed by schools so as to provide 
effective drug education to students. As 
such, Principles for School Drug Education 
advocates that a multi-dimensional approach 
be taken in schools. The approach endorsed 
is one that supports and fosters positive 
social networks. It provides that ‘young peo-
ple need to have clear expectations for their 
conduct as well as opportunities to partici-
pate in the life of the school and the broader 
community’ (Australian Government Depart-
ment of Education, Science and Training, 
2004). Further to this, it advises that drug 
education needs to be addressed within the 
context of health and wellbeing promotions 
rather than as a single issue. The partici-
pation of students in meaningful learning 
activities is considered the best strategy 
in developing the ability and capacity of 
young people to make informed decisions. 
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The development of a safe, supportive and 
inclusive school environment is considered 
necessary in order to facilitate the ability of 
students to engage in meaningful learning, 
informed decision making and positive rela-
tionships within society.
1.3 Australian drug policy
Australia lacks the plethora of anti-drug legis-
lation that is found within the United States 
and our National Drug Strategy is markedly 
different from the United States ‘War on 
Drugs’.1 Like the United States, Australia 
has a national ‘Tough on Drugs’ initiative. 
However, unlike the United States approach, 
the Australian National Drug Strategy advo-
cates harm minimisation. The National Drug 
Strategy suggests that three interacting 
components be taken into account when 
implementing drug and alcohol policies:
the individual and community involved•	
the social, cultural, physical, legal and •	
economic environment that the individ-
ual exists in, and
the drug itself (Ministerial Council on •	
Drug Strategy, 2004).
While harm minimisation does not condone 
drug use, it does seek to recognise that drug 
use is a community problem. Therefore, 
prevention and reduction strategies can be 
achieved only through wide-ranging and 
broad-based interventions that encompass 
the whole community. Further to this, the 
Australian National Drug Strategy recognises 
that approaches will vary according to the 
nature of the problem, the population group, 
the time and the locality.
The adoption of flexible principles and a 
harm-minimising approach distinguishes 
Australia’s drug strategy from the United 
States strategy. The Australian approach 
may be seen as reflective that ‘good public 
health laws require decision-makers to have 
regard for and value community and indi-
vidual interests’ (Reynolds, 2004).
War on Drugs1 . The Office of National Drug Control Policy (ONDCP) is the principal body 
empowered to set priorities, implement a national strategy, and certify federal drug control 
budgets in the United States. Established by the Anti-Drug Abuse Act of 1988, the aim of the 
national strategy is to reduce drug abuse, trafficking and their consequences (Eddy, 2003). 
In order to achieve these measures, the ONDCP has implemented a variety of punitive measures 
toward drug addicts and casual users alike, because drug abuse is no longer framed as a problem 
to be controlled but a problem to be eradicated. In the United States, to use a prohibited 
substance is defined as abuse, whether the user is addicted or not (Eddy, 2003). Specifically, 
drug abuse is to be curbed by preventing young people from using illegal drugs, reducing the 
number of users, and decreasing drug availability. Federal resources totalling US$1.6 billion are 
directed into education initiatives aimed at preventing drug use (The White House, 2007).
Aim
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2. Aims and 
research questions
2.1 Aims
The principal aim of this project was to eval-
uate the effectiveness and implications of 
using drug detection and screening meas-
ures or alternative programs to address drug 
use in schools.
2.2 Research questions
The main research questions were:
What approaches have been used for drug 1. 
detection and screening in schools?
How effective are these approaches for:2. 
detecting drug usea. 
deterring drug useb. 
reducing drug-related harm?c. 
What are the financial costs associated 3. 
with implementing drug detection and 
screening programs in schools?
What are the potential unintended harm-4. 
ful consequences associated with drug 
detection and screening in schools?
What are the legal, social and practi-5. 
cal implications of implementing drug 
detection and screening programs in 
schools?
What alternative approaches have been 6. 
used for detecting drug use in schools?
How effective are alternative approaches 7. 
for:
detecting drug usea. 
deterring drug useb. 
reducing drug-related harm?c. 
What are the legal, social and practical 8. 
implications of implementing alternative 
programs in schools?
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3. Methods
This research project comprised four sepa-
rate, though interrelated, components:
invited submissions•	
comprehensive literature review•	
online survey•	
analysis of existing datasets.•	
3.1 Submissions process
The aim of the submissions process was to 
obtain input from a range of key stakehold-
ers in the community. Key stakeholders in-
vited to make submissions included groups 
representing:
parents•	
educators, teachers and principals (gov-•	
ernment and non-government schools)
students (government and non-•	
 government schools)
alcohol and other drug (AOD) clinicians •	
and researchers
policy advisers from the education, legal •	
and AOD sectors
police, legal and criminal justice workers•	
youth services workers•	
civil liberties commentators.•	
3.1.1 Procedure
There were two components to the submis-
sions process:
personal invitations to specific groups and •	
organisations
general invitations for submissions via •	
newsletters and email distribution lists.
Personal invitations were emailed or posted 
to various organisations, associations and 
government departments to inform them 
about the project and invite them to make 
a submission. A list of these organisations 
is at Appendix B.
In addition, general invitations for submissions 
were sent to various professional newsletters 
and email distribution lists including:
Australian Policy Online (online newsletter •	
on the latest Australian social, economic, 
cultural and political research)
Of Substance•	  (national magazine on alco-
hol, tobacco and other drugs)
Australian Professional Society on Alcohol •	
and other Drugs (APSAD) newsletter
Australian Council of Social Service (ACOSS) •	
website
Alcohol and other Drugs Council of Australia •	
(ADCA) Update online bulletin board.
A submission pro-forma was enclosed with 
each letter of invitation and was available 
for download from the NCETA website. The 
pro-forma was developed to: 
facilitate the compilation and analysis of •	
responses
provide a framework to guide stakeholder •	
responses
ensure that comments were received on •	
certain pivotal areas.
The pro-forma comprised 12 questions 
grouped across two key themes: 
drug detection and screening measures•	
alternative measures to drug detection •	
and screening measures. 
M
ethods
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The questions pertained to the viability, 
effectiveness, impact and implications of 
drug detection and screening methods and 
alternative measures in schools. A section for 
general comments was included to enable 
additional input by key informants.
General information about the project, 
guidelines for preparing submissions, and a 
submission cover sheet were also provided 
along with the pro-forma. Respondents could 
choose to have all or part of their submission 
kept confidential. A copy of the submis-
sion package can be found at Appendix C. 
A maximum of five weeks was allocated for 
the preparation of submissions. A letter of 
acknowledgement was emailed to respond-
ents upon receipt of submissions. A list of 
organisations and individuals who provided 
submissions can be found at Appendix E.
3.2 Literature review process
A comprehensive literature review was under-
taken to collate and synthesise evidence from 
existing Australian and international literature 
pertaining to drug detection and screening 
programs and alternative drug deterrence 
programs implemented in schools.
The evidence base for this review was 
collected from a wide range of sources, 
including:
electronic databases (Table 1, 2000–August •	
2007)
peer-reviewed journals (Table 1, 2006– •	
August 2007)
websites (Table 2)•	
grey literature•	
experts in the content area.•	
Table 1: Electronic databases and peer-reviewed journals
Electronic databases Peer-reviewed journals
PubMed
Web of Science
Current Contents
Science Citations
Social Science Citations
Cochrane Library
PsycInfo
ERIC
CINAHL
Adolescence
American Journal of Bioethics
Archives of Pediatrics and Adolescent Medicine
Journal of Adolescence
Journal of Adolescent Health
Journal of American College Health
Journal of Early Adolescence
Journal of Research on Adolescence
Journal of School Health
Journal of Youth and Adolescence
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Table 2: Australian and international websites
Website URL
Alcohol and other Drugs Council of 
Australia
http://www.adca.org.au/
Australian Centre for Addiction Research http://www.acar.net.au/
Australian Drug Information network http://www.adin.com.au/
Australian National Council on Drugs http://www.ancd.org.au/
Canadian Centre on Substance Abuse http://www.ccsa.ca/ccsa/
CASA: National Center on Addiction and 
Substance Use at Columbia University
http://www.casacolumbia.org/
Center for Drug and Alcohol Studies http://www.udel.edu/cdas/
Center for Substance Abuse Treatment http://csat.samhsa.gov/
Centre for Youth Drug Studies http://www.cyds.adf.org.au/
Drug and Alcohol Services of 
South Australia
http://www.dassa.sa.gov.au/
National Institute on Alcohol Abuse and 
Alcoholism
http://www.niaaa.nih.gov/
National Institute on Drug Abuse (NIDA) http://www.nida.nih.gov/
National Institute of Mental Health http://www.nimh.nih.gov/
National Treatment Agency for 
Substance Misuse
http://www.nta.nhs.uk/
Office of National Drug Control Policy http://www.whitehousedrugpolicy.gov/
Office of Safe and Drug Free Schools http://www.ed.gov/about/offices/list/
osdfs/index.html
Student Drug Testing Coalition http://www.studentdrugtesting.org/
M
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Combinations of the following textwords and 
MeSH headings were used to identify rele-
vant literature in the electronic databases:
drug testing; drug screening; drug detec-•	
tion; urinalysis; sniffer dog; drug search; 
deterrent; drug education; drug preven-
tion
adolescent; children; school; college; •	
teenager; student.
The bibliographies of relevant papers were 
examined to identify additional potentially 
relevant research. Relevant papers were 
critically appraised according to levels of evi-
dence (National Health and Medical Research 
Council, 1999a) and criteria for methodo-
logical quality (EPOC, 2002).
3.3 Online survey process
An online questionnaire was developed to 
assess perceptions of the wider commu-
nity about drug detection and screening in 
schools. This method of data collection was 
employed due to its user-friendliness, cost 
and time efficiency, speed in the process of 
collecting and collating data, and its abil-
ity to maximise the penetration and reach 
of the survey.
The questionnaire included sections regard-
ing:
basic demographics such as age, gender, •	
location, employment status
drug testing in schools•	
alternatives to drug testing in schools•	
drug testing in general (e.g. in the work-•	
place, drug driving)
personal alcohol and/or drug use.•	
A section for additional comments was pro-
vided at the end of the questionnaire. A hard 
copy of the online questionnaire is at Ap-
pendix D. The survey took approximately 
5–10 minutes to complete and respondents 
were assured of their confidentiality and 
anonymity.
This component of the project was approved 
by the Flinders University Social and Behav-
ioural Research Ethics Committee.
3.3.1 Procedure
An invitation to participate in the online sur-
vey was distributed through various media 
including the NCETA website, professional 
email distribution lists, conferences and pro-
fessional magazines. Weekly reminders were 
sent out to increase response rates.
The questionnaire was accessed, completed 
and submitted online via SurveyMonkey, an 
online software program that allows for the 
design, administration and collation of sur-
veys via a secure website. The online survey 
was open for a period of approximately seven 
weeks, enabling adequate time for notifica-
tion and completion by respondents. Survey 
data were imported and collated via Survey-
Monkey and entered into an SPSS spread-
sheet for subsequent analysis. Responses 
were pooled and aggregated and not indi-
vidually analysed.
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3.4 Analysis of existing 
datasets process
To investigate some of the issues surround-
ing drug testing in schools, secondary 
analyses were conducted on the 2005 Aus-
tralian Secondary Students’ Alcohol and 
Drug (ASSAD) Survey.2 The ASSAD survey 
is conducted by the Centre for Behavioural 
Research in Cancer at the Cancer Council 
Victoria; in 2005, 21 805 secondary school 
students aged 12–17 participated from 376 
schools around Australia. The survey asked 
questions on use of licit and illicit drugs.
The main variables of interest were ‘regular 
use’ of particular drugs (defined as using a 
particular drug 10 or more times in the last 
year, on the advice of Cancer Council Vic-
toria). Steroid and analgesics use was not 
included in analyses as these substances were 
deemed not relevant to school drug testing. 
Analyses of prevalence of regular use in the 
total student population were conducted 
in SPSS, and cases were weighted by State, 
school type (government, Catholic or inde-
pendent), age level and gender to reflect the 
population distribution. Regular use among 
subgroups of students was compared using 
Stata 9.02, employing design-based F tests 
from Stata’s tabulation command. Inferential 
statistics incorporated corrections for clus-
tering effects, as schools were the primary 
sampling unit. More detail on the com-
plex sampling procedure used in the ASSAD 
survey is provided in reports by White and 
Hayman (White & Hayman, 2006a; 2006b; 
2006c).
This work was undertaken with the assistance of Vicki White (Cancer Council Victoria). The 2 
Cancer Council Victoria is acknowledged as the collector and owner of these data, and they 
conducted the secondary analyses on behalf of NCETA. However, NCETA bears responsibility 
for the presentation and interpretation of the data.
D
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4. Drug detection and 
screening programs
4.1 Impetus for drug 
detection and screening 
in schools
In conjunction with drug education and 
written drug policies, drug testing is some-
times viewed as an appealing strategy to deal 
with drug use among school-aged children, 
as it is assumed to be an objective means of 
detecting student drug use.
Before we discuss the principal aims and 
approaches to drug testing, it is important to 
examine the patterns and prevalence of drug 
use by school-aged children in Australia.
4.1.1 Prevalence of drug use in 
school-aged children
A range of datasets was examined to provide 
contextual information on the patterns and 
prevalence of AOD use by school-aged chil-
dren. Examination was made of the National 
Drug Strategy Household Survey (NDSHS) and 
the Australian Secondary School Students’ 
Use of Alcohol and Drug Survey (ASSAD). 
It was decided not to include data from 
the NDSHS, even though the 2004 data set 
includes data from 12 year olds and older, 
because of sampling limitations and because 
the ASSAD database was assessed to be more 
relevant for the current purposes.
The most comprehensive and representative 
of the available data sources is the Aus-
tralian Secondary Schools Survey (ASSAD) 
whereby data are collected every three years 
from young people aged 12–18 years within 
state and private schools across the country. 
The most recent ASSAD survey was under-
taken in 2005 and results reported in 2006 
(White & Hayman, 2006a; 2006b; 2006c). As 
part of this project, further specific analyses 
were undertaken and these data are reported 
below.
Secondary analysis of relevant datasets al-
lows us to map the prevalence and patterns 
of drug use in school-aged children. Patterns 
and prevalence of use are central considera-
tions in any screening and detection strategy 
as the screening ‘tools’ used need to be ap-
propriate to detect the substances in ques-
tion. Tables 10–14 present the findings of 
these secondary analyses, while  Tables 3–9 
present results compiled from the three exist-
ing ASSAD monographs (White & Hayman, 
2006a; 2006b; 2006c).
Descriptive data are presented in the tables 
below for use in the past week, month, year 
and ever or lifetime use. The data across each 
of these four time frames are presented by 
year of age from 12 through to 17, and then 
aggregated for all ages.
The data shown in Table 3 on drug use in 
the previous week indicate that cannabis is 
the illicit substance most commonly used. 
Prevalence of use in the past week is com-
paratively low, peaking among the 15, 16 
and 17 year olds at 5.9 per cent. Use of 
alcohol in the past week is high, and steadily 
increases from the age of 12 years through 
to 52 per cent of 17 year olds using alcohol 
in the past week.
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Prevalence of use over the past month is 
shown in Table 4. The pattern of use is simi-
lar for weekly use of the drug groups shown 
above in Table 3. That is, highest prevalence 
of use is found for alcohol, with levels of use 
increasing with age, culminating in 70 per 
cent of 17 year olds having used alcohol in 
the past month. Among illicit substances, 
cannabis is the most commonly used drug, 
with 11 per cent of 17 year olds having 
used it in the past month. Prevalence of all 
other drug types is low among the 12–17 
year old age groups at generally less than 
3 per cent.
Table 3: School students’ use of tobacco, alcohol, over-the-counter medications 
not for medical purposes, and illicit drugs in the last week (n = 22 694)
(Source: White & Hayman, 2006a, 2006b, 2006c)
Drug 12 13 14 15 16 17 12–17
Alcohol 12.0% 17.0% 29.0% 36.0% 48.0% 52.0% 30.0%
Tobacco 3.0% 5.0% 8.0% 11.0% 14.0% 19.0% 9.0%
Inhalants 6.4% 6.0% 5.5% 3.9% 2.5% 2.1% 4.6%
Cannabis 1.1% 2.4% 4.7% 5.9% 5.9% 5.9% 4.2%
Tranquillisers 1.5% 1.7% 2.7% 2.8% 2.1% 2.0% 2.1%
Note: Data were not presented for use of other drugs in the past week other than those shown in 
the above table.
Table 4: School students’ use of tobacco, alcohol, over-the-counter medications 
not for medical purposes, and illicit drugs in the last month (n = 22 694)
(Source: White & Hayman, 2006a; 2006b; 2006c)
Drug 12 13 14 15 16 17 12–17
Alcohol 17.0% 26.0% 41.0% 54.0% 67.0% 70.0% 43.0%
Tobacco 3.0% 6.0% 12.0% 16.0% 21.0% 23.0% 13.0%
Inhalants 9.9% 9.7% 9.2% 7.2% 3.6% 3.1% 7.5%
Cannabis 1.6% 3.6% 6.7% 10.4% 11.8% 11.1% 7.2%
Tranquillisers 2.4% 3.9% 4.4% 4.7% 4.0% 3.3% 3.8%
Amphetamines 1.4% 1.4% 2.6% 3.5% 3.1% 2.4% 2.4%
Ecstasy 0.7% 0.8% 2.1% 2.3% 2.3% 2.3% 1.7%
Hallucinogens 0.9% 0.7% 1.8% 2.0% 1.6% 1.1% 1.3%
Cocaine 0.8% 0.8% 2.1% 2.1% 1.4% 0.9% 1.3%
Steroids 0.9% 0.8% 1.7% 1.7% 1.1% 0.8% 1.2%
Opiates 0.6% 0.7% 1.6% 1.5% 1.1% 0.5% 1.0%
Any illicit drug 12–15: 7% 16–17: 13% 8%
Any illicit drug 
ex. cannabis 12–15: 3% 16–17: 4% 4%
D
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Highest prevalence for use reported in the 
last year reflects a pattern of use similar to 
weekly and monthly use in that use of alco-
hol is, by far, the most prevalent substance 
used (peaking at 89 per cent among 17 year 
olds). Across all age groups and drug types, 
use tends to increase with age (with the 
notable exception of the inhalants, where 
use declines with age). The illicit substance 
most commonly used is cannabis, with 25 
per cent of 17 year olds having used it at 
least once in the past year (Table 5).
Table 5: School students’ use of tobacco, alcohol, over-the-counter medications 
not for medical purposes, and illicit drugs in the last year (n = 22 694)
(Source: White & Hayman, 2006a; 2006b; 2006c)
Drug 12 13 14 15 16 17 12–17
Alcohol 44.0% 55.0% 67.0% 80.0% 87.0% 89.0% 68.0%
Tobacco 9.0% 12.0% 20.0% 27.0% 31.0% 39.0% 21.0%
Cannabis 2.9% 6.7% 12.7% 18.8% 24.7% 25.3% 14.2%
Inhalants 15.7% 15.3% 16.6% 12.5% 8.3% 5.9% 12.9%
Tranquillisers 5.6% 8.5% 10.5% 10.0% 10.1% 9.5% 9.0%
Amphetamines 2.0% 2.3% 4.3% 5.6% 6.4% 5.4% 4.2%
Ecstasy 1.2% 1.3% 3.4% 4.1% 4.9% 5.0% 3.2%
Hallucinogens 1.1% 1.3% 3.0% 3.5% 3.5% 2.9% 2.5%
Cocaine 1.0% 1.3% 3.1% 3.1% 2.9% 2.1% 2.2%
Steroids 1.7% 1.5% 2.8% 2.6% 1.6% 1.5% 2.0%
Opiates 1.1% 1.3% 2.5% 2.3% 2.1% 1.0% 1.7%
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Table 6 shows the lifetime prevalence of use 
for all drug types; that is, if the child used a 
designated substance at least once in their 
lifetime. Again, the pattern of use is similar 
for use weekly, monthly and in the past year, 
with very high levels of alcohol use (by 17 
years of age, 96 per cent of respondents had 
used alcohol at least once) followed by can-
nabis as the illicit drug most commonly used 
(by 17 years of age, 32 per cent had used 
cannabis at least once in their lifetime).
Table 6: School students’ use of tobacco, alcohol, over-the-counter medications not 
for medical purposes, and illicit drugs in their lifetime (ever) (n = 22 694)
(Source: White & Hayman, 2006a; 2006b; 2006c)
Drug 12 13 14 15 16 17 12–17
Alcohol 73.0% 80.0% 86.0% 91.0% 94.0% 96.0% 86.0%
Tobacco 16.0% 21.0% 35.0% 43.0% 50.0% 55.0% 35.0%
Inhalants 20.8% 19.1% 21.0% 16.5% 12.3% 9.9% 17.2%
Cannabis 4.6% 8.8% 15.4% 22.8% 30.0% 32.4% 17.8%
Tranquillisers 10.9% 14.2% 16.4% 16.9% 16.8% 16.3% 15.1%
Amphetamines 2.7% 2.9% 5.3% 6.6% 8.3% 7.2% 5.3%
Ecstasy 1.5% 1.9% 4.1% 4.8% 6.1% 5.9% 3.9%
Hallucinogens 1.4% 1.7% 3.8% 4.3% 4.9% 3.9% 3.2%
Cocaine 1.5% 1.8% 3.8% 3.5% 4.0% 2.9% 2.9%
Steroids 2.2% 2.4% 3.3% 3.2% 2.2% 1.9% 2.6%
Opiates 1.6% 1.9% 3.5% 3.0% 2.9% 1.6% 2.4%
Any illicit drug 12–15: 15.0% 16–17: 33.0% 20.0%
Any illicit drug 
ex. cannabis 12–15: 7.0% 16–17: 12.0% 8.0%
D
rug detection and screening program
s
17
Table 7: Changes in prevalence of use — of lifetime use of drugs, use of drugs 
in the last month, and use of drugs in the last week, 1996–2005
(Source: White & Hayman, 2006a; 2006b; 2006c)
1996 1999 2002 2005
Lifetime
Alcohol 90%** 90%** 87%**
Smoking 52%** 46%** 35%**
Tranquillisers 19%** 18%** 16%** 15%**
Cannabis 35%** 29%** 25%** 18%**
Hallucinogens 8%** 7%** 4%** 3%**
Amphetamines 6%** 7%** 7%** 5%**
Opiates 4%** 4%** 3%** 2%**
Cocaine 4%** 4%** 3%** 3%**
Ecstasy 4%** 4%** 5%** 4%**
Any illicit drug 36%** 32%** 27%** 20%**
Any illicit drug ex. cannabis 12%** 13%** 11%** 8%**
Month
Alcohol 51%** 52%** 45%**
Smoking 23%** 16%** 12%**
Tranquillisers 5%** 4%** 4%** 4%**
Cannabis 18%** 14%** 11%** 7%**
Hallucinogens 3%** 2%** 2%** 1%**
Amphetamines 2%** 3%** 3%** 2%**
Opiates 1%** 1%** 1%** 1%**
Cocaine 1%** 1%** 1%** 1%**
Ecstasy 1%** 2%** 2%** 2%**
Any illicit drug 19%** 15%** 13%** 8%**
Any illicit drug ex. cannabis 4%** 5%** 4%** 4%**
Week
Alcohol 36%** 37%** 30%**
Smoking 19%** 13%** 9%**
Tranquillisers 3%** 2%** 2%** 2%**
Cannabis 11%** 8%** 7%** 4%**
** significantly different from 2005 at p<0.01
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The patterns of lifetime, monthly and weekly 
drug use by school-aged children examined 
over time are shown in Table 7 with data 
from the ASSAD surveys conducted in 1996, 
1999, 2002 and 2005. White and Hayman 
(2006a; 2006b; 2006c) presented analyses 
examining whether changes over time were 
statistically significant.
The lifetime, monthly and weekly prevalence 
of use of alcohol and tobacco in 2005 was 
found to be significantly lower (p<0.01) 
than in previous years. Among the illicit 
substances, level of lifetime, monthly and 
weekly use in 2005 was significantly lower 
(p<0.01) for all drug groups.
Although similar data were not presented for 
inhalants and steroids, the ASSAD research-
ers advised that the prevalence of lifetime 
and monthly inhalant use had decreased, 
while the prevalence of steroids use had not 
changed since 1996 (Table 7).
This trend over time is also found in the 
National Drug Strategy Household Survey 
data (Australian Institute of Health and Wel-
fare, 2005), which show decreases from 1998 
to 2004 in use of any illicit drug use in the 
last 12 months among 14–19 year old males 
(1998: 38.2%; 2004: 20.9%) and females 
(1998: 37.1%; 2004: 21.8%). This is further 
broken down by age in Table 8 and Table 9 
for 12–15 and 16–17 year olds, respectively 
(White & Hayman, 2006a; 2006b; 2006c).
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Table 8: Changes in prevalence of use — of lifetime use of drugs, use of drugs in the 
last month, and use of drugs in the last week, 1996–2005, for 12–15 year olds
1996 1999 2002 2005
Lifetime
Alcohol 87%** 86%** 82%
Smoking 47%** 40%** 29%
Tranquillisers 19%** 17%** 16% 15%
Cannabis 28%** 23%** 19%** 13%
Hallucinogens 6%** 5%** 4%** 3%
Amphetamines 5%** 6%** 5%** 4%
Opiates 4%** 4%** 3%** 3%
Cocaine 4%** 3%** 3%** 3%
Ecstasy 3%** 3%** 4%** 4%
Any illicit drug 30%** 26%** 22%** 15%
Any illicit drug ex. cannabis 10%** 11%** 9%** 7%
Month
Alcohol 43%** 43%** 34%
Smoking 19%** 14%** 9%
Tranquillisers 5%** 4%** 4%** 4%
Cannabis 15%** 11%** 9%** 6%
Hallucinogens 2%**  2%** 2%**  1%
Amphetamines 2%** 2%** 2%** 2%
Opiates 1%** 1%** 1%** 1%
Cocaine 1%** 1%** 1%** 1%
Ecstasy 1%** 1%** 2%** 2%
Any illicit drug 16%** 13%** 10%** 7%
Any illicit drug ex. cannabis 4%** 4%** 4%** 3%
Week
Alcohol 28%** 29%** 22%
Smoking 15%** 11%** 7%
Tranquillisers 3%** 2%** 2%** 2%
Cannabis 9%** 7%** 5%** 4%
** significantly different from 2005 at p<0.01
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Table 9: Changes in prevalence of use — of lifetime use of drugs, use of drugs in the 
last month, and use of drugs in the last week, 1996–2005, for 16–17 year olds
1996 1999 2002 2005
Lifetime
Alcohol 94% 94% 95%
Smoking 69%** 63%** 52%
Tranquillisers 20%** 22%** 18% 17%
Cannabis 52%** 46%** 39%** 31%
Hallucinogens 14%** 11%** 6% 5%
Amphetamines 9% 11%** 10% 8%
Opiates 4%** 5%** 3% 2%
Cocaine 3% 4% 4% 4%
Ecstasy 5% 6% 7% 6%
Any illicit drug 53%** 48%** 41%** 33%
Any illicit drug ex. cannabis 17%** 18%** 15%** 12%
Month
Alcohol 70% 68% 68%
Smoking 35%** 28%** 22%
Tranquillisers 5%** 5%** 5%** 4%
Cannabis 27%** 20%** 17%** 12%
Hallucinogens 4%** 3%** 2% 1%
Amphetamines 3% 4% 3% 3%
Opiates 1% 1% 1% 1%
Cocaine 1% 1% 1% 1%
Ecstasy 1%** 3% 2% 2%
Any illicit 28%** 21%** 19%** 13%
Any illicit ex. cannabis 6% 6%** 5% 4%
Week
Alcohol 51% 48% 47%
Smoking 30%** 23%** 17%
Tranquillisers 3% 3% 3% 2%
Cannabis 17%** 12%** 10%** 6%
** significantly different from 2005 at p<0.01
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parent in the preceding tables, secondary 
analyses were conducted for this project to 
identify regular use patterns. Regular use was 
defined as using a particular drug 10 or more 
times in the last year (Table 10).
When the data on school students’ preva-
lence of drug use are examined in this way, 
it becomes apparent that regular use (i.e. 
defined as having used a particular substance 
more than 10 times in the last year) occurs 
among a very small proportion of the school 
student population. The drug mostly used 
on a regular basis is cannabis, but even here 
it is regularly used by under 4 per cent of 
the total school student population. Regular 
use of other illicits was below the 1 per cent 
level. Low levels of use present challenges 
for any detection devices and strategies and 
necessitate higher levels of testing sensitivity 
(see Section 4.2.4.).
These data are relevant to the current exami-
nation of drug testing in schools and they 
have important implications for the accu-
racy and efficacy of any tests that might be 
undertaken to attempt to detect use. For 
accuracy and efficacy, tests require a certain 
level of prevalence to allow the tests to be 
able to detect the presence of drug use.
Table 10: Mean frequencies of use and percentage of students aged 12–17 
using regularly (defined as 10 or more times in the last year)
Substance
Mean frequency 
of use in 
last year (SD)
Percentage of 
users using 
regularly 
Percentage of all 
students using 
regularly
Cannabis 5.2 (5.9) 24.1% 3.4%
Inhalants 3.9 (4.2) 13.4% 1.7%
Cocaine 3.7 (4.4) 20.2% 0.4%
Hallucinogens 8.7 (12.9) 19.0% 0.5%
Amphetamines 4.5 (5.1) 22.3% 0.9%
Ecstasy 4.4 (5.3) 18.9% 0.6%
Tranquillisers 3.8 (4.3) 9.9% 0.9%
Opiates 3.4 (4.4) 17.7% 0.3%
Steroids 5.0 (5.9) 24.4% 0.5%
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4.1.2 High-risk groups
There is clear evidence that social and eco-
nomic disadvantage is associated with the 
misuse of alcohol and other drugs. As Wilkin-
son and Marmot (2003) highlighted in their 
examination of the social determinants of 
health conducted for the World Health Or-
ganization, alcohol dependence, illicit drug 
use and cigarette smoking are all closely 
asso ciated with markers of social and eco-
nomic disadvantage.
Evidence from various sources indicates that 
young people are at differential risk for devel-
oping alcohol or other drug problems. The 
following data are from secondary analyses 
of the ASSAD data undertaken specifically 
for this project to examine patterns of use 
by potentially high-risk groups.
Prevalence of use of illicit drugs by non-
 Indigenous schoolchildren compared to In-
digenous students was compared and the 
data are shown in Table 11. Indigenous school 
students used all illicit substances at a sig-
nificantly greater level than non- Indigenous 
students. In some instances, the level of use 
was almost double (see, for example, cannabis 
15% vs 28%, amphetamines 4% vs 12%, and 
tranquillisers 9% vs 17%).
Table 11: Percentage of non-Indigenous (n = 20 712) and 
Indigenous (n = 881) students using each drug in the last year
Substance  
(use in last year)
Percentage of 
non-Indigenous 
students
Percentage of 
Indigenous 
students
Design-based F 
(df1, df2 = 1, 371)
Cannabis 15.2% 28.2% 100.5*** 
Inhalants 11.8% 19.7% 40.9*** 
Cocaine 2.0% 7.4% 85.5***
Hallucinogens 2.3% 8.5% 107.5***
Amphetamines 4.2% 11.9% 89.2***
Ecstasy 3.0% 8.5% 61.3***
Tranquillisers 8.8% 17.3% 58.4*** 
Opiates 1.5% 7.7% 169.8***
Any drug 28.2% 38.7% 45.6***
Notes:
df = degrees of freedom
*** p<0.001
‘Any drug’ refers to use of any of the drugs appearing in this table.
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Table 12 shows the prevalence of drug use 
over the last year among students who spoke 
a language other than English at home com-
pared to students who spoke English at home. 
Overall rates of drug use were not significantly 
different between students who spoke English 
at home and students who spoke a language 
other than English at home. However, the 
pattern of use for these two groups of school 
students is quite different.
Students who spoke a language other than 
English at home were significantly more likely 
to have used inhalants, cocaine, ecstasy and 
opiates but significantly less likely to have 
used cannabis and tranquillisers. Other varia-
tions in patterns of use may reflect different 
ethnic backgrounds and circumstances.
Table 12: Percentage of students who speak English at home (n = 18 761) and students who 
speak a language other than English at home (n = 2985) using each drug in the last year
Substance  
(use in last year)
Students speaking 
English at home
Other language 
spoken at home
Design-based F 
(df1, df2 = 1, 371)
Cannabis 16.3% 12.1% 21.9***
Inhalants 11.4% 16.0% 28.9***
Cocaine 2.0% 3.3% 18.1***
Hallucinogens 2.5% 2.8% 0.4
Amphetamines 4.4% 4.8% 0.9
Ecstasy 3.1% 4.2% 8.1**
Tranquillisers 9.4% 7.7% 9.0**
Opiates 1.6% 2.4% 8.4**
Any drug 28.7% 27.8% 0.8
Notes:
df = degrees of freedom
** p<0.01
*** p<0.001
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Prevalence of drug use over the last year 
by level of self-reported academic perform-
ance was also examined (Table 13). Academic 
performance levels were grouped according 
to above-average performance, average per-
formance and below-average performance. 
Across all illicit drug types there was a statis-
tically significantly higher level of drug use 
among the below-average academic perform-
ers compared to average or above-average 
academic performers. Differential levels of 
drug use were in the order of two to three 
times greater among below-average perform-
ers compared to above-average students.
Table 13: Percentage of students using each drug in the last year 
according to self-reported academic performance
Substance  
(use in last year)
Above-average 
performance 
(n = 9047)
Average 
performance 
(n = 11 254)
Below-average 
performance 
(n = 1386)
Design- 
based F1
Cannabis 11.6% 17.2% 31.1% 177.5***
Inhalants 9.8% 13.0% 20.9% 63.3***
Cocaine 1.8% 1.9% 7.0% 75.9***
Hallucinogens 2.2% 2.3% 7.3% 61.3***
Amphetamines 3.3% 4.6% 11.5% 92.4***
Ecstasy 2.6% 3.1% 8.8% 62.0***
Tranquillisers 7.6% 9.4% 18.0% 71.7***
Opiates 1.2% 1.7% 5.1% 56.5***
Any drug 23.2% 30.8% 45.8% 160.7***
Notes:
1 df1 = 2, df2 ranged from 712 to 741
*** p<0.001
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Prevalence of illicit drug use was also exam-
ined by self-reported disposable income (see 
Table 14). With the exception of inhalants, 
which may not involve the same cost issues 
as other illicit drugs, children with more dis-
posable income available to them each week 
were heavier users of the full range of illicit 
drugs compared to schoolchildren with less 
disposable income.
Age is likely to be a strong confounder in 
this analysis. Older students are more likely 
to have more disposable income and they are 
also more likely to use illicit drugs. To sepa-
rate out the influence of age and disposable 
income, a logistic regression analysis was run 
with any drug use in the last year as the de-
pendent variable (Table 14). After controlling 
for age, gender and school type (government, 
Catholic or independent), disposable income 
remained a significant predictor of drug use, 
with students with $21–$60 to spend each 
week 1.6 times (p<0.001, 95% CI = 1.5–1.8) 
more likely to have used any drug in the last 
year than students with $0–$20 to spend 
each week. Students with more than $60 to 
spend each week were 1.9 times (p<0.001, 
95% CI = 1.7–2.0) more likely to have used 
any drug in the last year than students with 
$0–$20 to spend each week.
Expulsion data
Data collected through the ASSAD surveys 
would not include students who have been 
expelled (for any reason including drug use) 
as they would no longer form part of the 
school population available to participate in 
the surveys. Hence, available expulsion data 
were examined to establish the prevalence 
of expulsion of students related to their 
drug use. Expulsion data could be found 
only for Tasmania and New South Wales. 
In Tasmania in 2005, there were only two 
expulsions, neither for drug use (Tasmania 
Office for Educational Review & Department 
Table 14: Percentage of students using each drug in the last year 
according to amount of disposable income per week
Substance  
(use in last year)
$0–$20 
(n = 11 756)
$21–$60 
(n = 5823)
$61+ 
(n = 4117)
Design- 
based F1
Cannabis 8.8% 21.2% 27.6% 419.0***
Inhalants 12.0% 12.8% 11.5% 1.7
Cocaine 1.2% 2.7% 4.2% 67.1***
Hallucinogens 1.5% 3.1% 5.0% 71.1***
Amphetamines 2.5% 5.7% 8.4% 123.5***
Ecstasy 1.4% 4.3% 7.0% 148.6***
Tranquillisers 6.9% 11.2% 12.6% 75.2***
Opiates 1.1% 1.9% 3.3% 43.7***
Any drug 22.6% 34.0% 38.4% 216.4***
Notes: 
1 df1 = 2, df2 ranged from 721 to 738
*** p<0.001
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of Education, 2005). There were 217 expul-
sions for misbehaviour in New South Wales 
in 2006 (New South Wales Department of 
Education and Training, 2006). This is not 
broken down by reason for expulsion, but for 
suspensions, 3 per cent were related to illicit 
drug use. If this is the same proportion for 
expulsions, then approximately seven expul-
sions were due to illicit drugs. Hence, the 
limited available data do not indicate high 
levels of drug-related expulsions.
4.1.3 Principal aims of drug 
detection and screening
There are three principal aims underlying the 
use of drug detection and screening pro-
grams in schools:
to deter initiation of drug use and encour-•	
age cessation, i.e. to reduce incidence and 
prevalence of drug use in young people
to detect users, i.e. to refer them to treat-•	
ment or counselling
to reduce drug-related harm, i.e. to im-•	
prove young people’s physical and psy-
chological wellbeing; reduce truancy and 
substance-related behavioural problems; 
and improve educational outcomes.
Deterrence theories generally assume that 
individuals weigh up the rewards versus 
costs of engaging or not engaging in risky 
activities before making a rational choice. 
Perceptions of deterrence differ across age 
and gender, with younger people, especially 
males, being least likely to believe that 
they will get caught using drugs (Marlowe, 
 Festinger, Foltz, Lee & Patapis, 2005). The 
guiding principle for including sanctions or 
punishment in response to infringements 
is that offenders will be discouraged from 
repeating the infraction. However, it is also 
possible that offenders will succumb to the 
‘gambler’s fallacy’,3 believing that they would 
be very unlikely, or unlucky, to be caught 
again. Some research evidence suggests that 
the least experienced and/or most impul-
sive individuals (i.e. young people) are more 
likely to hold this belief (Pogarsky & Piquero, 
2003). According to deterrence theory, sanc-
tions are seen as a necessary component to 
determining whether a testing program has a 
deterrent effect (Schaub, 2004), yet approxi-
mately 25 per cent of workers surveyed in 
the United States National Household Sur-
vey on Drug Abuse (2000, 2001) reported no 
official penalties or actions associated with a 
positive drug test (Carpenter, 2007).
Before describing the evidence on the effec-
tiveness of drug testing programs, it is useful 
to consider the key assumptions underpin-
ning the rationale for drug testing and how 
it may apply to school-aged children. A re-
cent United Kingdom report discussed three 
sets of assumptions in detail (McKeganey, 
2005) and the key points are described in 
Table 15.
The incorrect belief that the likelihood of a random event can be affected by, or predicted from, 3 
other independent events (Gambler’s fallacy, 2007). That is, if an individual has been caught and 
punished for using drugs, they incorrectly believe they will have less chance of being caught the 
next time they use drugs.
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Table 15: Main assumptions underlying the rationale for drug testing
Assumptions Limitations
Criminological theory and 
the power of surveillance
Surveillance is used as a 
tool for social control. 
If their behaviour is open 
to scrutiny, young people 
will avoid deviant acts 
(Foucault, 1980).
Surveillance alone is inadequate unless accompanied by:
social consensus about what defines deviant behaviour •	
Drug testing will reduce drug use only if young 
people believe they will experience stigma or negative 
consequences of their drug use if discovered. 
Individuals with pro-drug attitudes and little respect 
for societal norms are less likely to reduce drug use 
and may view a positive drug test as status.
capacity to apply negative sanctions or punishment •	
Without a negative sanction (e.g. exclusion, 
punishment from parents), drug testing is unlikely 
to deter future use. For example, athletes may view 
exclusion from competition as undesirable, but 
schoolchildren may welcome exclusion from classes.
capacity to handle concealment (e.g. masking) •	
Individuals may use masking agents, avoid providing 
a sample (e.g. absence from school if they expect to 
be tested), or switch to less detectable, and potentially 
more harmful, drugs or alcohol.
Early identification and 
intervention
Identification of drug use at 
an early stage may reduce 
the likelihood of developing 
into a drug ‘problem’.
Teenage drug use does not lead inevitably to problematic 
drug use.
While screening is sensible for health issues that •	
predictably lead to deterioration (e.g. cancers), this is 
not so for teenage drug use. The relevance of early 
identification applies only to a very small number of 
students (see section 4.1.3). 
Capacity to bolster 
resistance to drugs
Drug testing programs give 
students a reason to say 
‘No’ when they encounter 
drug use.
Routes to drug use differ.
Not all young people are pressured by their peers to •	
start using drugs. Young people may also select their 
friends on the basis of similar interests, including 
drug-using behaviour. 
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In addition, it is important to be aware of 
what drug testing does not aim to achieve. 
That is, drug tests cannot:
provide a direct or reliable measure of •	
intoxication or impairment
determine how much, how often or under •	
what circumstances a drug was used (e.g. 
passive ingestion of cannabis)
distinguish between experimental, occa-•	
sional or one-off users and those with 
problematic drug use
distinguish between similar metabolites •	
found in over-the-counter or legally pre-
scribed medications and illicit drugs (e.g. 
codeine vs illicit opiates).
While the terms ‘drug detection’ and ‘drug 
screening’ are often used interchangeably, 
they refer to different techniques, which may 
be used under varying circumstances.
Drug screening involves performing a test on 
a population to identify evidence of drug use 
in individuals, in the absence of suspected 
use and for the purpose of early identifica-
tion and treatment (e.g. random testing of 
urine of all students in a particular school, 
grade or group).
Drug detection is a diagnostic or confirma-
tory test performed when the possibility of 
drug use has been identified in a screening 
test or by other means (e.g. analysis of a stu-
dent’s urine where symptoms/signs indicate 
substance use). Drug detection is a term that 
may also be used to describe other strategies, 
such as sniffer dogs, drug searches or other 
drug detecting devices, or questionnaire-
style instruments.
4.1.4 Approaches to drug testing
The characteristics of drug testing programs 
vary substantially according to:
targeted drugs (alcohol, illicit substances, •	
performance-enhancing drugs)
who is tested (all students, student ath-•	
letes, at-risk groups)
sampling strategy (random sampling, all •	
students in target group)
frequency of testing (one-off, regular, •	
occasional, during sports season)
pre-testing information (with/without •	
notice)
degree of privacy and confidentiality •	
observed
response to positive test (opportunity •	
for appeal, rehabilitation/support or 
 exclusion/expulsion)
method of detection •	
detection of drug use i. 
biological material assays (urine, 
saliva, sweat, hair, blood etc) 
survey instruments (self-report 
questionnaires, interviews)
detection of drugs or drug items ii. 
sniffer dogs 
drug searches (person, possessions, 
lockers etc).
D
rug detection and screening program
s
29
4.2 Biometric measures of 
substance use
4.2.1 Drug testing strategies
There are four main drug testing strategies 
that can be utilised to detect drug use among 
school-aged children:
testing the entire school population•	
testing specific groups within the school •	
population
random testing•	
testing for cause.•	
Testing the entire school population involves 
testing all students who attend the school. 
The testing of specific groups involves iden-
tification of particular groups within the 
school population that may be more likely 
to use drugs compared to other groups; for 
example, testing might be restricted to stu-
dents aged 16–18 years old, as this is a group 
identified as at greater risk of drug-related 
harm (Australian Institute of Health and Wel-
fare, 2005). Alternatively, specific groups that 
may be at risk of particular types of drug use 
could be targeted (e.g. school athletes for 
anabolic steroids or performance-enhancing 
drugs). Random testing involves the testing 
of a predetermined proportion of the total 
school population and is usually conducted 
without notice with all students having an 
equal chance of being selected for a test. 
Testing for cause involves the testing of 
individual students where there is physical 
or other evidence of drug use, or where it 
is reasonable to suspect the student(s) may 
be using drugs.
4.2.2 Drug testing methods
Drug testing is a two-stage process. The first 
stage is an initial screen to detect the pres-
ence of a drug. This is then followed by 
a confirmatory test to assess (confirm) the 
accuracy of any initial positive results from 
the screening test. Consistent with Australian 
standards, initial positive screens must be 
confirmed by a validated analytical procedure 
using mass-spectrometry techniques (Stand-
ards Australia, 2001; 2006).
To carry out this two-stage process, two 
methods of drug testing are available:
on-site analysis using Point of Collection •	
Test (POCT) devices, and
laboratory analysis.•	
As most POCT devices use immunoassay 
techniques and are less reliable and accu-
rate than laboratory analysis, POCT devices 
are useful as initial screening tests only. 
However, laboratory testing can be utilised 
for both initial screening and confirmatory 
testing. Apart from this fundamental differ-
ence, POCT devices and laboratory testing 
each have unique advantages and disad-
vantages as a method for detecting drug 
use among school-aged children. These are 
outlined below.
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4.2.2.1 POCT devices
There are a large number of POCT devices 
commercially available in Australia. In general, 
these devices use immunoassay techniques 
and are recommended for use as an initial 
screening test only. While Australian stand-
ards concerning drug testing exist (Standards 
Australia, 2001; 2006), there are no Australian 
standards that specifically relate to POCT 
devices. However, a substantial proportion of 
the devices commercially available in Australia 
have received United States Food and Drug 
Administration approval. 
While some POCT devices reliably give test 
results that are consistent with more sophis-
ticated laboratory testing, there is wide varia-
bility in accuracy and reliability across devices 
(Verstraete & Puddu, 2000a; Verstraete & 
Raes, 2006). In addition, the use of POCT 
devices potentially introduces wide variabil-
ity in the expertise and qualifications of in-
dividuals who may be required to conduct 
on-site tests. This is an important point, as 
research indicates that even medical general 
practitioners can have limited expertise con-
cerning technical and ethical issues related to 
testing (Evans & Thornett, 2003; Levy, Harris, 
Sherritt, Angulo & Knight, 2006).
Advantages
Tests are usually less expensive than lab-•	
oratory testing.
Tests are relatively easy to administer with •	
little training required.
Test results are generally available within a •	
few minutes of the test being conducted.
Disadvantages
Most POCT devices have a lower level of •	
accuracy and reliability compared to lab-
oratory analyses.
The range of drugs that can be detected •	
by most POCT devices is limited (a number 
of devices may be required to test for a 
range of different drugs).
POCT devices cannot distinguish between •	
prescribed drugs or over-the-counter 
medications and illicit drug use.
Most POCT devices do not allow for a •	
permanent record of the raw test results 
to be kept for medical or legal reasons.
Visual display markers utilised by POCT •	
devices vary widely and are subject to 
misinterpretation.
There is increased potential for staff •	
with limited training in drug testing to 
be exposed to health and safety hazards, 
inappropriately conduct the test, or mis-
interpret results.
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4.2.2.2 Laboratory testing
There is also a large number of drug testing 
services that offer laboratory testing; how-
ever, only a few Australian laboratories are 
accredited to Australian standards. Laboratory 
testing can involve a range of immunoassay 
and chromatography methods to detect drug 
use. A detailed description of the different 
types of immunoassay and chromatography 
analysis methods utilised by laboratories 
is available elsewhere (Lu & Taylor, 2006; 
Simpson, Braithwaite,  Jarvie, Stewart, Walker, 
Watson et al., 1997). In general, these meth-
ods give much more reliable and accurate 
results compared to POCT devices.
Advantages
Much more reliable and accurate than •	
testing with POCT devices.
Can detect a much wider range of drugs •	
than POCT devices.
Better able to distinguish between pre-•	
scription or over-the-counter drugs and 
illicit drugs (however, the medical his-
tory of the specimen donor may still 
be required to definitively distinguish 
between some drug types).
Can detect the adulteration or dilution of •	
specimen samples.
Has the ability to store raw data and •	
results of tests for future medical or legal 
access.
Laboratory staff are likely to have more •	
expertise in the conduct of tests and the 
interpretation of test results compared to 
those using POCT devices.
Disadvantages
Laboratory testing is generally more •	
expensive than POCT testing.
Laboratory testing also involves a chain •	
of custody procedure that increases the 
financial and time costs of the testing 
process.
Slower turnaround time for test results •	
compared to testing with POCT devices.
4.2.3 Types of drug tests
Blood testing is considered the ‘gold stand-
ard’ for accuracy and reliability, but for a 
variety of reasons it is not suitable for the 
detection of drugs that might be used by 
school-aged children. In particular, blood 
testing is an invasive medical procedure that 
can pose a health and safety risk to both 
donor and collector. Blood testing is not 
discussed further in this report. Apart from 
blood tests, there is a range of other differ-
ent types of tests that may be suitable for 
the detection of drugs used by school-aged 
children including:
urine•	
saliva•	
hair•	
sweat tests.•	
Differences between urine, saliva, hair and 
sweat tests, together with the advantages 
and disadvantages of each test, are briefly 
outlined below.
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4.2.3.1 Urine
Urinalysis is the most frequently used and 
most researched type of drug test currently 
conducted in workplace, clinical and custo-
dial settings. Donors are usually required to 
produce a urine sample, delivered directly 
into a sterile tamper-proof container. While 
Australia standards (Standards Australia, 
2001) allow for the physical observation of 
the urine being passed into the collection 
device, in most cases donors are allowed 
to produce the specimen in a private toi-
let cubicle. However, donors are supervised 
entering and leaving the cubicle and water 
in the toilet cistern and bowl is dyed to pre-
vent sample dilution. Urinalysis is the least 
expensive of all drug test types, whether 
conducted using a POCT device or in the 
laboratory. For most drug types, it can detect 
use that has occurred up to three days prior 
to the test. One exception to this is can-
nabis use, in which case occasional use can 
be detected up to six days prior to the test, 
while for regular use the window of detec-
tion can increase to several weeks.
Advantages
Relatively inexpensive compared to other •	
test types.
Most widely researched test type.•	
Sufficient quantities of specimen sample •	
can be obtained for confirmatory analysis 
and retesting.
A substantial number of Australian lab-•	
oratories have expertise in urinalysis.
The accuracy and reliability of test results •	
from some urinalysis POCT devices are 
similar to laboratory analysis.
Higher concentrations of drug metabo-•	
lites4 are present in urine compared to 
other types of specimen samples, mak-
ing detection of drug use more likely in 
urinalysis compared to some other test 
types.
Australian standards for specimen col-•	
lection, detection and quantification of 
drugs in urine exist (Standards Australia, 
2001).
Disadvantages
Other than for cannabis use, the window •	
of detection provided by urinalysis is rela-
tively short compared to some other test 
types (e.g. hair and sweat).
The supervised collection of urine can •	
be an invasive and disturbing process, 
especially for children and young ado-
lescents.
Collection facilities that maintain donor •	
privacy and comfort need to be pro-
vided.
Good quality POCT devices can be more •	
expensive than laboratory urinalysis.
Dilution, adulteration or substitution of •	
urine samples is more easily achieved 
compared to other specimen samples.
Can be time-consuming if the donor can-•	
not readily provide a sample or is required 
to produce a second sample.
Metabolites are chemical compounds created as a drug is activated or deactivated by internal 4 
chemical processes after ingestion. In some cases, very little of the actual (parent) drug is evident 
in biological samples; however, recent use can be determined by the presence of drug metabolites.
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4.2.3.2 Saliva/oral fluid testing
Saliva testing is a relatively new technol-
ogy that is increasing in popularity as a less 
invasive form of testing compared to urin-
alysis. Saliva samples are usually collected 
from inside the donor’s mouth by use of a 
swab or pipette. However, while less inva-
sive than urinalysis, the collection of saliva 
is not without problems. Given the rela-
tively small amounts of saliva present in the 
mouth, the collection of sufficient quanti-
ties for confirmatory analysis or retesting 
can be problematic. While more saliva can 
be generated by stimulation (e.g. the chew-
ing of gum), this alters the pH level of the 
saliva collected, which in turn can influ-
ence the test result. In addition, a number 
of relatively recent evaluations have con-
cluded that saliva POCT devices are limited in 
their ability to detect cannabis use (Crouch, 
Walsh, Flegel, Cangianelli, Baudys & Atkins, 
2005;  Verstraete & Raes, 2006; Walsh, Flegel, 
Crouch, Cangianelli & Baudys, 2003) and 
cannabis is the illicit substance most likely to 
be used by school-aged children (Australian 
Institute of Health and Welfare, 2005).
Advantages
Specimen collection process is less inva-•	
sive than urine specimen collection.
Specimen is available immediately.•	
Collection of sample is more easily super-•	
vised which reduces the opportunity for 
specimen substitution, dilution or adul-
teration.
Higher concentrations of the parent drug •	
in saliva compared to urine allow for more 
reliable identification of drug type.
There are Australian standards for speci-•	
men collection, detection and quan-
tification of drugs in saliva (Standards 
Australia, 2006).
Disadvantages
Can be difficult to collect sufficient sam-•	
ple quantities for subsequent confirmatory 
analysis or retesting.
The window of detection for saliva tests •	
is much shorter (12–24 hours) than for 
other test types.
Oral contamination (e.g. eating or drink-•	
ing) can adulterate or dilute the sample.
Due to the risk of oral contamination, •	
donors need to be supervised for up to 30 
minutes prior to sample collection.
May have a limited ability to detect some •	
drug types (e.g. cannabis).
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4.2.3.3 Hair testing
While hair analysis is not new, hair testing 
to detect drug use is not used as frequently 
as urine or saliva analysis. Hair testing in-
volves the analysis of samples of hair strands, 
usually taken from the donor’s scalp. While 
research on the issue is sparse, it appears 
that the time it takes for drug use to be de-
tectable in human hair varies from one to 
seven days according to drug type (Wennig, 
2000). The main advantage of hair analysis 
is the relatively long window of detection 
offered. While there is wide inter-individual 
variability, human hair usually grows at the 
rate of 1 cm per month (Wennig, 2000) and 
while different models have been proposed 
to explain how drugs are incorporated into 
hair, it is generally accepted that, as drugs 
are used, evidence of use is permanently en-
capsulated within the hair shaft (Wennig, 
2000). Theoretically, and depending on the 
length of hair being analysed, a history of 
drug use can be determined for months or 
even years prior to the test. However, as hair 
strands of 2–3 cm, cut close to the scalp, are 
normally taken for hair analysis, the window 
of detection is usually limited to 60–90 days 
prior to the test.
Advantages
Provides a long window of detection com-•	
pared to other tests.
Relatively non-invasive compared to urine •	
testing.
Less sample storage and transportation •	
problems compared to urine, saliva and 
sweat specimen samples.
Sufficient quantities of hair specimen •	
samples can be readily obtained for con-
firmatory analysis and retesting.
Hair sample substitution is more difficult •	
to achieve compared to urine or saliva 
samples.
Disadvantages
No POCT devices for hair analysis are cur-•	
rently available.
Few laboratories with expertise in hair •	
analysis exist in Australia.
Cannot detect recent drug use (i.e. use in •	
the hours/days prior to the test).
More expensive compared to urine and •	
saliva analysis.
Difficult to detect low levels of drug use •	
(e.g. single episodes of use or very occa-
sional use).
Test can be easily evaded (e.g. shave •	
hair).
The use of hair treatments and differ-•	
ences in hair colour and hair structure 
can make test results difficult to interpret 
(Wennig, 2000).
Hair is susceptible to environmental/•	
passive drug contamination (Romano, 
Barbera & Lombardo, 2001).
At present, there are no commercial Aus-•	
tralian laboratories that offer hair analysis 
services.
No Australian standards exist for specimen •	
collection, detection and quantification 
of drugs in hair.
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4.2.3.4 Sweat testing
Sweat testing is a relatively new technol-
ogy that can utilise two approaches to drug 
detection. The first is aimed at the detection 
of recent use and involves the collection of 
a sample of sweat at one point in time with 
the use of a swab, an analysis of which can 
detect drug use up to 48 hours prior to the 
test. The second approach, which is more 
commonly used, is aimed at monitoring drug 
use that may occur over a predetermined 
time period. This approach involves applying 
an adhesive patch to the donor’s skin for up 
to seven days. During this time, any drugs 
excreted by sweat are collected and stored in 
the patch. The patch is subsequently removed 
from the donor and analysed. Sweat patches 
are particularly useful for detecting low lev-
els of drug use (e.g. single episodes of use). 
However, there is some evidence to indicate 
this may lead to unacceptably high levels of 
false positives (Levisky, Bowerman, Jenkins, 
Johnson, Levisky & Karch, 2001). There is 
also some evidence indicating the ability of 
sweat patches to detect single episodes of 
use may decline the longer the patch is worn 
(Pichini, Navarro, Pacifici, Zaccaro, Ortuno, 
Farre et al., 2003; Uemura, Nath, Harkey, 
Henderson, Mendelson & Jones, 2004).
Advantages
Sweat collection is less invasive than urine •	
collection (although sweat patches need 
to be worn continually for up to seven 
days).
Sweat patches can allow for continuous •	
monitoring over a period of time and 
thus provide a longer window of detec-
tion than urine and saliva analysis.
Sweat patches are easily applied and •	
removed with little training required.
It is difficult to substitute sweat specimen •	
samples and sweat patches are relatively 
tamper-proof.
Sweat patches can detect low levels of •	
use (e.g. single episodes of use or very 
occasional use).
Disadvantages
Very few POCT devices exist.•	
No commercial laboratories with expertise •	
in sweat analysis exist in Australia.
More expensive compared to urine and •	
saliva analysis.
The necessity to store sweat specimens •	
at a very low temperature creates storage 
and transportation problems.
Sweat patches are susceptible to environ-•	
mental contamination prior to application 
and during use (Kidwell & Smith, 2001).
Sweat patches can be easily adulterated or •	
contaminated by accidental or deliberate 
removal during the monitoring period.
Sweat patch tests can be evaded by refrain-•	
ing from drug use during the monitoring 
period and returning to use after the patch 
is removed.
Sweat testing is a relatively under-researched•	  
technology compared to urine, saliva and 
hair testing.
Positive test results need to be confirmed by •	
a different test type (usually urin alysis).
No Australian standards exist for specimen •	
collection, detection and quantification of 
drugs in sweat.
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Table 16: A summary of specific issues related to drug tests: 
a comparison of four biological specimens
Issue Urine Saliva Hair Sweat
Level of invasiveness High Low Low Low
Window of detection Up to 3 days1 Up to 48 hours 7–90 days2 Up to 7 days3
Environmental 
contamination risk
Low Low High Medium
Sample adulteration/
dilution risk
Medium Medium Medium Medium
Sample substitution risk Medium Low Low Low
Collection difficulty High Low Low Low
Sample storage/
transportation difficulty
Medium Medium Low High
Availability of POCT 
devices
High High N/A Limited
Availability of 
Australian laboratories
High Medium N/A N/A
Applicable Australian 
standards
Yes Yes No No
Cost: POCT device4 Low Low N/A Low/medium
Cost: laboratory screen4 Low Medium High Low/medium
Cost: laboratory 
confirmation4
Low/medium Medium/high High Low/medium
Notes:
1 Window of detection for cannabis use can be up to several weeks depending on frequency of use.
2 Window of detection for recent use may vary according to drug type from 1 to 7 days.
3 Sweat patches do not detect past use, rather they monitor drug use that occurs while the patch 
is worn.
4 For more detailed information on costs, refer to section 4.2.5.
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4.2.4 Effectiveness of drug 
detection and screening programs
Consideration of the implementation of drug 
detection or screening strategies among 
school-aged children requires close exami-
nation of a range of factors. A key factor is 
the efficacy of the range of drug tests that 
are currently available.
The assessment of how good or reliable a 
particular drug testing technique is involves 
a number of different technical calcula-
tions. Each of these different calculations 
gives information about different aspects 
of the test. It is important to be familiar 
with these technical calculations and what 
they are attempting to assess and how this 
informs the determination of how good a 
test is and how useful, or otherwise, it might 
be in the school setting.
For any drug test on a given population 
sample, there are four potential outcomes 
(see Table 17).
a true positive (a drug is detected and a (a) 
drug is present)
a false positive (a drug is detected, but (b) 
no drug is present)
a false negative (no drug is detected, but (c) 
a drug is present)
a true negative (no drug is detected and (d) 
no drug is present).
Table 17: Possible outcomes of a drug test
Drug present?
YES NO
Drug 
detected?
YES True 
Positives 
(a)
False 
Positives 
(b)
NO False 
Negatives 
(c)
True 
Negatives 
(d)
An ideal test accurately measures what it 
is supposed to measure. That is, an ideal 
test indicates use of drugs when drugs have 
been taken (true positive) and shows no use 
of drugs when drugs have not been taken 
(true negative). The higher the proportions 
of the true positives and true negatives the 
better the test. The ability of any test to 
accurately detect drug use is determined by 
three criteria — sensitivity, specificity, and 
accuracy. Each of these three key criteria is 
explained below.
In summary, there is a range of drug testing 
strategies that could be utilised to detect 
drug use among school-aged children, 
including testing the entire school popula-
tion, testing specific groups within the school 
population, random testing, and ‘for cause’ 
testing. The choice of strategy would largely 
depend on the needs and resources of indi-
vidual schools. Regardless of which strategy 
is chosen, initial screening tests could be 
conducted using POCT devices; however, any 
positive test would need to be confirmed by 
subsequent laboratory analysis. There is also 
a range of different test types that can be 
utilised including urine, saliva, hair and sweat 
analysis. Each of these tests has advantages 
and disadvantages. A summary of the main 
issues associated with the different types of 
tests is outlined opposite in Table 16.
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4.2.4.1 Sensitivity
Sensitivity refers to how good a test is at correctly identifying people who use drugs. Sen-
sitivity is calculated as the number of true positives detected by the test, expressed as a 
percentage of all actual positive cases (both true positives and false negatives) and can be 
described algebraically as:
Sensitivity (%) =
  true positives (a)
 true positives (a) + false negatives (c)
For example, of 100 samples that are known to contain drugs, a test that correctly classi-
fies 90 samples as positive for drugs (true positives) and incorrectly classifies 10 samples as 
negative for drugs (false negatives) would have a sensitivity of 90 per cent.
i.e.  90 (a) 
=
 90 
= 90%
 90 (a) + 10 (c)  100
4.2.4.2 Specificity
Sensitivity, however, is only one criterion for a test’s efficacy. Not only is it important for a 
test to be able to correctly identify those that have used drugs (in this context), it is equally 
important that it can distinguish between those who have used drugs and those who have 
not used drugs. This is called specificity.
Specificity refers to how good the test is at identifying people who do not use drugs. Speci-
ficity is the number of true negatives detected by the test, expressed as a percentage of all 
actual negative cases (both true negatives and false positives), and can be described alge-
braically as:
Specificity (%) =
  true negatives (d)
 true negatives (d) + false positives (b)
For example, of 100 samples that are known not to contain drugs, a test that correctly clas-
sifies 90 samples as negative for drugs (true negatives) and incorrectly classifies 10 samples 
as positive for drugs (false positives) would have a specificity of 90 per cent.
i.e.  90 (d) 
=
 90  
= 90%
 90 (d) + 10 (b)  100
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The sensitivity, specificity and accuracy of 
any test can vary greatly and are depend-
ent on various conditions and circumstances. 
To ensure appropriate, rigorous and accu-
rate tests are used, standards concerning 
acceptable levels of sensitivity, specificity 
and accuracy need to be set. Evaluations 
of the effectiveness of various test devices, 
such as those outlined below, have gener-
ally established minimum acceptable levels 
for different drug testing settings as: ≥ 90% 
sensitivity, ≥ 90% specificity, and ≥ 95% 
accuracy (Verstraete & Puddu, 2000a).
Further consideration should be given to 
whether these minimum acceptable levels are 
adequate for the testing of children in school 
settings. For instance, a specificity level of 
90 per cent that accepts a false positive error 
rate of 10 per cent, or one in ten, may be 
unacceptable in the school setting. If tests 
with a specificity level of 90 per cent are 
acceptable, mechanisms would need to be 
in place to cope with the consequences of 
false positives. Falsely accusing a child of 
illicit drug use may have legal, social and 
psychological sequelae.
False positives can result from the test 
detecting a legal substance that is chemically 
similar to the target drug (e.g. over-the-
counter or prescribed medications). For 
example, codeine, like all opioids, metabo-
lises to morphine and most drug tests cannot 
distinguish between codeine and other opi-
oids (such as heroin) that also metabolise to 
morphine. Other factors that can contrib-
ute to false positives include environmental 
4.2.4.3 Accuracy
The third key criterion is accuracy. Accuracy is an indicator of how good a test is overall, 
taking into account the sensitivity and specificity of the test. Accuracy is determined by the 
number of tests conducted where drug use was correctly detected expressed as a percent-
age of all test results. It can be described algebraically as:
Accuracy (%) =
  true positives (a) + true negatives (d)
 true positives (a) + false positives (b) + false negatives (c) + true negatives (d)
For example, from 100 samples, a test that correctly classifies 10 samples as positive for 
drugs (true positives), correctly classifies 80 samples as negative for drugs (true negatives), 
and incorrectly classifies 10 samples as being positive or negative (false positives or false 
negatives) would have an accuracy of 90 per cent.
i.e. 10 (a) + 80 (d) 
=
 90  
=  90%
 10 (a) + 5 (b) + 5 (c) + 80 (d)   100
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contamination at the time of the test, passive 
drug exposure,5 poor interpretation of test 
results, poor quality testing, or test device/
method error or malfunction. False negatives 
can result from sample adulteration or sub-
stitution, poor interpretation of test results, 
poor quality testing, or test device/method 
error or malfunction.
While sensitivity, specificity and accuracy are 
indicators of a test’s efficacy in detecting 
drug use, there is a range of other factors 
that can influence the efficacy, usefulness 
and appropriateness of drug tests. A posi-
tive test merely indicates that a drug, or drug 
metabolite,6 is present at or above a desig-
nated cut-off level.7 While a positive test 
may indicate that a drug/drug metabolite 
is present at a designated cut-off level, it 
cannot determine dose level, time of use, 
frequency of use, or degree of impairment. 
In contrast, a negative test does not nec-
essarily mean that the person tested has 
not used drugs. For example, a drug/drug 
metabolite may be detected which is below 
the cut-off level. Alternatively, use may have 
occurred at a time outside the test’s window 
of detection.
4.2.4.4 The effectiveness of POCT devices in 
detecting drug use
Evidence concerning the effectiveness of 
urine and saliva POCT devices in detect-
ing drug use is mixed. While some studies 
have concluded that urine and saliva devices 
are effective (Crouch et al., 2005; Moody, 
Fang, Andrenyak, Monti & Jones, 2006; 
Peace,  Tarnai & Poklis, 2000; Walsh, Crouch, 
 Danaceau, Cangianelli, Liddicoat & Adkins, 
2007; Walsh et al., 2003), others have cau-
tioned against the use of these devices, 
particularly in clinical settings (George & 
Braithwaite, 1995; 2002).
Research on the effectiveness of urine and 
saliva POCTs raises two main issues of con-
cern. First, while some devices have been 
found to be relatively accurate and relia-
ble, there is wide variability between devices 
(Peace et al., 2000; Verstraete & Puddu, 
2000a; Walsh et al., 2003). In particular, 
research indicates saliva POCT devices are 
limited in their ability to detect cannabis 
use (Crouch et al., 2005; Walsh et al., 2003). 
Second, the ease of using urine and saliva 
POCT devices and the degree of difficulty in 
interpreting the test results also vary widely 
(Gronholm & Lillsunde, 2001; Verstraete & 
Puddu, 2000a; Verstraete & Raes, 2006).
Passive exposure can occur when a non-drug user comes into contact with or in close proximity 5 
to drugs or a person using drugs. Hair tests, for example, have been shown to be particularly 
sensitive to passive exposure from cannabis smoke (Uhl & Sachs, 2004).
Metabolites are chemical compounds created as a drug is activated or deactivated by internal 6 
chemical processes after ingestion. In some cases, very little of the actual (parent) drug is 
evident in biological samples; however, recent use can be determined by the presence of drug 
metabolites.
In general, cut-off levels are set at a point likely to maximise the detection of true positives, 7 
while at the same time minimising the likelihood of false negatives. Australian standards have 
set cut-off levels for POCT and laboratory urinalysis (Standards Australia, 2001), and while target 
drug/drug metabolite concentrations in saliva have been set (Standards Australia, 2006), there 
are currently no Australian standards on cut-off levels for saliva, hair or sweat testing.
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A comprehensive evaluation of urine and 
saliva POCT devices was provided by two 
studies conducted on behalf of the European 
Police Services Commission (Verstraete & 
Puddu, 2000a; Verstraete & Raes, 2006). The 
first of these studies evaluated 15 urine and 
three saliva POCT devices that are commer-
cially available. This study conducted tests 
on 2968 individuals across eight European 
countries and identified several urinaly-
sis devices that met the evaluation criteria 
of ≥ 95% accuracy, ≥ 90% sensitivity and 
≥ 90% specificity when compared to labora-
tory gas chromatography/mass spectrometry 
analysis (Verstraete & Puddu, 2000a). How-
ever, none of the urinalysis devices scored 
highly for all drug categories and there was 
wide variability between different devices 
and drug types. For example, accuracy for 
amphetamine detection varied from 66 to 
100 per cent, sensitivity from 16 to 100 per 
cent, and specificity from 56 to 100 per cent 
across urine devices. For cannabis, accuracy 
varied from 85 to 97 per cent, sensitivity 
from 70 to 99 per cent, and specificity from 
90 to 100 per cent across urine devices. For 
the three saliva POCT devices evaluated, the 
first study concluded that:
The present generation of onsite (oral 
fluid) tests are insufficiently sensitive 
and/or specific to give reliable results 
for most classes of drugs. (Verstraete & 
Puddu, 2000b, p.5)
A second evaluation of nine commercially 
available saliva POCT devices was subse-
quently conducted by the same researchers 
on 2046 individuals across Europe and the 
United States from 2003 to 2005 ( Verstraete 
& Raes, 2006). None of the saliva POCT 
devices tested met the evaluation criteria 
of ≥ 95% accuracy, ≥ 90% sensitivity, and 
≥ 90% specificity for three of the main drug 
types used in Australia (i.e. amphetamines, 
cannabis and benzodiazepines). For amphet-
amine detection, accuracy varied from 75 to 
98 per cent, sensitivity from 40 to 83 per 
cent, and specificity from 80 to 100 per cent 
for different devices. For cannabis, accuracy 
varied from 55 to 96 per cent, sensitivity 
from 0 to 74 per cent, and specificity from 
70 to 100 per cent for different devices.
Relatively few studies have evaluated sweat 
POCT devices. Available research indicates 
that these devices provide results compara-
ble to urine POCT devices (Kintz,  Tracqui, 
 Mangin & Edel, 1996; Taylor, Watson, Tames 
& Lowe, 1998). However, other studies have 
concluded that while sweat POCT devices 
give results of comparable reliability to urine, 
caution needs to be applied as sweat patches 
are subject to environmental contamination 
(Kidwell, Blanco & Smith, 1997) and can re-
sult in a high proportion of false negatives 
(Huestis, Cone, Wong, Umbricht & Preston, 
2000).
4.2.4.5 Sensitivity and specificity modelling 
for saliva tests
The Rosita report evaluated oral fluid screen-
ing tests for cannabis, cocaine, ampheta-
mines and opiates, and reported the mean 
specificity and sensitivity of the tests for each 
drug. Based on these data, the possible out-
comes of drug detection in a school of 1000 
students can be modelled (Tables 18–20). 
Prevalence of regular use is used in the mod-
elling on the hypothesis that occasional 
users, using less than 10 times a year, are 
unlikely to be detected using saliva tests.
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Table 18: Sensitivity and specificity of tests identified in the Rosita study
Drug Regular users Mean specificity Mean sensitivity True + False - True - False +
% of positives 
that are true
Cannabis 34 92% 46% 15 19 888 78 16%
Cocaine 4 94% 77% 3 1 936 60 5%
Amphetamines 9 94% 79% 7 2 931 60 10%
Opiates 3 99% 61% 1 2 987 10 9%
Table 19: Sample results from tests with the best sensitivity
Drug
Regular 
users Device Failure rate Specificity Sensitivity Fails True + False - True - False +
% of positives 
that are true
Cannabis 34 Oralab 26% 99% 74% 260 18 7 707 8 69%
Cocaine 4 Oralab 26% 97% 97% 260 2 0 714 24 8%
Amphetamines 9 Drugwipe 4% 96% 83% 40 7 1 913 39 15%
Opiates 3 Oralab 26% 100% 100% 260 2 0 737 0 100%
Table 20: Sample results from tests with the best specificity
Drug
Regular 
users Device Failure rate Specificity Sensitivity Fails True + False - True - False +
% of positives 
that are true
Cannabis 34 Oraline 39% 100% 25% 390 5 15 589 0 100%
Cocaine 4 SalivaScreen 47% 100% 75% 470 1 1 527 0 100%
Amphetamines 9 SalivaScreen 47% 100% 78% 470 3 1 525 0 100%
Opiates 3 Oralab 26% 100% 100% 260 2 0 737 0 100%
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Table 18: Sensitivity and specificity of tests identified in the Rosita study
Drug Regular users Mean specificity Mean sensitivity True + False - True - False +
% of positives 
that are true
Cannabis 34 92% 46% 15 19 888 78 16%
Cocaine 4 94% 77% 3 1 936 60 5%
Amphetamines 9 94% 79% 7 2 931 60 10%
Opiates 3 99% 61% 1 2 987 10 9%
Table 19: Sample results from tests with the best sensitivity
Drug
Regular 
users Device Failure rate Specificity Sensitivity Fails True + False - True - False +
% of positives 
that are true
Cannabis 34 Oralab 26% 99% 74% 260 18 7 707 8 69%
Cocaine 4 Oralab 26% 97% 97% 260 2 0 714 24 8%
Amphetamines 9 Drugwipe 4% 96% 83% 40 7 1 913 39 15%
Opiates 3 Oralab 26% 100% 100% 260 2 0 737 0 100%
Table 20: Sample results from tests with the best specificity
Drug
Regular 
users Device Failure rate Specificity Sensitivity Fails True + False - True - False +
% of positives 
that are true
Cannabis 34 Oraline 39% 100% 25% 390 5 15 589 0 100%
Cocaine 4 SalivaScreen 47% 100% 75% 470 1 1 527 0 100%
Amphetamines 9 SalivaScreen 47% 100% 78% 470 3 1 525 0 100%
Opiates 3 Oralab 26% 100% 100% 260 2 0 737 0 100%
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4.2.4.6 Laboratory analysis
Due to the risk of POCT devices producing 
false positive test results, it is a requirement 
of Australian standards (Standards Australia, 
2001; 2006) that any positive test is con-
firmed by laboratory analysis. Laboratory 
analysis is likely to be more accurate and reli-
able than field analysis with a POCT device 
for a variety of reasons including:
More advanced and sophisticated immu-•	
noassay and gas chromatography/mass 
spectrometry analysis can be undertaken 
in a laboratory compared to the analysis 
methods used by POCT devices.
Contamination risks may be lower in a •	
laboratory due to more control over envir-
onmental conditions compared to field 
testing.
The equipment utilised in a laboratory •	
is more likely to be subjected to regular 
monitoring and calibration.
Laboratory staff are likely to have higher •	
level skills and qualifications concerning 
the conduct of sample analyses and the 
interpretation of test results compared to 
staff who conduct field tests with POCT 
devices.
While laboratory analysis is likely to be more 
accurate and reliable than field analysis using 
a POCT device, laboratory analysis can also 
be subject to error. There are a number of 
Australian laboratories offering drug test-
ing services; however, few of these labora-
tories are accredited to Australian standards. 
In many cases, the standards and proce-
dures of these laboratories differ, and in 
some cases may be of a lower standard than 
those required for accreditation. As a result, 
the reliability and accuracy of these tests 
may come under question. No studies were 
loca ted that evaluated the effectiveness of 
Australian laboratory drug testing services. 
However, several international studies have 
raised concerns regarding the accuracy and 
reliability of laboratory testing. For exam-
ple, in one United States study (Riley, Lu 
&  Taylor, 2000) the same 931 urine sam-
ples were submitted to two independent 
laboratories for analysis. Of these samples, 
a total of 52 resulted in a different analysis 
outcome from the two laboratories. Thirty-
eight were found to be positive at the first 
laboratory and negative at the second. Four-
teen were found to be negative at the first 
laboratory and positive at the second (Riley 
et al., 2000). The researchers concluded that 
differential results between the two labora-
tories may have largely been due to differ-
ences in procedural and operational factors. 
Such findings raise serious concerns about 
the veracity of testing even when undertaken 
by laboratories.
A more recent study in the United States also 
identified that a significant proportion of 
tests within the same laboratory can be sus-
ceptible to misinterpretation (Levy,  Sherritt, 
Vaughan, Germak & Knight, 2007). Levy et 
al. examined 710 urinalysis results obtained 
from 110 adolescent patients in a hospi-
tal substance abuse program and found 
re- analysis indicated 40 samples originally 
classified as negative were too dilute to ac-
curately interpret (i.e. they may have been 
adulterated) and 45 tests originally classified 
as positive for illicit drug use were due to the 
licit use of prescribed medication (Levy et al., 
2007). This is an error rate of 12 per cent.
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Like most workplaces, laboratories that test 
for drugs can be subject to human or equip-
ment error and mistakes can be made. In 
addition, the collection, storage, transporta-
tion and analysis of samples require a large 
amount of manual handling. Different pro-
cedures involved in this handling may result 
in sample deterioration or contamination, 
or test results being misinterpreted. There 
is evidence to indicate that the reliability 
and accuracy of laboratory analysis can vary 
between laboratories (Lu &  Taylor, 2006; 
Montagna, Polettini, Stramesi, Groppi & 
Vignali, 2002; Riley et al., 2000) and accord-
ing to the methods of analysis utilised by 
individual laboratories (Baptista, Monsanto, 
Pinho Marques, Bermejo, Avila,  Castanheira 
et al., 2002; Eichhorst, Etter, Lepage & 
 Lehotay, 2004).
In summary, currently available research indi-
cates that, in the majority of cases, POCT 
devices and laboratory analysis can detect 
drug use. However, for POCT devices the risk 
of false positives is relatively high depend-
ing on the type of device used, the target 
drug, and the expertise of the person con-
ducting the test. This risk is reduced, but 
not eliminated, by laboratory confirmation 
of positive POCT tests. The acceptability of 
this risk needs to be assessed against the 
implications of a school-aged child being 
falsely accused of using illicit drugs. If the 
outcome is negligible, then the risk may be 
deemed unacceptable. However, the potential 
ramifications of a false positive also need to 
be considered. These may include the child 
being incorrectly labelled a ‘drug user’, ostra-
cised by their peers, experiencing decreased 
self-esteem, or it may result in a negative 
impact on student–teacher or child–parent 
relationships.
4.2.5 Financial costs of drug 
detection and screening programs
Research on the cost of drug testing pro-
grams in general, and school drug testing 
programs in particular, is limited. Much of 
the available research is either dated, specific 
to international contexts, or provides little 
detail on how cost estimates were deter-
mined. For example, in a survey of nine 
United States schools that conducted pre-
dominantly urine testing during the 2001–02 
school year, Dupont, Campbell and Mazza 
(2002) estimated that the mean cost for 
each test conducted was US$42. However, 
this estimate is limited for several reasons. 
First, the cost estimate is restricted to the 
United States context and based on 2001 
US$ values. Factors affecting cost may differ 
in the Australian context and costs asso-
ciated with testing may have increased or 
decreased since 2001. Second, and more 
importantly, limited detail is provided as to 
how these costs were determined. It appears 
DuPont et al.’s (2002) estimate may have 
been based on the laboratory costs for each 
test only, with no consideration of any addi-
tional expenses that may be associated with 
conducting the test.
An earlier and more detailed examination of 
the costs associated with workplace urine 
testing estimated the cost of on-site POCTs 
at US$49.39 per test and US$66.70 per off-
site laboratory test (Ozminkowski, Mark, 
Cangianelli, Walsh, Davidson, Blank et al., 
2001). Ozminkowski et al.’s estimate not only 
included the fixed cost for each type of test, 
but also included fixed and variable costs 
associated with factors such as staff time to 
administer the test, donor time to take the 
test, test preparation time, and costs associ-
ated with test result tracking and recording 
(Ozminkowski et al., 2001).
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4.2.5.1 NCETA survey of suppliers of testing 
products and services
In order to overcome the limitations of exist-
ing information about costs and provide a 
more relevant and contemporary estimate 
of the cost of school drug testing, NCETA 
canvassed information from 11 of the main 
Australian suppliers of drug testing prod-
ucts or services. Each company was con-
tacted by telephone during August 2007 and 
asked to provide details of their fees and/
or prices for the various products and serv-
ices they provided. All suppliers contacted 
provided this information verbally or via 
subsequent email.
The services and products provided by the 
companies contacted varied and included:
provision of POCT devices and/or labora-•	
tory access for confirmations
provision of laboratory analysis•	
provision of drug testing services and •	
staff (including specimen collection and 
analysis)
a combination of the above.•	
The cost estimates in this section provide a 
series of detailed breakdowns from the basic 
cost of purchasing tests to the full cost im-
plications involved in the actual implemen-
tation of different testing regimes. The cost 
estimates are broken down as follows:
The basic cost (per person) of purchasing •	
POCT, laboratory screens and laboratory 
confirm tests for urine, saliva, hair and 
sweat tests (Table 22) — urine tests are 
the least costly.
The cost of purchasing the cheapest of •	
these tests in the school setting for dif-
ferent testing regimes (when testing (i) a 
total school population once, (ii) a 10% 
random sample three times, (iii) a 5% 
targeted sample three times, and (iv) a 
2% ‘for cause’ sample once with 50% 
retested) (see Table 23).
The costs calculated in the second item •	
above are then revised with the additional 
expenses involved in collection, sample 
storage, transportation, administration etc 
(see Table 24).
The cost of external agency staff to un-•	
dertake the tests was then calculated at 
an hourly rate (see Table 25) and at a 
fixed fee per school (see Table 26).
Finally, a full cost scenario is calculated •	
in Table 27 factoring in all identified 
expenses and using the fixed fee plus 
costs model.
The above were calculated for a hypothetical 
school of 500 students, then calculated for 
all government and non-government schools 
separately, and then combined across Aus-
tralia using actual student enrolment figures 
for 2006.
As shown in Table 21 when all costs are cal-
culated the following estimate is arrived at 
for undertaking drug testing for all schools 
nationally (using either saliva or urine tests), 
for each of the four possible testing regimes.
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Information obtained from the companies 
surveyed allowed for POCT and laboratory 
analysis costs for the four different drug 
test types, described in section 4.2.2, to 
be determined as outlined in Table 22. All 
costs detailed in Table 22 refer to the pur-
chase of a single test that can be used to 
test one person only. These costs do not 
include any additional on-costs such as 
freight, handling, sample collection, or test 
administration costs.
Table 21: Summary overview of all testing costs for all Australian 
school students (2006 enrolment figures)
Testing 
method Urine Saliva
St
ra
te
gy
To
ta
l s
ch
oo
l 
po
pu
la
ti
on
Ra
nd
om
 
sa
m
pl
e
Ta
rg
et
ed
 
gr
ou
ps
Fo
r 
ca
us
e
To
ta
l s
ch
oo
l 
po
pu
la
ti
on
Ra
nd
om
 
sa
m
pl
e
Ta
rg
et
ed
 
gr
ou
ps
Fo
r 
ca
us
e
Times 
tested p/a
1 3 3 1 1 3 3 1
Total cost 
(All schools)
$302.3m $91.4m $47.9m $11.7m $355.2m $110.6m $58.6m $15.9m
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Price variations for each test type are due to 
several factors. In part, cost variation can be 
attributed to competition and market forces 
(i.e. different companies offered the same 
test type at different prices). Price variations 
also reflect variations in sale volumes and 
product quality. Most companies surveyed 
offered price reductions for bulk orders, with 
discounts of up to 20 per cent for orders of 
250 or more tests. Similarly, the price varied 
with the quality and extent of products/serv-
ices provided. For example, the less expensive 
urine POCT devices required more sample 
collection time and more collector training 
than the more expensive test devices.
Overall, urine tests appeared the least costly. 
The least expensive urine POCT was a single 
panel device but, as this device can detect 
only one type of drug, several of these devices 
may be required to test one student for a 
range of drugs. Thus, six-panel devices may 
be more cost-effective. This issue aside, the 
cost of urine POCT devices and laboratory 
analysis was substantially less than other test 
types. However, this has to be weighed against 
costs associated with the need to provide 
private and comfortable collection facilities 
for urine specimen collection. The provision 
of facilities for saliva, hair or sweat collection 
may not be as resource-intensive.
Table 22: Cost per person of Australian POCT and laboratory analysis 
for urine, saliva, hair and sweat testing
Cost per test Urine Saliva Hair3 Sweat4
POCT devices 1 panel $3–$71
6 panel $13–$252
6 panel $21–$34 N/A $30–$505
Lab screen $25–$30 $80–$90 $170 $45–$60
Lab confirmation $55–$75 $80–$275 $200–$300 inclusive
Notes:
1 A one-panel test can detect only one specified drug per test.
2 A six-panel test can detect six different specified drugs per test.
3 There are currently no Australian laboratories that offer commercial screening or confirmation 
services for hair samples. All samples need to be sent overseas.
4 There is only one sweat POCT device currently available in Australia. There are no Australian 
laboratories that offer screening or confirmation services for sweat samples. All samples need to 
be sent to overseas laboratories.
5 The price of the one sweat POCT device varied according to the number of different drugs that 
various models of the device could detect. The single drug model cost $30, the two-drug model 
$40, and the three-drug model $50.
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The detail provided in Table 22 also allows 
for costs associated with different test strat-
egies outlined in section 4.2.2 to be esti-
mated. These cost estimates are detailed in 
Table 23 and are based on the following 
assumptions:
In all cases the least expensive price •	
quoted by the companies surveyed was 
used except for urine and sweat POCT 
devices in order to provide the most con-
servative cost estimate.
For urine, the price of the six-panel •	
POCT device was chosen as it is more 
comparable with saliva POCT devices. 
In addition, the mid-range price of $18 
(range = $13–$25) for the six-panel 
urine POCT was chosen as this was 
likely to be more cost-effective than 
the more labour-intensive, but less 
expensive, urine POCT devices.
For sweat, the most expensive ($50) •	
POCT device was chosen as it was able 
to detect three different drug types and 
thus was more comparable to the six-
panel urine and saliva devices.
A school population of 500 students was •	
used to estimate costs.
A positive test rate of 3.4 per cent of •	
the sample tested was utilised as this is 
consistent with previously reported data 
indicating 3.4 per cent of all students are 
regular users (defined as using 10 or more 
times a year) of cannabis (the most com-
monly used drug). It was reasoned that 
drug testing was most likely to detect 
regular as opposed to occasional use.8
A sample of 10 per cent of the total •	
school population tested on three occa-
sions throughout the school year was 
chosen for calculating the cost of ran-
dom testing.
A sample of 5 per cent of the school pop-•	
ulation was chosen for the targeted group 
strategy and, in this case, a positive test 
rate of 7 per cent (twice the prevalence 
rate for random testing) was utilised as 
the targets for this strategy are selected 
on the basis they are more likely to use 
drugs than other groups.
A sample of 2 per cent of the school pop-•	
ulation was chosen for the ‘for cause’ 
strategy and, in this case, the positive test 
rate was increased to 50 per cent as the 
individuals tested using this strategy are 
selected on the basis that it is reasonable 
to suspect they are using drugs.
However, it could be argued that drug testing can detect occasional use and, as such, costings 8 
are also presented at Appendix A using a prevalence rate of 20 per cent which is consistent with 
AIHW data that found 20.9 per cent of males and 21.8 per cent of females have recently (in the 
past 12 months) used illicit drugs (Australian Institute of Health and Welfare, 2005).
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Table 23: Cost estimates for the purchase of different test types, applied to 
different testing strategies (for a school population of 500 students)
Testing method Urine Saliva Sweat Hair1 
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Times tested p/a 1 3 3 1 1 3 3 1 1 3 3 1 1 3 3 1
POCT             
Laboratory 
screen1    
Quantity 500 50 25 10 500 50 25 10 500 50 25 10 500 50 25 10
Cost $18 $18 $18 $18 $21 $21 $21 $21 $50 $50 $50 $50 $170 $170 $170 $170
Subtotal (a) $9000 $2700 $1350 $180 $10 500 $3150 $1575 $210 $25 000 $7500 $3750 $500 $85 000 $25 500 $12 750 $1700
Laboratory 
confirmation 
Quantity (3.4%) 17 2 2 5 17 2 2 5 17 2 2 5 17 2 2 5
Cost $55 $55 $55 $55 $80 $80 $80 $80 $45 $45 $45 $45 $200 $200 $200 $200
Subtotal (b) $935 $330 $330 $275 $1360 $480 $480 $400 $765 $270 $270 $225 $3400 $1200 $1200 $1000
Total cost per 
school
Total (a + b) $9935 $3030 $1680 $455 $11 860 $3630 $2055 $610 $25 765 $7770 $4020 $725 $88 400 $26 700 $13 950 $2700
Total student 
population 
2006 
Government 
schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost 
(govt.schools) $44.7m $13.6m $7.6m $2m $53.3m $16.3m $9.2m $2.7m $115.9m $34.9m $18.1m $3.3 $397.5m $120.1m $62.7m $12.1m
Non-
government 
schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost 
(non-govt 
schools) $22.3m $6.8m $3.8m $1m $26.6m $8.2m $4.6m $1.4m $57.7m $17.4m $9m $1.6m $198m $59.8m $31.2m $6m
Total cost 
(All schools) $67m $20.4m $11.4m $3m $79.9m $24.5 $13.8m $4.1m $173.6m $52.3m $27.1m $4.9m $595.5m $179.9m $93.9m $18.1m
Note: 1 POCT devices are unavailable for hair analysis.  
However, overseas laboratories can screen hair for drug use.
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Table 23: Cost estimates for the purchase of different test types, applied to 
different testing strategies (for a school population of 500 students)
Testing method Urine Saliva Sweat Hair1 
Strategy To
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Times tested p/a 1 3 3 1 1 3 3 1 1 3 3 1 1 3 3 1
POCT             
Laboratory 
screen1    
Quantity 500 50 25 10 500 50 25 10 500 50 25 10 500 50 25 10
Cost $18 $18 $18 $18 $21 $21 $21 $21 $50 $50 $50 $50 $170 $170 $170 $170
Subtotal (a) $9000 $2700 $1350 $180 $10 500 $3150 $1575 $210 $25 000 $7500 $3750 $500 $85 000 $25 500 $12 750 $1700
Laboratory 
confirmation 
Quantity (3.4%) 17 2 2 5 17 2 2 5 17 2 2 5 17 2 2 5
Cost $55 $55 $55 $55 $80 $80 $80 $80 $45 $45 $45 $45 $200 $200 $200 $200
Subtotal (b) $935 $330 $330 $275 $1360 $480 $480 $400 $765 $270 $270 $225 $3400 $1200 $1200 $1000
Total cost per 
school
Total (a + b) $9935 $3030 $1680 $455 $11 860 $3630 $2055 $610 $25 765 $7770 $4020 $725 $88 400 $26 700 $13 950 $2700
Total student 
population 
2006 
Government 
schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost 
(govt.schools) $44.7m $13.6m $7.6m $2m $53.3m $16.3m $9.2m $2.7m $115.9m $34.9m $18.1m $3.3 $397.5m $120.1m $62.7m $12.1m
Non-
government 
schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost 
(non-govt 
schools) $22.3m $6.8m $3.8m $1m $26.6m $8.2m $4.6m $1.4m $57.7m $17.4m $9m $1.6m $198m $59.8m $31.2m $6m
Total cost 
(All schools) $67m $20.4m $11.4m $3m $79.9m $24.5 $13.8m $4.1m $173.6m $52.3m $27.1m $4.9m $595.5m $179.9m $93.9m $18.1m
Note: 1 POCT devices are unavailable for hair analysis.  
However, overseas laboratories can screen hair for drug use.
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4.2.5.2 Additional costs
The costs outlined in Table 23 do not include 
costs associated with the collection, storage 
and transport of specimens. The time taken 
to collect specimen samples can vary accord-
ing to the specimen collected and the type of 
collection device. In addition, POCT results 
should be recorded and Australian standards 
(Standards Australia, 2001; 2006) require a 
chain of custody procedure to be followed 
for any positive specimens that need to be 
transported to a laboratory for confirma-
tion. This can involve a substantial time cost 
for both the specimen donor and specimen 
collector. Information provided by the drug 
testing service companies surveyed indicated 
that, for safety and procedural reasons, two 
collectors are required at each test site and 
that, on average, only 8–10 specimens could 
be collected and processed in one hour.
Similarly, specimen collection and storage 
facilities can also substantially add to the 
cost of drug testing. Private and comfort-
able collection areas need to be provided 
and some specimen samples collected (e.g. 
urine and sweat) may require refrigeration to 
prevent deterioration. In addition, the trans-
portation of positive specimens to labora-
tories for confirmation adds to the costs. 
Containers suitable for specimen transpor-
tation are provided by the companies sur-
veyed at a cost of $12–$17 per container 
and freight charges ranged from $15 to $20 
per container.
Previous estimates of the total costs of on-
site POCT workplace testing which have taken 
into account collection, storage, transporta-
tion, administration, and other associated 
costs (Ozminkowski et al., 2001) indicate that 
the real cost of urine POCTs was approxi-
mately double the cost of purchasing the 
POCT device. Adjusting for these additional 
costs, using a similar rate as that adopted by 
Ozminkowski et al. (2001) would conserva-
tively add an additional $20 cost to each 
test conducted (see Table 24).
D
rug detection and screening program
s
53
Several companies surveyed also offered drug 
testing services which involved provision of 
trained staff to carry out the collection and 
testing of samples. These services were sup-
plied at either an hourly rate or a fixed fee 
per test. Most companies surveyed restricted 
drug testing services to urine and/or saliva 
testing. The hourly rate for these services 
ranged from $80 per hour to $275 per hour. 
Different hourly rates varied according to:
number of staff provided (lower rates in-•	
volved only one staff member; however, 
most providers recommended two staff 
members)
qualifications of staff (staff with nursing •	
qualifications were more expensive)
number of hours required (higher rates •	
applied to less than four hours’ work)
location of testing (rural, regional and •	
outer-metropolitan locations attracted a 
higher hourly rate and additional travel-
ling charges)
services included in the hourly fee (lower •	
fees did not include the provision of POCT 
devices and other test consumables).
For all companies surveyed, laboratory con-
firmation of positive tests was an additional 
charge, regardless of the hourly rate charged. 
Estimated costs associated with testing a 
school population of 500 students based on 
an hourly rate and the four testing strategies 
are outlined in Table 25. While the estimates 
in Table 25 appear to be more attractive 
when compared to Table 24, it must be re-
membered that they do not include:
travelling time and costs of the service •	
provider
hourly costs associated with laboratory •	
confirmations
cost of donor time•	
cost of school staff time to organise and •	
coordinate the tests, and
administrative costs associated with the •	
recording and reporting of test results.
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Table 24: Cost estimates for the purchase of different test types plus additional on-costs, 
applied to different testing strategies (for a school population of 500 students)
Testing method Urine Saliva Sweat Hair1 
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Times tested p/a 1 3 3 1 1 3 3 1 1 3 3 1 1 3 3 1
POCT             
Laboratory 
screen1    
Quantity 500 50 25 10 500 50 25 10 500 50 25 10 500 50 25 10
Cost $18 $18 $18 $18 $21 $21 $21 $21 $50 $50 $50 $50 $170 $170 $170 $170
On-costs (+ $20) $38 $38 $38 $38 $41 $41 $41 $41 $70 $70 $70 $70 $190 $190 $190 $190
Subtotal (a) $19 000 $5700 $2850 $380 $20 500 $6150 $3075 $410 $35 000 $10 500 $5250 $700 $95 000 $28 500 $14 250 $1900
Laboratory 
confirmation 
Quantity (3.4%) 17 2 2 5 17 2 2 5 17 2 2 5 17 2 2 5
Cost $55 $55 $55 $55 $80 $80 $80 $80 $45 $45 $45 $45 $200 $200 $200 $200
On-costs (+ $20) $75 $75 $75 $75 $100 $100 $100 $100 $65 $65 $65 $65 $220 $220 $220 $220
Subtotal (b) $1275 $450 $450 $375 $1700 $600 $600 $500 $1105 $390 $390 $325 $3740 $1320 $1320 $1100
Total cost per 
school 
Total (a + b) $20 275 $6150 $3300 $755 $22 200 $6750 $3675 $910 $36 105 $10 890 $5640 $1025 $98 740 $29 820 $15 570 $3000
Total student 
population 
2006 
Government 
schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost 
(govt schools) $91.2m $27.7m $14.8m $3.4m $99.8m $30.4m $16.5m $4.1 $162.3m $49m $25.4m $4.6m $444m $134.1 $70m $13.5m
Non-government 
schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost 
(non-govt 
schools) $45.4m $13.8m $7.4m $1.7m $49.8m $15.1m $8.2m $2m $81m $24.4 $12.6m $2.3m $221.1m $66.8m $34.9m $6.7m
Total cost 
(All schools) $136.6m $41.5m $22.2 $5.1m $149.5m $45.5m $24.7m $6.1m $243.3m $73.4m $38m $6.9m $665.1m $200.9m $104.9m $20.2m
Note: 1 POCT devices are unavailable for hair analysis.  
However, overseas laboratories can screen hair for drug use.
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Table 24: Cost estimates for the purchase of different test types plus additional on-costs, 
applied to different testing strategies (for a school population of 500 students)
Testing method Urine Saliva Sweat Hair1 
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Times tested p/a 1 3 3 1 1 3 3 1 1 3 3 1 1 3 3 1
POCT             
Laboratory 
screen1    
Quantity 500 50 25 10 500 50 25 10 500 50 25 10 500 50 25 10
Cost $18 $18 $18 $18 $21 $21 $21 $21 $50 $50 $50 $50 $170 $170 $170 $170
On-costs (+ $20) $38 $38 $38 $38 $41 $41 $41 $41 $70 $70 $70 $70 $190 $190 $190 $190
Subtotal (a) $19 000 $5700 $2850 $380 $20 500 $6150 $3075 $410 $35 000 $10 500 $5250 $700 $95 000 $28 500 $14 250 $1900
Laboratory 
confirmation 
Quantity (3.4%) 17 2 2 5 17 2 2 5 17 2 2 5 17 2 2 5
Cost $55 $55 $55 $55 $80 $80 $80 $80 $45 $45 $45 $45 $200 $200 $200 $200
On-costs (+ $20) $75 $75 $75 $75 $100 $100 $100 $100 $65 $65 $65 $65 $220 $220 $220 $220
Subtotal (b) $1275 $450 $450 $375 $1700 $600 $600 $500 $1105 $390 $390 $325 $3740 $1320 $1320 $1100
Total cost per 
school 
Total (a + b) $20 275 $6150 $3300 $755 $22 200 $6750 $3675 $910 $36 105 $10 890 $5640 $1025 $98 740 $29 820 $15 570 $3000
Total student 
population 
2006 
Government 
schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost 
(govt schools) $91.2m $27.7m $14.8m $3.4m $99.8m $30.4m $16.5m $4.1 $162.3m $49m $25.4m $4.6m $444m $134.1 $70m $13.5m
Non-government 
schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost 
(non-govt 
schools) $45.4m $13.8m $7.4m $1.7m $49.8m $15.1m $8.2m $2m $81m $24.4 $12.6m $2.3m $221.1m $66.8m $34.9m $6.7m
Total cost 
(All schools) $136.6m $41.5m $22.2 $5.1m $149.5m $45.5m $24.7m $6.1m $243.3m $73.4m $38m $6.9m $665.1m $200.9m $104.9m $20.2m
Note: 1 POCT devices are unavailable for hair analysis.  
However, overseas laboratories can screen hair for drug use.
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Table 25: Cost estimates for the provision of testing services at an hourly rate, 
applied to different testing strategies (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups3 For cause3
Total school 
population Random sample Targeted groups3 For cause3
Quantity tested 500 50 25 10 500 50 25 10
Tests p/hr 8 8 8 8 8 8 8 8
Hours needed 63 6 4 4 63 6 4 4
Hourly rate1 $80 $80 $80 $80 $80 $80 $80 $80
Times tested p/a 1 3 3 1 1 3 3 1
Subtotal (a) $5040 $1440 $960 $320 $5040 $1440 $960 $320
POCT device cost $9000 $2700 $1350 $180 $10 500 $3150 $1575 $210
Lab confirmation cost $935 $330 $330 $275 $1360 $480 $480 $400
Subtotal (b)2 $9935 $3030 $1680 $455 $11 860 $3630 $2055 $610
Total cost per school
Total (a)+(b) $14 975 $4470 $2640 $775 $16 900 $5090 $3015 $930
Total student population 2006 
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $67.3m $20.1m $11.9m $3.5m $76m $22.9m $13.6m $4.2m
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost (non-govt schools) $33.5m $10m $5.9m $1.7m $37.9m $11.4m $6.8m $2.1m
Total cost (All schools) $100.8m $30.1m $17.8m $5.2m $113.9m $34.4m $20.4m $6.3m
Notes:
1 The hourly rate is costed on the lowest price of $80 per hour and calculated on the assumption 
that eight tests can be performed in one hour.
2 As the lower hourly rates quoted by service providers do not include POCT devices and laboratory 
confirmations, these costs are added.
3 As targeted groups and ‘for cause’ testing involves less than four hours of testing, it is likely that 
a minimum service fee of four hours would be charged.
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Rates for a fixed service fee varied from $48 
to $80 per test performed for urine testing 
and from $62 to $115 per test performed 
for saliva testing. Again, fees varied accord-
ing to the qualifications of the staff (nursing 
staff attracted a higher rate), the number of 
tests conducted (most required a minimum 
of 50 tests to attract the lower rate), the 
location of tests (rural, regional and outer-
metropolitan locations attracted additional 
travelling charges), and the services provided 
(in general, higher test fees included the cost 
of the POCT device). For all companies sur-
veyed, laboratory confirmation of positive 
tests was an additional charge to the fee 
per test rate. Estimated costs associated with 
testing a school population of 500 students 
based on a fixed fee per test rate are outlined 
in Table 26. Estimated costs associated with 
testing a school population of 500 students 
based on a fixed fee per test rate, including 
the cost of purchasing POCT devices and 
additional on-costs of $29 per test, are out-
lined in Table 27.
Table 25: Cost estimates for the provision of testing services at an hourly rate, 
applied to different testing strategies (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups3 For cause3
Total school 
population Random sample Targeted groups3 For cause3
Quantity tested 500 50 25 10 500 50 25 10
Tests p/hr 8 8 8 8 8 8 8 8
Hours needed 63 6 4 4 63 6 4 4
Hourly rate1 $80 $80 $80 $80 $80 $80 $80 $80
Times tested p/a 1 3 3 1 1 3 3 1
Subtotal (a) $5040 $1440 $960 $320 $5040 $1440 $960 $320
POCT device cost $9000 $2700 $1350 $180 $10 500 $3150 $1575 $210
Lab confirmation cost $935 $330 $330 $275 $1360 $480 $480 $400
Subtotal (b)2 $9935 $3030 $1680 $455 $11 860 $3630 $2055 $610
Total cost per school
Total (a)+(b) $14 975 $4470 $2640 $775 $16 900 $5090 $3015 $930
Total student population 2006 
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $67.3m $20.1m $11.9m $3.5m $76m $22.9m $13.6m $4.2m
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost (non-govt schools) $33.5m $10m $5.9m $1.7m $37.9m $11.4m $6.8m $2.1m
Total cost (All schools) $100.8m $30.1m $17.8m $5.2m $113.9m $34.4m $20.4m $6.3m
Notes:
1 The hourly rate is costed on the lowest price of $80 per hour and calculated on the assumption 
that eight tests can be performed in one hour.
2 As the lower hourly rates quoted by service providers do not include POCT devices and laboratory 
confirmations, these costs are added.
3 As targeted groups and ‘for cause’ testing involves less than four hours of testing, it is likely that 
a minimum service fee of four hours would be charged.
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Table 26: Cost estimates for the provision of testing services 
at a fixed fee per test (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups For cause1
Total school 
population Random sample Targeted groups For cause1
Times tested p/a 1 3 3 1 1 3 3 1
POCT
Quantity 500 50 25 10 500 50 25 10
Service fee $48 $48 $48 $801 $62 $62 $62 $1151
Subtotal (a) $24 000 $7200 $3600 $800 $31 000 $9300 $4650 $1150
Laboratory confirmation
Quantity (3.4%) 17 2 2 5 17 2 2 5
Service fee $55 $55 $55 $55 $80 $80 $80 $80
Subtotal (b) $935 $330 $330 $275 $1360 $480 $480 $400
Total cost per school
Total (a + b) $24 935 $7530 $3930 $1075 $32 360 $9780 $5130 $1550
Total student population 2006 
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $112.1m $33.9m $17.7m $4.8m $145.5m $44m $23.1m $7m
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost (non-govt schools) $55.9m $16.9m $8.8m $2.4m $72.5m $21.9m $11.5m $3.5m
Total cost (All schools) $168m $50.8m $26.5m $7.2m $218m $65.9m $34.6m $10.5m
Note: 1 As testing for cause is likely to involve only one or two tests being conducted 
on each occasion, it is likely that the maximum fixed fee amount would apply.
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Table 26: Cost estimates for the provision of testing services 
at a fixed fee per test (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups For cause1
Total school 
population Random sample Targeted groups For cause1
Times tested p/a 1 3 3 1 1 3 3 1
POCT
Quantity 500 50 25 10 500 50 25 10
Service fee $48 $48 $48 $801 $62 $62 $62 $1151
Subtotal (a) $24 000 $7200 $3600 $800 $31 000 $9300 $4650 $1150
Laboratory confirmation
Quantity (3.4%) 17 2 2 5 17 2 2 5
Service fee $55 $55 $55 $55 $80 $80 $80 $80
Subtotal (b) $935 $330 $330 $275 $1360 $480 $480 $400
Total cost per school
Total (a + b) $24 935 $7530 $3930 $1075 $32 360 $9780 $5130 $1550
Total student population 2006 
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $112.1m $33.9m $17.7m $4.8m $145.5m $44m $23.1m $7m
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost (non-govt schools) $55.9m $16.9m $8.8m $2.4m $72.5m $21.9m $11.5m $3.5m
Total cost (All schools) $168m $50.8m $26.5m $7.2m $218m $65.9m $34.6m $10.5m
Note: 1 As testing for cause is likely to involve only one or two tests being conducted 
on each occasion, it is likely that the maximum fixed fee amount would apply.
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Table 27: Cost estimates for the provision of testing services at a fixed fee 
per test plus on-costs and the purchase of POCT devices, applied to different 
testing strategies (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups For cause1
Total school 
population Random sample Targeted groups For cause1
Times tested p/a 1 3 3 1 1 3 3 1
POCT
Quantity 500 50 25 10 500 50 25 10
Service fee $48 $48 $48 $80 $62 $62 $62 $115
POCT device cost $18 $18 $18 $18 $21 $21 $21 $21
On-costs ($20/test) $20 $20 $20 $20 $20 $20 $20 $20
Subtotal (a) $43 000 $12 900 $6540 $1180 $51 500 $15 450 $7725 $1560
Laboratory confirmation
Quantity (3.4%) 17 2 2 5 17 2 2 5
Service fee $55 $55 $55 $55 $80 $80 $80 $80
Confirmation test cost $55 $55 $55 $55 $80 $80 $80 $80
Subtotal (b) $1870 $660 $660 $550 $2720 $960 $960 $800
Total cost per school
Total (a + b) $44 870 $13 560 $7110 $1730 $54 220 $16 410 $8685 $2360
Total student population 2006 
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $201.8m $61m $32m $7.8m $243.8m $73.8m $39.1m $10.6m
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost (non-govt schools) $100.5m $30.4m $15.9m $3.9m $121.4m $36.8m $19.5m $5.3m
Total cost (All schools) $302.3m $91.4m $47.9m $11.7m $355.2m $110.6m $58.6m $15.9m
Note: 1 As testing for cause is likely to involve only one or two tests being conducted 
on each occasion, it is likely that the maximum fixed fee amount would apply.
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Table 27: Cost estimates for the provision of testing services at a fixed fee 
per test plus on-costs and the purchase of POCT devices, applied to different 
testing strategies (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups For cause1
Total school 
population Random sample Targeted groups For cause1
Times tested p/a 1 3 3 1 1 3 3 1
POCT
Quantity 500 50 25 10 500 50 25 10
Service fee $48 $48 $48 $80 $62 $62 $62 $115
POCT device cost $18 $18 $18 $18 $21 $21 $21 $21
On-costs ($20/test) $20 $20 $20 $20 $20 $20 $20 $20
Subtotal (a) $43 000 $12 900 $6540 $1180 $51 500 $15 450 $7725 $1560
Laboratory confirmation
Quantity (3.4%) 17 2 2 5 17 2 2 5
Service fee $55 $55 $55 $55 $80 $80 $80 $80
Confirmation test cost $55 $55 $55 $55 $80 $80 $80 $80
Subtotal (b) $1870 $660 $660 $550 $2720 $960 $960 $800
Total cost per school
Total (a + b) $44 870 $13 560 $7110 $1730 $54 220 $16 410 $8685 $2360
Total student population 2006 
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $201.8m $61m $32m $7.8m $243.8m $73.8m $39.1m $10.6m
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost (non-govt schools) $100.5m $30.4m $15.9m $3.9m $121.4m $36.8m $19.5m $5.3m
Total cost (All schools) $302.3m $91.4m $47.9m $11.7m $355.2m $110.6m $58.6m $15.9m
Note: 1 As testing for cause is likely to involve only one or two tests being conducted 
on each occasion, it is likely that the maximum fixed fee amount would apply.
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4.3 Psychometric measures 
of substance use
4.3.1 Methods and types of 
psychometric tests
While biometric tests are often assumed to 
be a more accurate indication of drug use as 
they are not subject to some of the poten-
tial biases inherent in self-report, such as 
poor recall, conscious or unconscious denial 
or distortion, they may also be influenced 
by sources of error (e.g. measurement arte-
facts, false positives/negatives). Moreover, 
a biological snapshot cannot be used to 
accurately infer general consumption/use 
of drugs over time or chronic patterns of 
use. That is, the dichotomous results from 
biometric testing are not useful for predict-
ing other outcomes.
An alternative means of identifying indi-
viduals who are using drugs is a range of 
screening instruments, which are predomi-
nantly self-administered. Such instruments 
have been designed to detect: (i) single 
domain risks, such as use of alcohol, specific 
drugs or substances in general; or (ii) mul-
tiple domain risks, including substance use, 
risky sexual practices, suicidal ideation or 
use of weapons. Some screening instruments 
may also be useful for monitoring changes 
in substance use over time and/or monitor-
ing progress of interventions. Table 28 lists 
a sample of screening instruments.
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Table 28: Psychometric measures of risky behaviours
Instrument
Target 
population Method Focus
ARBS (Adolescent 
Risk Behavior Screen) 
(Jankowski, 
Rosenberg, 
 Sengupta, 
Rosenberg & 
Wolford, 2007)
Adolescents 9-item 
self-report 
questionnaire 
with multiple 
responses
Substance use; risk behaviours 
(use of seatbelts, fighting); suicidal 
ideation; eating disorders
ASSIST (Alcohol 
Smoking and Sub-
stance Involvement 
Screening Test) 
developed by WHO
General 
population
8-item 
interview 
questionnaire 
with multiple 
responses
Substance use (alcohol, tobacco 
and other drugs)
AUDIT (Alcohol 
Use Disorders 
Identification Test) 
(Cook, Chung, Kelly 
& Clark, 2005)
General 
population
10-item 
self-report 
questionnaire 
with multiple 
responses
Alcohol use
CAGE 
(Cook et al., 2005; 
Knight, Goodman, 
Pulerwitz & 
DuRant, 2000)
Adult 
population
CAGE–AA 
modified 
for 
adolescents
4-item self-
report yes/no 
questionnaire
Alcohol use
Have you felt you should Cut down 
on your drinking?
Have people Annoyed you by 
criticising your drinking?
Have you felt bad or Guilty about 
your drinking?
Have you had a drink first thing in 
the morning (Eye-opener) to steady 
your nerves?
CPQ (Cannabis 
Problems 
Questionnaire) 
(Copeland, Gilmour, 
Gates & Swift, 2005; 
Martin, Copeland, 
Gilmour, Gates & 
Swift, 2006)
General 
population
CPQ–A 
modified 
for 
adolescents 
(14–18 yrs)
54-item self-
report yes/no 
questionnaire
Cannabis use
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Instrument
Target 
population Method Focus
CRAFFT 
(Cook et al., 2005; 
Cummins, Chan, 
Burns, Blume, 
Larimer & Marlatt, 
2003)
Adolescents 6-item self-
report yes/no 
questionnaire
Substance use
Have you ridden in a Car driven by 
person using drugs/alcohol?
Do you use alcohol/drugs to Relax?
Do you use alcohol/drugs when Alone?
Do you Forget things while using 
drugs/alcohol?
Do your family/Friends tell you to 
cut down on drinking/drug use?
Have you gotten into Trouble while 
using drugs/alcohol?
DAP–4 (Drug and 
Alcohol Problem 
QuickScreen) 
(Knight et al., 2000)
Adolescents 30-item self-
report yes/no 
questionnaire
Substance use
DAST (Drug Abuse 
Screening Test) 
(Martino, Grilo 
& Fehon, 2000; 
Yudko, Lozhkina & 
Fouts, 2007)
General 
population
DAST–A is 
modified 
for 
adolescents
10-28 item 
self-report 
yes/no 
questionnaire
Substance use
DUSI (Drug Use 
Screening Inventory) 
(Christie, Marsh, 
Sheridan, Wheeler, 
Suaalii-Sauni, Black 
et al., 2007)
Youth 
and adult 
versions
159-item 
self-report 
questionnaire
Substance use
GAIN (Global 
Appraisal of 
Individual Needs) 
(Lennox, Dennis, 
Scott & Funk, 
2006)
General 
population
Semi-
structured 
interview 
(8 sections)
99 scales & 
subscales
1606 items in 
full version
Background; substance use; 
physical health; risk behaviours; 
mental health; environment; legal; 
vocational 
D
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Instrument
Target 
population Method Focus
HEADS FIRST 
(Fournier & Levy, 
2006)
Adolescents Structured 
interview 
(10 sections)
Medical, social, psychological 
issues: home; education; abuse; 
drugs; safety; friends; image; 
recreation; sexuality; threats
MSI–X (Marijuana 
Screening 
Inventory) 
(Alexander & 
Leung, 2006)
General 
population
31-item self-
report yes/no 
questionnaire
Cannabis use
POSIT (Problem 
Oriented Screening 
Instrument) 
(Latimer, O’Brien, 
McDouall, 
Toussova, Floyd & 
Vasquez, 2004)
Teenagers 139-item 
self-report 
questionnaire
Substance use
Substance use/abuse risk; alcohol 
abuse/dependence disorders; 
substance use frequency
SACS (Substances 
and Choices Scale) 
(Christie et al., 
2007)
Adolescents 10-item 
self-report 
questionnaire 
with multiple 
responses
Alcohol and substance use
SDQ (Strengths 
and Difficulties 
Questionnaire) 
(Christie et al., 
2007)
Children 
and young 
people 
(3–16 
years)
25-item 
interview 
questionnaire
Problems
Emotional, conduct, attention, 
relationships, social
SSI–AOD (Simple 
Screening 
Instrument for 
Alcohol and 
Other Drug Abuse 
(Knight et al., 2000)
General 
population
16-item 
questionnaire
Substance use
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4.3.2 Effectiveness of 
psychometric measures of 
substance use
The effectiveness of psychometric measures 
of substance use varies depending on a range 
of factors:
validity of instrument (sensitivity, specifi-•	
city, predictive value)
reliability of instrument for target pop-•	
ulation (not all instruments have been 
adequately validated in youth population)
focus of questions (single vs multiple •	
domains of risk)
ease of use (self-report vs interview; time •	
required for completion)
competency of staff interpreting results•	
follow-up action (access/availability of •	
appropriate programs or treatments).
Advantages of psychometric tests
non-invasive•	
not dependent on a window of detec-•	
tion
collection of data is simple; no equip-•	
ment required
may provide a temporal pattern of sub-•	
stance use, rather than a single point in 
time
may provide a context for substance use •	
(e.g. other risky behaviours)
not subject to substitution or environ-•	
mental contamination.
Disadvantages of psychometric tests
subject to self-report biases (under-•	
 reporting, exaggeration, poor recall)
potential literacy problems•	
security of records (privacy, confidentiality).•	
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Table 29: Validity of psychometric screening instruments
Instrument Validity Advantages Disadvantages
ARBS (Adolescent 
Risk Behavior Screen) 
(Jankowski et al., 
2007)
Cut-off score = 17.5
Sensitivity = 82%
Specificity = 84%
Accuracy = 84%
Brief, easily 
administered, easy to 
score; completed in 
10 minutes
Not tested in 
diverse groups
Poor positive 
predictive 
value (35%), 
which yields 
high false 
positive rate
ASSIST (Alcohol 
Smoking and 
Substance Involvement 
Screening Test ) 
developed by WHO 
(Humeniuk & Ali, 
2006; WHO ASSIST 
Working Group, 2002)
Global illicit use
Cut-off score = 6.5
Sensitivity = 88%
Specificity = 89%
Accuracy = >80%
Good test–retest 
reliability
Brief, verbally 
administered, easy to 
score, acceptable and 
easy to understand
Not validated 
in adolescents
AUDIT (Alcohol 
Use Disorders 
Identification Test) 
(Cook et al., 2005)
Cut-off score = 9
Sensitivity = 76%
Specificity = 79%
Accuracy = 84%
Overall good 
test performance 
in adolescents 
(15–24 years) 
(Cook et al., 2005)
Measures 
alcohol use 
only
CAGE 
(Cook et al., 2005; 
Knight et al., 2000)
Cut-off score = 1
Sensitivity = 69%
Specificity = 63%
Accuracy = 70%
Brief, verbally 
administered, easy 
to remember, easy 
to score
Average test 
performance 
in adolescents 
(15–24 years) 
(Cook et al., 
2005)
CPQ–A 
(Cannabis Problems 
Questionnaire) 
(Copeland et al., 2005; 
Martin et al., 2006)
Daily cannabis use:
Sensitivity = 52%
Specificity = 93%
Cannabis 
dependence:
Sensitivity = 78%
Specificity = 90%
Good test–retest 
reliability in 
adolescents 
(14–18 years)
Easy to administer, 
easy to score
Measures 
cannabis use 
only
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Instrument Validity Advantages Disadvantages
CRAFFT 
(Cook et al., 2005; 
Cummins et al., 2003)
Cut-off score = 2
Sensitivity = 94%
Specificity = 63%
Accuracy = 79%
Good test performance 
in adolescents 
(15–24 years)
Easy to administer, 
easy to score; free and 
accessible for use
Brevity of 
instrument 
limits its 
usefulness; 
unable to 
measure 
treatment 
outcomes
DAP–4 (Drug and 
Alcohol Problem 
QuickScreen) 
(Knight et al., 2000)
Partially validated 
4 items 
(Knight, Shrier, 
Bravender, Farrell, 
Vander Bilt & 
Shaffer, 1999)
Easy to administer Not fully 
validated
DAST–A (Drug Abuse 
Screening Test — 
Adolescent) 
(Martino et al., 2000; 
Yudko et al., 2007)
Cut-off score = 6
Sensitivity = 79%
Specificity = 85%
Accuracy = 82%
Good internal 
consistency, high 
test–retest reliability 
and good validity in 
adolescent psychiatric 
in-patients 
Brief, easy to 
administer, 5 minutes 
to complete
DUSI (Drug Use 
Screening Inventory) 
(Christie et al., 2007)
Not validated Comprehensive 
questionnaire
Long, takes 
>20 minutes 
to complete
GAIN (Global Appraisal 
of Individual Needs) 
(Buchan, Dennis, Tims 
& Diamond, 2002; 
Lennox et al., 2006)
Sensitivity = 95%
Specificity = 31%
Comprehensive 
questionnaire
Good test–retest 
reliability; good 
internal consistency; 
easy to score; 
normalised to 
adolescents in many 
settings; inexpensive
Long, takes 
60–120 
minutes to 
complete
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Instrument Validity Advantages Disadvantages
POSIT (Problem 
Oriented Screening 
Instrument) 
(Knight et al., 1999; 
Latimer et al., 2004)
Cut-off score = 1
High school
Sensitivity = 71%
Specificity = 73%
Middle school
Sensitivity = 86%
Specificity = 48%
Good internal 
consistency, 
good test–retest 
reliability, validated 
in adolescents 
(12–19 years);
validated in multiple 
settings (schools, 
juvenile justice system)
20 minutes to 
complete
SACS (Substances and 
Choices Scale) 
(Christie et al., 2007)
Sensitivity = 86%
Specificity = 81%
Good internal 
consistency, 
good test–retest 
reliability, validated 
in adolescents 
(13–18 years) 
Acceptable to young 
people; simple and 
brief; able to measure 
changes over time; free 
and accessible over the 
internet
Focus on 
problems; 
intended to be 
used with SDQ
SDQ (Strengths 
and Difficulties 
Questionnaire) 
(Christie et al., 2007; 
Goodman, 2001; 
Hawes & Dadds, 2004)
Total difficulties
Cut-off 
score =17–18
Sensitivity = 23%
Specificity = 94%
Moderate–strong 
internal reliability
Free and readily 
accessible over the 
internet; acceptable to 
young people
Does not 
measure 
substance use 
behaviours or 
implications
SSI–AOD (Simple 
Screening Instrument 
for Alcohol and Other 
Drug Abuse 
(Knight et al., 2000)
Cut-off scores:
0–1 = low risk
2–3 = minimal risk
4+ = moderate–
high risk
Good internal 
consistency, high test–
retest reliability
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4.4 Use of sniffer dogs 
and drug searches
Possession of drugs and drug items, such as 
pipes or other implements, may also indi-
cate drug-using behaviour. Drug detection 
‘sniffer’ dogs have been trained to detect 
the scent of illicit drugs, such as cannabis, 
ecstasy, meth/amphetamine, cocaine and 
heroin (Barbour, 2006).
The use of drug sniffer dogs in schools and 
searches of students’ lockers or belongings 
have been subject to frequent litigation in 
the United States (Stader, 2002) and no stud-
ies have evaluated the effectiveness of such 
searches for deterring drug use or reducing 
drug-related harms in students.
In Australia, drug detection dogs are not used 
in the school environment. The Police Powers 
(Drug Detection Dogs) Act 2001 (NSW) (the 
‘Drug Dogs Act’, now repealed9) authorised 
police to use drug detection dogs, without 
a warrant, in public places, such as licensed 
premises, public transport routes and sports/
entertainment venues. Drug detection dogs 
could also be used in other public places, 
with a warrant, if police had a reasonable 
suspicion that drug offences were taking 
place in the public place.
In a review of the Drug Dogs Act, the New 
South Wales Ombudsman examined police 
records and court documents, and conducted 
community consultations to evaluate the 
use of drug detection dogs by New South 
Wales police (Barbour, 2006). Over the two-
year review period (February 2002– February 
2004), 17 drug detection dogs made over 
10 200 indications.10 No record of the total 
number of people screened was availa-
ble. Approximately 40 per cent of indica-
tions were in persons aged 18–25 years, 
whereas 7 per cent occurred in persons under 
18 years.
In accordance with police policy, indication 
by a drug detection dog allows police to 
search the person. The rate of finding drugs 
by search was approximately 26 per cent 
(a range of 7–56 per cent depending on the 
dog) of those indicated by a drug detec-
tion dog. Cannabis was the most frequently 
detected drug (84%), followed by ecstasy 
(8.5%) and meth/amphetamine (7.7%). The 
quantities of drug found were generally very 
small amounts and predominantly resulted 
in a caution, without legal proceedings or 
prosecution. Where drugs were not located, 
the person sometimes admitted prior drug 
contact, either their own use or passive con-
tact with the drug (e.g. in the same location 
as others using cannabis).
The review concluded that drug detection 
dogs were able to target drug supply in 1.4 
per cent of indications, where the quantity 
of drug found was sufficient to lay supply 
charges, but found no evidence that drug 
detection dogs deterred drug use or reduced 
drug-related crime.
The 9 Police Powers (Drug Detection Dogs) Act 2001 (NSW) was repealed in December 2005 and 
replaced with the Law Enforcement (Powers and Responsibilities) Act 2002 (NSW).
When a dog detects the scent of a drug, it normally sits next to the scent to indicate the 10 
location to the dog handler.
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While drug detection dogs were generally 
unobtrusive and non-threatening, some peo-
ple were distressed and fearful of the dogs. 
Police also received a number of complaints 
from people concerned about the use of drug 
detection dogs (>50 written complaints). Com-
plaints primarily pertained to false indica-
tions, infringement of civil liberties, feelings of 
embarrassment, humiliation and anger, esca-
lation of searches to charges for non-drug-
related offences (e.g. resisting arrest), police 
use of personal information, and victimisation 
based on racial or other minority status.
Some reports included in the review sug-
gested that the use of drug detection dogs 
may encourage drug users to engage in more 
harmful drug behaviours in order to evade 
detection. For example, drug users want-
ing to avoid carrying drugs consumed larger 
quantities of drugs at one time instead of 
smaller amounts over a longer period, con-
sumed drugs at home before driving to an 
entertainment venue, purchased drugs from 
unknown sources at a venue, and switched to 
drugs that they believed were less detectable, 
but potentially more harmful (e.g. GHB).
4.5 How effective are 
drug testing programs at 
deterring drug use?
The evidence base pertaining to the effec-
tiveness of drug testing programs in schools 
is scarce and available research is generally 
limited in scope and poor in quality. While 
there is a large volume of literature about 
drug testing programs for school-aged chil-
dren, the overwhelming majority of articles 
comprise anecdotal evidence and journal-
istic comment. Few studies have examined 
specifically the effectiveness of drug test-
ing programs for school students and none 
has been conducted rigorously in a con-
trolled, unbiased manner. Table 30 provides 
a brief summary of the available studies that 
assessed the effectiveness of drug testing 
programs in schools.
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Table 30: Summary of studies assessing the effectiveness of drug testing programs
Study Study design Quality Setting Population Intervention Outcomes assessed Results
(Brady, 
2004)
Cross-sectional 
survey 
(American Drug 
and Alcohol 
Survey)
Poor Hunterdon 
Central Regional 
High School, 
New Jersey USA
550 student athletes, 
grades 9–12 
(1997–1999)
948 student athletes, 
grades 9–12, 
in extracurricular 
activities, or holding 
parking permits (2002)
Random drug testing program 
(no details provided)
Frequency of use of:
stimulants•	
cannabis•	
alcohol•	
any drug•	
Reported drug use:
declined in testing period•	
increased in non-testing •	
period
Reported alcohol use:
increased in testing •	
period (grades 10–12)
decreased in non-testing •	
period (grades 10–12)
(McKinney, 
2004b)
Cross-sectional 
surveys
Poor 2 Indiana 
high schools, 
Columbus USA
High school student 
athletes & students in 
extracurricular activities, 
grades 9–12 (study 
sample unknown)
Random drug testing program 
implemented in one school 
(1999–2003) (no details 
provided); written policy, student 
assistance, student counselling
One Indiana high school, without 
drug testing program (2001)
Cannabis and other 
drug use (no details 
provided)
Reported drug use:
lower in drug testing •	
school
(DuPont et 
al., 2002)
Cross-sectional 
surveys
Poor 9 secondary 
schools across 
USA, with 
apparently 
successful drug 
testing programs
246–2500 student 
athletes, students in 
extracurricular activities, 
or student drivers
Random drug testing programs; 
primarily urinalysis; hair analysis 
at one school 
Proportion of positive 
drug tests
4 schools used self-
reported drug use 
No formal evaluation 
conducted in any school
(Goldberg, 
Elliot, 
MacKinnon, 
Moe, Kuehl, 
Nohre et al., 
2003)
Cross-sectional 
surveys
Poor 2 Oregon 
high schools, 
Portland USA
276 student athletes
135 tested; 141 not 
tested
(1999–2000)
SATURN study 
Random drug testing program 
(urinalysis) implemented at 
Wahtonka High School 
Lifetime drug use; 
30-day drug use; 
attitudes and beliefs
Reported drug use:
lower in drug testing •	
school
Drug use risk factors:
higher in drug testing •	
school
(Yamaguchi, 
Johnston 
& O’Malley, 
2003a; 
2003c)
Cross-sectional 
surveys
Average  410 secondary 
schools across 
USA
(Monitoring the 
Future study data)
75 000 children in 
grades 8, 10, 12
(1998–2001)
Range of drug testing programs:
random testing of all students, •	
student athletes, students in 
extracurricular activities, or 
those with parking permits
targeted testing of students •	
with suspicion of use
12-month 
cannabis use
12-month other 
drug use
Reported rates of drug use 
in student athletes and 
experienced cannabis users 
similar in schools with 
and without drug testing 
programs
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& O’Malley, 
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Cross-sectional 
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Average  410 secondary 
schools across 
USA
(Monitoring the 
Future study data)
75 000 children in 
grades 8, 10, 12
(1998–2001)
Range of drug testing programs:
random testing of all students, •	
student athletes, students in 
extracurricular activities, or 
those with parking permits
targeted testing of students •	
with suspicion of use
12-month 
cannabis use
12-month other 
drug use
Reported rates of drug use 
in student athletes and 
experienced cannabis users 
similar in schools with 
and without drug testing 
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All evidence is derived from United States 
studies where drug testing programs have 
largely targeted athletes and students involved 
in extracurricular activities. This follows legal 
proceedings in which the constitutionality 
of drug testing programs has been chal-
lenged in several cases (see Section 5). In 
addition, all available studies used a self-
report, cross-sectional survey design, which 
may have limitations for measuring drug 
use. For example, one study reported that 
the proportion of teenagers self- reporting 
illicit drug use in the United States National 
Household Survey on Drug Abuse (NHSDA) 
did not correlate with objective measures, 
such as the proportion of teenagers in drug 
overdose deaths or drug-related hospital 
emergency treatments (Males, 2005). 
In contrast, a recent validity study compared 
self-reported drug use data from the same 
NHSDA survey with results of urine and hair 
specimens collected from the same respond-
ents (Harrison, Martin, Enev & Harrington, 
2007). While there were some differences 
between reported use and test results (e.g. 
some reported use and tested negative; others 
did not report use and tested positive), self-
reported drug use was verified by objective 
biological testing in most respondents aged 
12–25 years (e.g. 93 per cent agreement in 
three-day self-reported cannabis use and 
urine drug test results). Therefore, the validity 
of self-reported data may depend on the 
quality of the survey instrument and the 
reliability of an objective comparator.
4.5.1 Hunterdon study
One widely cited study that has been used 
as evidence of the effectiveness of drug test-
ing was conducted at Hunterdon Central 
Regional High School in New Jersey (Brady, 
2004). Between 1997 and 2000, a drug test-
ing program was implemented to detect drug 
use in student athletes.11 Five hundred and 
fifty students (approximately 24 per cent of 
all enrolled students in grades 9–12) were 
surveyed twice using a self-report question-
naire: (i) prior to the implementation of the 
drug testing program (1996–1997); and (ii) 
during the period in which drug testing was 
conducted (1999–2000).12 In 2002 (during 
the period in which random drug testing was 
suspended), 948 students (approximately 36 
per cent of all enrolled students in grades 
9–12) were surveyed (Brady, 2004). Students 
were stratified by their level of risk into three 
levels:
high risk = multi-drug users, stimulant •	
users and heavy cannabis users
moderate risk = occasional drug users and •	
light cannabis users
low risk = students who had tried, but •	
were not current users; those who had 
negligible use; and those who had never 
used.
The study provided no information about the type of testing, or what drugs were being tested for.11 
Random suspicionless drug testing was believed to violate the Fourth Amendment of the United 12 
States Constitution, which ruled that individuals and their property could be searched only on 
the basis of evidence that a crime had been committed or was about to be committed (i.e. where 
there was probable cause) (McKeganey, 2005). The program was suspended in 2000 following 
a Supreme Court challenge to the constitutionality of random drug testing (Board of Education 
of Independent School Dist. No. 92 of Pottawatomie County v Earls (2002), but reinstated for 
athletes and students undertaking extracurricular activities in December 2002.
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Overall, there was a decline in self-reported 
use when the drug testing program was in 
place, with a subsequent increase in use 
when the program was suspended. For exam-
ple, 1.4 per cent of grade 9 students were 
classified as high-risk, multi-drug users prior 
to drug testing — this reduced to 0.6 per 
cent during the testing period and increased 
to 2.5 per cent when drug testing was sus-
pended. A similar pattern was reported for 
the other risk levels and for the older grades. 
While these data may appear to indicate that 
the drug testing program was successful in 
reducing and/or deterring drug use, cau-
tion should be taken before reaching this 
conclusion as this study was fraught with 
methodological and interpretive weaknesses 
that severely limit its usefulness in deter-
mining the effectiveness of drug testing in 
deterring drug use. The study’s limitations 
include:
The lack of control data makes it impos-•	
sible to determine whether changes in 
behaviour were due to the drug testing 
program or to a range of other poten-
tially confounding factors that may have 
existed in parallel (e.g. changes in drug 
availability and/or cost, external health 
promotion messages or preventive strat-
egies).
Additional elements to the drug testing •	
procedures, such the presence of a writ-
ten drug policy, drug education, student 
counselling and assistance, were not eval-
uated to assess their impact on students’ 
behaviour. It is possible that these com-
ponents alone contributed to a reduction 
in reported drug use.
The representativeness of survey partici-•	
pants is also unknown as it was not clear 
what proportion of eligible13 students was 
tested or surveyed or how many eligible 
students were absent on data collection 
days.
The validity of the survey instrument•	 14 is 
unknown.
Notwithstanding the potential inaccura-•	
cies inherent in self-reported surveys of 
drug use (Males, 2005), the reliability of 
data from the Hunterdon survey is also 
in question as it was unclear whether the 
survey was supervised by an independent 
agency or by staff that may have sup-
ported the drug testing program.
It was not clear whether reported reduc-•	
tions were significant as no statistical 
analyses were performed.
The research data also showed some anoma-
lous findings. For example, while there were 
some reported reductions in use during the 
period that testing was suspended (e.g. the 
proportion of grade 12 heavy cannabis users 
decreased from 2.1 per cent during drug test-
ing to 0.6 per cent during suspension), the 
proportion of grade 10–12 students using 
alcohol increased during the drug testing 
period, with a subsequent decrease during 
suspension. No explanations were provided 
to account for these changes. However, in 
relation to the latter effect, it is not unrea-
sonable to speculate that this may represent 
a displacement effect. That is, students were 
increasing their alcohol intake during the 
drug testing period in lieu of taking drugs.
Eligible students were those in grades 9–12, excluding school drop-outs, absentees and students 13 
with ≥ 3 inconsistent responses, or those deemed to have exaggerated responses.
The American Drug and Alcohol Survey was developed by Rocky Mountain Behavioral Sciences 14 
Institute, Fort Collins, CO.
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Although the United States Supreme Court 
identified student athletes as suitable candi-
dates for drug testing in their 2002 judge-
ment, there is little evidence to suggest that 
student athletes are more at risk of social drug 
use compared with their non- athlete peers 
(Albrecht, Anderson & McKeag, 1992). On 
the contrary, studies have shown that, apart 
from anabolic steroids and other performance-
 enhancing drugs, student athletes have lower 
drug use compared to non- athlete college stu-
dents (Schnirring, 1995; Taylor, 1997). Taylor 
(1997) proposed a model of compensating 
behaviour, which suggests that drug testing 
may persuade a small number of athletes to 
reduce (or modify) their drug use, but may also 
induce marginal athletes to quit participation 
in sports and revert to the higher levels of 
drug use shown by their non-athlete peers. 
This may result in a small reduction in drug 
use for some, but a redistribution of drug use 
from relatively low levels to a higher level of 
use for others.
Not only does this policy invade the pri-
vacy of a group of students who are rel-
atively unlikely to use drugs, but it also 
discourages athletic participation and may 
actually lead to an increase in overall drug 
use. (Taylor, 1997, p.362)
4.5.2 Student Drug Testing 
Coalition
Similar poor-quality research on drug test-
ing programs has also been reported in 
several short papers prepared by members 
of the Student Drug Testing Coalition. These 
papers provide simple descriptive statistics 
and school principals’ views of drug testing 
programs (McKinney, 2002; 2004a; 2004b; 
2005). For example, 85 per cent of school 
principals believed that students’ drug use 
decreased when drug testing was imple-
mented and increased when it was suspended 
(McKinney, 2002; 2004a; 2005). However, 
given that the argument for the use of drug 
testing is predicated on the assumption that 
teachers do not know who is using drugs, it 
is unclear how they could determine whether 
there was any change in use in the absence 
of testing. Data from these studies do not 
provide adequate evidence of effectiveness; 
they serve only to indicate that some teach-
ers support the drug testing program.
In a comparison of two schools, one with 
and the other without a drug testing pro-
gram, McKinney (2004b) suggested that the 
school with drug testing had lower levels 
of drug-related expulsions and suspensions, 
lower cannabis use, higher graduation rates, 
and that students felt safer, were more dis-
approving of cannabis use, and less likely to 
use inhalants, tranquillisers or amphetamines 
compared to the school without a drug test-
ing program. However, the author provided 
no indication of how comparable the drug-
testing and non-drug-testing schools were 
with respect to other potential confound-
ing characteristics, such as socio economic 
status, ethnicity and gender, school size 
and location — factors known to impact 
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on the prevalence of drug use by school-
children (Hawkins et al., 2002; Masten, 2004; 
National Crime Prevention, 1999; Spooner 
et al., 2001; Wilkinson & Marmot, 2003). In 
addition, if there were differences between 
these two schools after the implementation 
of drug testing, these cannot be attributed to 
the drug testing program as baseline meas-
ures of drug use were not recorded in the 
schools before implementing the program. 
Therefore, data derived from comparisons 
between these schools are unreliable.
A post hoc survey was also conducted in 
nine United States schools, which used a 
variety of drug testing programs (DuPont 
et al., 2002). Overall, survey results showed 
limited data pertaining to the effectiveness 
of drug testing programs. No schools con-
ducted formal evaluations, yet reductions in 
the number of positive tests for a variety of 
substances were reported. Since the survey 
results included only those schools that de-
scribed their programs as ‘successful’, it is not 
surprising that the authors concluded that 
drug testing programs were successful. No 
control schools were included in the survey 
to determine whether other components of 
the program (e.g. drug education, parental/
community support) contributed to reduced 
drug use. For example, evidence from a sur-
vey of secondary school students in Victoria 
(Australia) and Washington (United States) 
showed significant associations between 
drug education with strong abstinence or 
harm minimisation messages (without drug 
testing programs) and reduced drug or al-
cohol use at school (Evans-Whipp, Bond, 
 Toumbourou &  Catalano, 2007).
4.5.3 SATURN study
In 1999, the SATURN (Student Athlete Test-
ing Using Random Notification) study was 
undertaken and involved a pilot evaluation 
of the effectiveness of a drug testing pro-
gram implemented as a deterrent to drug 
and alcohol use among high school athletes 
(Goldberg et al., 2003). Student athletes in 
two Oregon high schools, with and without 
a drug testing program, completed survey 
questionnaires at the beginning and end of 
the school year. Between the initial survey 
and the end-of-year survey, the proportion 
of student athletes reporting illicit drug use 
in the 30 days prior to testing decreased sig-
nificantly in the drug-testing school, whereas 
30-day use for control athletes (without 
drug testing program) increased (p<0.05). 
No change in tobacco or alcohol use was 
reported in either school. This is not surpris-
ing, as tobacco was not included in the tested 
substances and students were probably aware 
that alcohol use was unlikely to be detected 
one day after use. However, while random 
drug testing may have reduced reported 
use of illicit drugs in student athletes in the 
school conducting drug testing, risk factors 
for drug use, including norms of use, belief 
in lower risk of drugs and poorer attitudes 
toward school, increased significantly in the 
same group (p<0.05). Goldberg et al. (2003) 
suggest that students’ attitudes may have 
become more negative due to the percep-
tion that the new school policy would reduce 
their individual freedom. This is consistent 
with reported negative attitudes of employ-
ees after the introduction of workplace drug 
testing programs (Konovsky & Cropanzano, 
1991; Rosse, Miller & Ringer, 1996).
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The SATURN study, which was funded by 
a drug testing grant, raised many ethical 
concerns about the participation of chil-
dren in this type of research (Chiodo, Moe & 
Goldberg, 2004; Shamoo & Moreno, 2004a; 
2004b; Verma, 2004) and federal authori-
ties suspended this study during the pilot-
ing phase due to poor methodology (Winter, 
2003). Students in the study who refused 
to be tested were barred from participation 
in sports. Thus, the lack of options for stu-
dents to refuse drug testing failed to meet 
the  Office of Human Research Protection 
standards (Verma, 2004). Other study limita-
tions, which severely limit the generalisability 
of results, included: a high study dropout 
rate (> 40%); small sample size; and self-
selection to the intervention group. In addi-
tion, students in both schools knew whether 
they would be tested (or not) at least three 
months before testing began. Thus, baseline 
data were not a true measure of drug use 
before the intervention was implemented.  
Despite poor methodology, the SATURN study 
was used as evidence in the Supreme Court 
ruling against Earls (Board of Education of 
Independent School Dist. No. 92 of Pottawato-
mie County v. Earls (2002).15 Goldberg, the 
SATURN study’s principal  author, admitted 
that the study did not prove that testing 
reduced drug consumption and stressed the 
need for a larger randomised controlled study 
with longer follow-up and evaluation across 
an adequate number of suitably matched 
schools (Winter, 2003).
4.5.4 Michigan study
Drug testing programs are often predicated 
on the basis that drug testing will deter use. 
If this assumption is correct, it follows that 
less drug use should occur in schools with a 
drug testing program compared to schools 
that do not test. Thus, a large national United 
States study, known as the ‘Michigan’ study, 
examined the association between drug test-
ing and self-reported drug use in over 75 000 
children in grades 8, 10 and 12 from 1998 
to 2001 (Yamaguchi, Johnston & O’Malley, 
2003b; 2003c). Data were obtained primar-
ily from the Monitoring the Future (MTF) 
study, which comprises a series of annual 
surveys of secondary school students in the 
United States (Johnston, O’Malley,  Bachman 
& Schulenberg, 2007). 
Between 1998 and 2001, approximately 18 
per cent of all schools surveyed in the United 
States (74/410 secondary schools) reported 
implementing a drug testing program (Yama-
guchi et al., 2003b). Results showed that 
the presence of a drug testing program was 
not associated with the prevalence or fre-
quency of cannabis or other illicit drug use 
in schools (grades 8, 10 and 12). In addition, 
drug testing programs were not associated 
with lower use of cannabis or other illicit 
drugs in targeted subgroups, i.e. male ath-
letes or experienced cannabis users.
Lindsay Earls was an 18-year-old, high-achieving high school student who never took drugs. 15 
The mandatory drug testing policy at her school required her to provide a urine sample before 
she could join the choir. She objected to the invasion of privacy and having to prove her 
innocence without evidence of wrongdoing before gaining permission to participate.
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A follow-up study containing one year of 
additional data in a larger sample of schools 
confirmed the lack of effect shown in the 
initial study (Yamaguchi et al., 2003a). How-
ever, due to the cross-sectional study design, 
causal effects cannot be determined. A key 
limitation of this survey was that it failed to 
distinguish between schools that conducted 
regular random tests and those that tested 
only occasionally. In addition, it was unclear 
how well the program had been implemented 
(e.g. appropriate collection of materials, 
adequate supervision of tests, strategies to 
minimise opportunities for cheating). A well-
designed, randomised controlled study with 
appropriate baseline measures, comparison 
of different drug testing approaches, fre-
quency of testing, potential adverse outcome 
measures (e.g. truancy, drop-outs, diversion 
to other drugs or alcohol, disconnectedness 
from school) and examination of the cost-
effectiveness of drug testing is needed for 
this purpose.
The implementation of drug testing programs 
in schools is a highly controversial issue that 
has evoked much debate amongst researchers 
and policy makers alike. While the magnitude 
of support for random drug testing from 
government, schools, parents and anti-drug 
agencies is frequently cited in commentaries 
and research papers (Edwards, 2003;  Office 
of National Drug Control Policy, 2006), there 
are no sound research data to provide evi-
dence of its effectiveness. It appears that 
there may also be a shift away from commu-
nity support for school drug testing. Despite 
earlier indications to the contrary, a recent 
report prepared by the American Civil Lib-
erties Union and the Drug Policy Alliance 
(Kern, Gunja, Cox, Rosenbaum, Appel & 
Verma, 2006) showed that school officials, 
parents and experts are inclined to oppose 
the introduction of drug testing programs 
for a variety of reasons, including: 
cost of testing•	
invasion of privacy•	
unfair burden placed on schools•	
unproven efficacy of drug testing•	
failure to reflect reality of what works•	
fear that drug testing will draw resources •	
from prevention programs based on robust 
scientific research
exclusion policy for positive tests may •	
exacerbate students’ problems
misappropriation of school role•	
erosion of student–teacher trust relation-•	
ship.
4.5.5 Drug testing in 
the workplace
Since there is a paucity of research evaluating 
drug testing programs in schools, it may be 
useful to consider some of the research that 
has been conducted on drug testing programs 
in the workplace. However, it must be noted 
that the key motives for introducing a drug 
testing program into the workplace are related 
to occupational health and safety concerns 
and productivity. That is, employees may be 
working under the influence of substances 
that impair their concentration and reaction 
times, thus potentially putting themselves, co-
workers and, at times, the general public in 
danger; and their use of drugs may increase 
rates of absenteeism. This rationale differs 
markedly from that underlying drug testing 
in the school environment, which is concerned 
largely with reducing overall prevalence of 
drug use in young people.
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Research on drug testing programs in the 
workplace has frequently reported a nega-
tive correlation between testing and drug 
use (Carpenter, 2007; French, Roebuck & 
Alexandre, 2004; Hoffman & Larison, 1999). 
However, correlations cannot be interpreted 
as having a causal deterrent effect. Levels of 
drug use in workplaces with drug testing pro-
grams may be attributed to other factors:
Self-selection processes — workers who •	
use illicit drugs are less likely to work for 
companies that have drug-testing pro-
grams (Bush & Autry, 2002; Hoffman & 
Larison, 1999); and more health-conscious 
workers or those with more negative at-
titudes towards drug use may opt for 
jobs with drug-testing programs (Sujak, 
 Villanova & Daly, 1995).
Other drug programs/policies — drug edu-•	
cation, written policies, employee assist-
ance programs may operate as effective, 
if untested, deterrent strategies and an 
overestimation of effect of drug testing is 
likely to occur unless these are accounted 
for in analyses.
Negative attitudes towards drug use within •	
the general ‘culture’ of the workplace.
Using a multivariate logistic regression model, 
Carpenter (2007) analysed data from the 2000 
to 2001 United States National Household 
Surveys on Drug Abuse (NHSDA), and found 
small, but consistent, patterns supporting 
the hypothesis that workplace drug testing 
deterred worker drug use, especially where 
drug testing was frequent and penalties were 
severe (e.g. termination of employment). How-
ever, a significant, though slightly smaller, 
effect was also apparent in workplaces that 
provided a drug education program, employee 
assistance program and written drug policy, 
but without a formal drug testing program.
In addition, some studies have shown that 
job applicants react negatively to intensified 
personal scrutiny by their potential employers 
by showing less loyalty to their employer and 
being less productive on the job (Konovsky & 
Cropanzano, 1991; Rosse et al., 1996). That is, 
while drug testing may reduce the proportion 
of workers testing positive for drugs, it comes 
at a cost of less positive work behaviours. 
Perceptions of fairness of drug testing depend 
on the characteristics of the job (i.e. accept-
ance is higher if safety is a major concern in 
the workplace) and drug testing procedures, 
such as the type of drug tested for (e.g. less 
positive towards alcohol testing compared 
with other drugs), the type of information 
requested (e.g. medical information is viewed 
as an invasion of privacy) and the response 
to a positive test (e.g. rehabilitation is viewed 
more positively than termination) (Konovsky & 
Cropanzano, 1991). Similar negative attitudes 
may develop in children who are required to 
undergo drug testing in the school envir-
onment. However, no studies have directly 
measured these outcomes.
In summary, student drug testing programs 
in the United States and United Kingdom 
show very poor evidence of effectiveness and 
are based on methodologically flawed re-
search, with a high likelihood of bias leading 
to an overestimation of any positive effect. 
Currently, there are no empirical data per-
taining to effectiveness or cost- effectiveness 
from independent unbiased studies on which 
to base a case to support drug testing in 
schools. That is, there is insufficient evi-
dence to suggest that drug detection pro-
grams deter the initiation of, or encourage 
cessation of, drug use in schoolchildren. In 
contrast, however, there is good research evi-
dence of other strategies that work to deter 
drug use among school-aged children and 
that can be readily and economically applied 
in the school setting (see Section 8).
D
rug detection and screening program
s
81
4.6 How effective are drug 
testing programs at reducing 
drug-related harm?
Two of the key assumptions in support of 
drug testing schoolchildren are that testing 
has the potential to provide:
early identification of drug problems, •	
allowing opportunity for early interven-
tion
appropriate intervention or treatment to •	
minimise the harms associated with drug 
use — such as a decline in physical health 
(injuries, accidents or self-harm), psycho-
logical wellbeing (depression, anxiety, psy-
chosis), educational performance (grades, 
attendance), and family and other social 
relationships — and/or reduce drug-related 
criminal activities.
Existing research has focused primarily on 
measuring reductions in positive drug tests or 
self-reported drug use. Few studies evaluating 
the effectiveness of drug testing programs 
have measured changes in other outcomes 
that may be impacted by drug use, or poten-
tial adverse effects of implementing a drug 
testing program.
The following qualitative study is one of the 
few studies that have assessed the broader 
impact of drug testing in schools. After the 
introduction of mandatory drug testing of 
college athletes in the United States, a study 
by Coombs and Coombs (1991) examined the 
impact of drug testing on students’ morale 
and psychological wellbeing. Data, which 
were collected from 500 survey question-
naires and 57 in-depth interviews, showed 
that most athletes (71.4%) were untroubled 
by the drug testing experience, with some 
reporting other benefits, such as increased 
awareness and knowledge about drug harms, 
or changes in drug-associated behaviour. The 
remainder found it stressful, embarrassing, 
humiliating or upsetting. Some feared they 
may be wrongly identified and disqualified 
from competition for using cold or asthma 
medication or other over-the-counter medi-
cines; others felt degraded and humiliated by 
the experience, or offended by the implied 
suspicion. For some, the prospect of drug 
testing led them to change the times or types 
of drugs they consumed to avoid detection, 
rather than reduce overall use. It is also pos-
sible that drug testing in schools may foster 
a culture of resistance where students take 
pride in beating the test or boast about test-
ing positive.
Similarly, several negative outcomes, which 
are risk factors for increased substance use, 
were associated with the drug testing program 
implemented in the SATURN study described 
above (Goldberg et al., 2003). Compared with 
their peers in the control school, student 
athletes in the drug testing school:
believed that random drug testing pro-•	
vided fewer benefits
believed there were fewer negative conse-•	
quences of random drug testing
believed that authority figures were more •	
tolerant of drug use
had greater preference for risky drug use •	
behaviour
had poorer attitudes towards the school.•	
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4.7 Potential adverse 
outcomes of drug testing 
programs
No studies have directly evaluated the safety 
of random drug testing of schoolchildren or 
any potential adverse outcomes. In a national 
consultation of 1700 Catholic secondary 
schools in Australia (660 000 students), the 
Jesuit Social Services examined how schools 
responded to incidents of illicit drug use by 
students (Norden, 2005). The Keeping Them 
Connected report concluded that, rather than 
reducing drug use by students, random drug 
testing, which was implemented in a handful 
of schools, forced the problem underground, 
reflecting a breakdown in trust and commu-
nication and making it harder for schools 
to handle. The messages received by stu-
dents in drug testing schools were: ‘don’t 
allow your continuing drug behaviour to be 
detected by school authorities; and if you 
or another student has problems in relation 
to illicit drug use, don’t approach school 
authorities for assistance’ (Norden, 2005). 
Thus, ‘the approach was seen to be effec-
tive in protecting the school’s reputation as 
being “tough on drugs”, but questionable 
with respect to the school’s duty of care for 
the student concerned.’
Thus far, a number of potentially deleterious 
outcomes from implementing drug testing 
programs have been identified, including:
breakdown in parent–child and/or school–•	
child relationship, by creating an envir-
onment of resentment, distrust and suspicion 
(Kern et al., 2006) — this may lead to loss 
of school connectedness and runaway be-
haviour
increase in school exclusions and truan-•	
cies
reduced participation in healthy extra-•	
curricular activities, which may result 
in pursuit of other more harmful risky 
behaviours
diversion to other substances that are not •	
tested, or less detectable, yet potentially 
more harmful, including alcohol, inha-
lants, ecstasy (Knight & Mears, 2007)
unwarranted invasion of privacy — dis-•	
tressing, embarrassing, humiliating for 
child to be observed while urinating. 
Given that most students are not likely 
to be using drugs (non-users, occasional/
experimental users), such psychological 
and emotional responses may affect a 
large proportion of children
breach of confidentiality — students must •	
declare prescription or over-the-counter 
medications
false sense of drug-free environment — •	
children with serious drug problems may 
still have negative test results if their drug 
use is outside the window of detection, or 
they have used masking agents or other 
evasion techniques (Knight & Mears, 
2007)
D
rug detection and screening program
s
83
lack of developmentally appropriate ado-•	
lescent treatment/interventions after test-
ing positive (Knight & Mears, 2007)
school time and resources used on drug •	
testing programs instead of education
ambiguous role for schools as monitors of •	
students’ drug use. Is drug testing an ap-
propriate role for schools? Is this responsi-
bility better suited to more appropriately 
qualified individuals, such as a primary 
health care provider?
penalties for drug use — for example, loss •	
of financial aid to United States students 
with a drug conviction, including canna-
bis possession (Students for Sensible Drug 
Policy, 2007). Such action discriminates 
against poorer students who need public 
aid to gain access to higher education.
Schools with drug testing programs have 
adopted a variety of policies, which often 
include a range of sanctions, in the event 
of a student returning a positive drug test 
result. Sanctions may range from a ‘zero 
tolerance’ policy, with exclusion from extra-
curricular activities, suspension or expulsion 
from school, to a non-punitive response, 
with education, counselling and support 
for students.
Despite drug testing policies implemented 
within United States schools being variously 
described by advocates as proactive, prevent-
ative and non-punitive, disciplinary measures 
invariably follow a positive drug test. This 
may be premised on the idea that for a ran-
dom drug testing regime to be efficacious 
it ‘would have to contain some additional 
element of punishment’ (McKeganey, 2005). 
Even though school policies may vary sub-
stantially, commonalities between many 
programs include:
Students participating in extracurricular •	
activities from grades 7–12 are usually 
targeted.
Students are unable to participate in •	
extracurricular activities unless they agree 
to participate in the schools testing pro-
gram.
The most popular tests employed are urin-•	
alysis and saliva testing.
Tests are conducted on a random and •	
reasonable suspicion basis.
Non-compliance with a request to pro-•	
duce a sample will be treated as a positive 
test result.
While many policies have a voluntary •	
component, a student who fails the test 
is still subjected to the same disciplinary 
measure as a student who is targeted for 
cause.
Positive test results are followed with dis-•	
ciplinary measures.
Positive results are communicated to par-•	
ents, the school and the relevant activity 
coordinator.
Positive results are kept in a file to be •	
destroyed once a student leaves school.
(Brendtro & Martin, 2006; Hallfors, Pankratz 
& Hartman, 2007; McKeganey, 2005).
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Out-of-school suspensions and expulsions 
give rise to another set of problems for stu-
dents, schools and parents, namely safety 
concerns related to lack of professional sup-
port and adult supervision during the suspen-
sion period and discontinuity of education 
(Taras, 2003). For example, poor academic 
achievers are over-represented among sub-
stance users (Cox, Zhang, Johnson & Bender, 
2007) and the population of young people 
who are at greatest risk of harm from regu-
lar use of substances may overlap with the 
population who are also at serious risk of 
self-harm, or who are victims of abuse by 
adults (Caan, 2005).
Ironically, students who are most likely to be 
suspended or expelled are also most in need 
of adult supervision. Suspension or expul-
sion from school may exacerbate any existing 
academic and learning difficulties, provide 
them with more opportunity to engage in 
risky or criminal activities, and predispose 
them to greater risk of substance use or 
to quit school permanently (Taras, 2003). 
Therefore, the context of substance use is 
important and should be considered before 
implementing drug testing programs. Poten-
tial humiliation and alienation of vulnerable 
students in an environment of mistrust may 
inadvertently potentiate risks to their long-
term psychological wellbeing.
4.7.1 Connectedness and young 
people’s psychosocial wellbeing
Several studies have explored the relation-
ships between children’s and adolescents’ 
connectedness to their family, peers and/or 
school and health, psychosocial and edu-
cational outcomes (Bond, Patton, Glover, 
Carlin, Butler, Thomas et al., 2004; Bond, 
Butler, Thomas, Carlin, Glover, Bowes & 
Patton, 2007; Bonny, Britto, Klostermann, 
Hornung & Slap, 2000; Harrison & Narayan, 
2003; Patton, Bond, Butler & Glover, 2003; 
Patton, Bond, Carlin, Thomas, Butler, Glover, 
Catalano & Bowes, 2006; Resnick, Harris & 
Blum, 1993).
School connectedness relates to children’s 
and adolescents’ sense of belonging to their 
school, feeling valued, and a belief that they 
are treated fairly by supportive and caring 
staff (Patton et al., 2003; Resnick et al., 
1993). Students with high levels of school 
connectedness have been found to have 
significantly lower rates of substance use, 
violence, suicidal ideation or behaviour, and 
emotional distress as well as positive edu-
cational outcomes, compared with students 
scoring low on school connectedness (Res-
nick, Bearman, Blum, Bauman, Harris, Jones 
et al., 1997; Resnick et al., 1993).
Young people who are not engaged with 
learning or who have poor relationships 
with peers and teachers are more likely to 
use drugs and engage in socially disrup-
tive behaviours, report anxiety/depressive 
symptoms, have poorer adult relationships 
and fail to complete secondary school. 
(Bond et al., 2007, p.357.e10)
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The Gatehouse Project was developed in 
Australia using a whole-school environment, 
multi-level approach to promote emotional 
wellbeing of children by increasing their con-
nectedness to school (Bond et al., 2004). An 
evaluation of this project was undertaken in 
a randomised controlled trial in 26 metro-
politan and regional secondary schools (2678 
students) in Victoria. Four years after im-
plementing the Gatehouse Project, children 
at the intervention schools had significantly 
lower rates of substance use, antisocial be-
haviour and early initiation of sexual be-
haviour compared to those at the control 
schools (Patton et al., 2006).
Any activities that lessen school connect-
edness may impact on students’ health and 
emotional wellbeing and increase their like-
lihood of developing depressive symptoms 
and/or using alcohol or other drugs (Resnick 
et al., 1997). Students who feel resentful, 
embarrassed, humiliated or distressed by 
having to undergo drug testing may lose 
valuable connectedness with their school and 
school staff. Yamaguchi et al. suggest that 
the strongest predictor of student drug use is 
students’ attitudes toward drug use and their 
perceptions of peer drug use (Yamaguchi et 
al., 2003c).
In addition, few physicians support random 
drug testing of schoolchildren. In a sur-
vey of 359 physicians in the United States, 
approximately 80 per cent of all respondents 
(family physicians, paediatricians and ado-
lescent medicine providers) and 93 per cent 
of adolescent medicine specialists disagreed 
or strongly disagreed with recommenda-
tions to drug-test schoolchildren (Levy et al., 
2006). Identification of drug use in children 
is an important role for the primary health 
care provider who is in a better position to 
identify, educate and provide appropriate 
treatment for children at risk, while main-
taining privacy and confidentiality.
In summary, few studies evaluating drug 
testing programs in schools have assessed 
longer-term outcomes, such as students’ 
physical or psychological health and well-
being, or academic performance. Moreover, 
no studies have explored the potential ad-
verse effects of drug testing in schools. It ap-
pears from the limited findings in these few 
studies (Brady, 2004; Coombs & Coombs, 
1991; DuPont et al., 2002; Goldberg et al., 
2003; McKinney, 2002; 2004a; 2004b; 2005; 
Yamaguchi et al., 2003a; 2003b) that drug 
testing has little effect in reducing overall 
drug use, while paradoxically increasing a 
wide range of risk factors for drug use and 
other risky adolescent behaviours. These in-
advertent consequences of a drug testing 
program raise concerns about the full and 
longer-term impact of drug testing, which 
to date has not been evaluated adequately. 
Therefore, there is insufficient evidence to 
suggest that drug testing programs reduce 
harms associated with drug use.
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5. Ethical and legal 
implications of 
drug detection and 
screening programs
In examining the ethical and legal impli-
cations of drug testing and screening, it is 
necessary to determine whether drug testing 
students is legal in Australia under exist-
ing legislation. Currently, there is no specific 
legislation that addresses this issue; thus, the 
legal status of schools to test students is 
undetermined. However, given that govern-
ment schools derive their powers from State 
education legislation, any government school 
seeking to implement drug testing would 
need to ensure that the policy reflected the 
relevant State legislation. In contrast, non-
government schools may incorporate a drug 
testing policy as part of their initial contract 
to enrol a student. This section addresses 
some common law issues that have been 
raised in workplace testing cases, as well as 
some legal and ethical issues surrounding the 
concept of consent in the medical field.
Issues examined below include:
Duty of care•	 : explored through an exami-
nation of the standard of care expected 
from Australian schools, the scope of the 
duty and the implications of deeming a 
school to have an in loco parentis16 role.
Right to bodily inviolability•	 : considered 
through looking at the quality and nature 
of issues such as privacy, consent and 
necessity.
Rights of the child•	 : as determined with 
reference to Australian legislation and the 
ratification of international treaties.
Drug testing as a deterrence strategy•	 .
Similarities and differences between schools •	
and the workplace: with reference to the 
legal concept of reasonableness in the im-
plementation and application of drug test-
ing policies.
To date, drug testing and screening of school-
children has been employed as a drug pre-
vention strategy in many schools within the 
United States. Their experience is also out-
lined here and contrasted with Australia’s legal 
framework, which differs markedly from that 
of the United States in a number of impor-
tant respects. The comparisons between Aus-
tralian and United States legal perspectives 
(New South Wales v Lepore, 2003) are relevant 
to the issue of drug testing in schools as the 
United States experience is often presented to 
support the implementation of similar proc-
esses in this country.
According to the Butterworths’ 16 Australian Legal Dictionary (Nygh & Butt, 1997, p.577), the term 
in loco parentis means ‘in place of the parent’ and describes ‘a person who looks after another’s 
child for and on behalf of the parent and acts as a substitute parent and assumes responsibility 
for providing for the child in the parent’s absence’.
Ethical and legal im
plications of drug detection and screening program
s
87
5.1 Duty of care
The introduction of drug testing in schools 
invokes consideration of the extent of a 
school’s duty of care towards its students.17 In 
2003, the High Court described the student– 
school relationship as similar to the duty of 
care imposed upon an employer and employee 
(New South Wales v Lepore, 2003). The duty 
of care stated in Richards v Victoria (1969) 
was considered to be reflective of the law in 
Australia and held that this duty:
required only that the teacher should take 
such measures as in all the circumstances 
were reasonable to prevent physical injury 
to the pupil. This duty not being one to 
insure against injury, but to take reason-
able care to prevent it, required no more 
than the taking of reasonable steps to 
protect the plaintiff against risks of injury 
which ex hypothesi [the teacher] should 
reasonably have foreseen. (Richards v Vic-
toria, 1969)
A school’s duty to take reasonable care is 
non-delegable. This means that a school 
cannot empower another person with the 
responsibility to take care; the school author-
ity must ensure that reasonable care is taken. 
Due to the non-delegable duty of the school, 
if a school were to introduce drug testing, 
it would then become the school’s respon-
sibility to ensure that all children were ade-
quately aware of the drug testing procedures 
and the risks inherent within the procedure. 
Further to this, schools would be responsible 
for ensuring that everyone conducting the 
tests handled the child and the sample pro-
duced in a manner that was sensitive to the 
child as well as ensuring that the confiden-
tiality of the test results was secure.
In this sense, the duty of a school is posi-
tive. A school will be liable for harm caused 
if it fails to take positive steps to ‘omit to 
protect children under their charge’ (Yeo, 
1998). However, this duty does not neces-
sarily extend to ‘an obligation to prevent any 
kind of harm’ (New South Wales v Lepore, 
2003). The school’s duty of care has been 
described in the following terms: 
To take all reasonable care to pro-1. 
vide suitable and safe premises. The 
standard of care must take into ac-
count the well-known mischievous 
propensities of children, especially in 
relation to attractions and lures with 
obvious or latent hazards.
To take all reasonable care to provide 2. 
an adequate system to ensure that 
no child is exposed to any unneces-
sary risk of injury; and to take all 
reasonable care to see that the sys-
tem is carried out… (Commonwealth 
v Introvigne, 1982)18
As such, the positive duty of a school is to 
provide a safe and secure school environ-
ment.
Early reference to the duty of the school towards its pupils may be found in the High Court of 17 
Australia’s rejection of the notion that ‘the schoolmaster was bound to take care of his boys as a 
careful father would take care of his boys’ (Williams v Eady, 1893). The duty of care found in the 
case of Williams v Eady over a century ago has been described as unreal and of little assistance 
in modern urban schools (New South Wales v Lepore, 2003).
This was a case where the Commonwealth through an intergovernmental agreement had control 18 
of the school, even though it had delegated the running of the school to the New South Wales 
State Government.
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5.1.1 Scope of the duty of care
The scope of a duty of care has been said 
to be ‘functional, as well as geographical 
and temporal’ (New South Wales v Lepore, 
2003). Justice Murphy described the scope 
of a school’s duty of care as ‘a duty to en-
sure that reasonable care is taken of them 
whilst they are on the school premises during 
hours when the school is open for attend-
ance’ (Commonwealth v Introvigne, 1982; 
New South Wales v Lepore, 2003).
The scope of the duty to ensure that rea-
sonable care is taken in the supervision of 
children does not, however, extend to a duty 
of constant supervision. The High Court, in 
the case of Roman Catholic Church v Hadba 
(2005), considered it unreasonable to ‘have 
a system in which children are observed … 
for every single moment of time’. This was 
assessed as ‘well beyond the bounds of rea-
sonableness’19 on the basis that such an 
increased level of supervision would:
damage the teacher–pupil relationships •	
by removing even the slightest element 
of trust
retard the development of responsibility •	
in children
call for a great increase in the number of •	
supervising teachers and in the costs of 
providing them. 
(Roman Catholic Church v Hadba, 2005)
United States law, however, assesses the 
duty and scope of a school more broadly 
than Australian law. For example, schools 
in the United States have been identified 
as ‘special needs’ settings, allowing them to 
waive the requirement to establish probable 
cause to undertake a search for drugs. In 
the United States cases of Board of Edu-
cation of Independent School Dist. No. 92 
of Pottawatomie County v Earls (2002) and 
Vernonia School District 47J v Acton et al. 
(1995), the necessity of the school’s drug 
testing policy was derived from the ‘spe-
cial needs’ of a school environment due to 
its status of in loco parentis.20 Schools were 
determined to have ‘special needs’ due to the 
necessity to ‘establish discipline and main-
tain order…’ (New Jersey v TLO, 1985) and 
the requirement of probable cause was con-
sidered overtly onerous for a ‘Government 
which seeks to prevent the development 
of hazardous conditions’. Nonetheless, the 
judgement in Vernonia stated that schools 
had to demonstrate that there was a perva-
sive drug culture at the school or within the 
community in order to implement a random 
drug testing policy.
In this case, a young girl had sustained an injury while playing on a ‘flying fox’. The school 19 
had developed a clear code of conduct for students while playing on this piece of equipment 
and they had assigned a teacher to oversee this area of the playground. However, the teacher 
had momentarily left the equipment after noticing some other children were not playing 
appropriately in another area of the yard. In arriving at their conclusion that the school had not 
breached their duty of care, the High Court Justices spoke of the necessity of the plaintiff to 
establish that some other form of supervision was not just available in a theoretical sense but 
could actually be observed in reality.
Unlike a search conducted to establish guilt in a criminal case, probable cause is not a 20 
requirement in the determination of a search conducted for administrative purposes — a belief 
that a particular circumstance exists is sufficient. Further to this, in the United States, searches 
do not need to be supported by probable cause when the search is being conducted by an 
institution described as having ‘special needs’ (New Jersey v TLO, 1985).
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In contrast to the above finding, the United 
States Supreme Court in the more recent 
judgement of Earls considered that there was 
not an onus upon schools to demonstrate 
that a drug culture existed and argued that it 
would make little sense to wait until a drug 
problem had developed before allowing a 
school to implement a random drug testing 
program (Board of Education of Independent 
School Dist. No. 92 of Pottawatomie County 
v Earls, 2002). The Supreme Court rational-
ised in the Earls case that random student 
drug testing policies were reasonable due to 
the construction that school administrators 
and teachers were at the forefront in the 
‘war against drugs’ and that drug use among 
young people was ‘epidemic’ (Hyman, 2006; 
Johnston et al., 2007).
The United States Supreme Court further rea-
soned that as a relationship of in loco paren-
tis existed between schools and students:
the need to prevent and deter substantial 
harm of childhood drug use provides the 
necessary immediacy for a school testing 
policy. (Board of Education of Independ-
ent School Dist. No. 92 of Pottawatomie 
County v Earls, 2002)
The necessity for schools to act was said to 
be ‘founded in their relationship of having 
undertaken a special responsibility of care 
and direction for the children’ (Vernonia 
School District 47J v Acton et al., 1995). As 
such, the Supreme Court considered in Earls 
that ‘when the government acts as guardian 
… the relevant question is whether the search 
is one that a reasonable guardian … might 
undertake.’ In this regard, it was decided that 
due to their social status, children were less 
entitled to an expectation of privacy and 
freedom of interference from the State than 
an adult (Board of Education of Independent 
School Dist. No. 92 of Pottawatomie County 
v Earls, 2002).21
In Australia, however, the common law duty 
of care that a school has towards its pupils 
varies substantially from that in the United 
States. The principle of in loco parentis as 
applied in United States cases would be 
considered as apportioning too much respon-
sibility to teachers and schools in general for 
the care and welfare of a child outside of 
school hours. This is because in Australia it is 
considered that ‘teachers will not usually be 
responsible for ensuring that their pupils are 
fed while at school, for the choice of school 
study or activity undertaken by a pupil or for 
the company they keep’ (Yeo, 1998). Further 
to this, under Australian common law, par-
ents do not have a positive duty to protect 
their children from harm.22 That is, a parent 
cannot be held liable for an omission, they 
can be held liable only for a positive action. 
Australian courts have limited the duty of 
care of parents for a number of public pol-
icy reasons:
The imposition of a legal duty of care •	
upon parents would intrude unduly into 
the private sphere of domestic relations.
The impossibility of identifying a rec-•	
ognisable standard of care of parental 
supervision.
This statement as to the status of children was already established in the case of 21 New Jersey v 
TLO (1985) 469 US 325 where a student who was suspected of smoking in the girl’s room had 
her purse searched and the teacher found marijuana.
Some cases in the United States have extended the duty of care to parents in the event of an 22 
omission. In California the standard imposed is that of a ‘reasonable parent’: Gibson v Gibson 
(1971) 479 P 2d 648.
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Parents owe their children a moral duty •	
to act in their best interests; therefore, 
the imposition of a legal duty is overly 
onerous.
Permitting a child to benefit financially •	
from their parents will not actually impart 
any benefit upon the child due to the par-
ents being in a lesser position. 
(Yeo, 1998)
The duty of care is not the only area where 
Australian and United States law varies sub-
stantially. The High Court of Australia has 
referred to the protection of privacy given 
by the Fourth Amendment in the United 
States Bill of Rights as being, in practice, 
of little assistance to the protection of indi-
viduals.23 Due to the nature of public health 
law, ethical considerations such as the right 
to personal autonomy and bodily inviola-
bility and the nature and quality of consent 
given to children are especially pertinent. 
Australian law interprets the rights of free-
dom from bodily interference and privacy as 
having derived from fundamental principles 
of democracy.
5.1.2 Privacy
The concept of privacy has traditionally been 
difficult to define and the judiciary in Aus-
tralia has been reluctant to acknowledge that 
a tort of privacy exists.24 This is due to the 
acknowledgement that, in many instances, 
a claim to privacy impedes the right of free-
dom of expression. However, in recent times, 
courts have acknowledged that privacy is a 
principle drawn from the fundamental value 
of personal autonomy (ABC v Lenah Game 
Meats Pty Ltd, 2001).25 Privacy has been rec-
ognised as having four categories:
Information privacy1. , which involves 
the establishment of rules govern-
ing the collection and handling of 
personal data such as credit informa-
tion, and medical and government 
records. It is also known as ‘data 
protection’
Bodily privacy2. , which concerns the 
protection of people’s physical selves 
against invasive procedures such as 
genetic tests, drug testing and cav-
ity searches
Privacy of communications3. , which 
covers the security and privacy of 
mail, telephones, electronic mail and 
other forms of communication, and
In their judgement in 23 ABC v Lenah Game Meats Pty Ltd (2001), the Justices referred to an article 
which claimed that ‘privacy law in the US delivers far less than it promises’. This was considered 
because claims to privacy always failed when balanced against considerations of public interest.
However, in 24 Victoria Park Racing v Taylor (1937), Justice Rich spoke of the capacity for the court 
to develop a tort of privacy especially with the advance of technological development (Victoria 
Park Racing and Recreation Grounds Company Limited v Taylor, 1937).
However, in 25 ABC v Lenah Game Meats Pty Ltd (2001) the Court stopped short of developing a 
common law right to privacy, preferring instead to let the concept be dealt with under the head 
of other torts — nuisance, breach of confidentiality, defamation and trespass.
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Territorial privacy4. , which concerns 
the setting of limits on intrusion 
into the domestic and other envi-
ronments such as the workplace or 
public space. This includes searches, 
video surveillance and identity 
checks. (Australian Law Reform Com-
mission, 2006)
Statutory law in Australia is generally focused 
on the regulation of information privacy and 
bodily privacy and is generally protected by 
the laws of assault and trespass. However, 
with vast advances in technological devel-
opment there is growing concern that these 
legislative and common law provisions do 
not extend far enough (New South Wales 
Law Reform Commission, 2007).
The notion of privacy lies at the heart of 
liberty in a modern state. This is illustrated 
in the Canadian case of R v Dyment (1988) 
where the need to maintain privacy was 
determined to be essential for the wellbeing 
and development of an individual.26 The 
Supreme Court of Canada concluded that 
the ‘need to place restraints upon govern-
ments to pry into the lives of citizens went 
to the essence of a democratic state’ and 
held that the state can conduct a search only 
when there was prior authorisation through 
either consent or a search warrant.
The United States Supreme Court considered 
that ‘students within the school environment 
have a lesser expectation of privacy than 
members of the population generally’ as evi-
denced by the compulsory requirement that 
children attend school (New Jersey v TLO, 
1985). Further to this, the justices expressed 
the view that this lesser expectation of pri-
vacy was evidenced by the fact that children 
who attend school are required to be ade-
quately immunised and receive medical sight, 
hearing and developmental testing while at 
school. As such, it was held that, in order for 
a school to properly maintain and discipline 
its students, the right to freedom from bod-
ily invasion which exists in the United States 
Constitution does not extend to students. 
The inconsistency of the statement, how-
ever, may be found in the fact that sight, 
hearing and dental check-ups do not attract 
punitive punishments for failing to comply 
with societal standards. Further to this, while 
Australian children may also be subjected to 
hearing, sight and dental check-ups while at 
school, immunisation to date is not consid-
ered a prerequisite for school attendance. In 
Australia, as opposed to the United States, 
none of these health initiatives is compul-
sory and all are conducted after obtaining 
consent from the parents. The Australian 
Government has elected to promote these 
vital health initiatives through programs 
of public education, persuasion and finan-
cial incentives rather than compulsion and 
punishment.
In summary, duty of care in Australia is con-
siderably more limited in its extent than in 
the United States. The duty of care of an 
Australian school does not normally extend 
to cover activities outside school hours and 
acknowledges the child’s right to privacy (see 
below). On these grounds, it is unlikely that a 
case could be made that drug testing would 
be necessitated or justified as part of the 
school’s duty of care.
In the case of 26 R v Dyment (1988) a person who was being treated in hospital after a car accident 
had a vial of their blood given to the police without their consent. The judges in this case 
balanced the need, beneficence and importance of law enforcement against the needs of the 
public to be free from unjustified searches. The judges considered that an individual’s right to 
privacy lay not in the physicality of the search but in the moral indignity of the search.
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5.2 The fundamental right 
to bodily inviolability
In Australia, the right to freedom from bod-
ily invasion is considered a natural and an 
absolute right. An individual’s right to bod-
ily integrity is entrenched within Australia’s 
statutory laws as common assault.27 It is 
often noted in judgements that since ‘the 
law  cannot draw the line between differ-
ent degrees of violence … it totally prohibits 
the first and lowest stage of it; every man’s 
person being sacred, and no other hav-
ing a right to meddle with it, in any the 
slightest manner’ (Blackstone, 1830). The 
common law definition of common assault 
provides that:
An assault is any act which intentionally 
— or possibly recklessly — causes another 
person to apprehend immediate and un-
lawful personal violence … and the actual 
intended use of force to another person 
without their consent. (Fagan v Commis-
sioner of Metropolitan Police, 1969)
It is relevant to note in the context of pro-
posing to drug-test schoolchildren that the 
physical element of an assault is judged with 
reference to the mental state of the victim. 
In this respect, if a reasonable person in the 
position of the victim is put in fear, then the 
physical element of the assault has occurred. 
There are two defences available to a per-
son who is charged with an assault: consent 
and necessity.
5.2.1 Consent
While there is a degree of uncertainty as 
to whether the onus is on the complainant 
or the defendant to prove consent, current 
Australian law has favoured that the defend-
ant needs to prove consent (Plenty v Dillon, 
1991). With regards to medical testing, there 
are two key legal elements of consent: 
provision to participants, at their level •	
of comprehension, of information about 
the purpose, methods, demands, risks, 
inconveniences, discomforts and possi-
ble outcomes of the research (including 
the likelihood and form of publication of 
research results); and
the exercise of voluntary choice to par-•	
ticipate. 
(National Health and Medical Research Coun-
cil, 1999b)
The High Court decision in Department of 
Health and Community Services v JWB and 
SMB (1992) (‘Marion’s case’) recognised 
the ability of children to consent to medi-
cal treatment. In this case, the High Court 
applied what is referred to as the Gillick prin-
ciple of competence. In Gillick v West Norfolk 
and Wisbech Area Health Authority (1986),28 
Lord Scarman stated that:
As a matter of Law the parental right to 
determine whether or not their minor 
child below the age of sixteen will have 
medical treatment terminates if and when 
the child achieves sufficient understand-
ing and intelligence to understand fully 
what is proposed. 
Victoria is the only State which does not have statutory legislation for common assault. However, 27 
the crime still exists at common law within this jurisdiction. For the other States, the relevant 
legislation is: Crimes Act 1900 (ACT), s.26; Crimes Act 1900 (NSW), s.61; Criminal Code (NT), 
s.188; Criminal Code (Qld), s.335; Criminal Law Consolidation Act 1935 (SA), s.39; Criminal Code 
(Tas), s.184; Criminal Code (WA), s.313.
This is an English case where a mother of five daughters challenged the legality of a medical 28 
document being circulated which gave advice about contraceptive devices to girls.
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Preventative medical interventions (drug 
testing could be considered to belong to 
this class of activities) have been described 
by the courts as falling within the concept of 
‘non-therapeutic’ medical testing due to its 
relation to the enforcement of ‘social values 
or values other than the maintenance and 
enhancement of the natural attributes and 
functions of the … child’ (‘Marion’s case’).29 
Justice Brennan, in Marion’s case, consid-
ered that non-therapeutic testing must have 
regard to:
the fundamental right to bodily invio-•	
lability
the gravity of the procedure and its eth-•	
ical, social and personal consequences, 
and
an invasion of bodily integrity can be jus-•	
tified only if it can be shown that the 
non-therapeutic purpose possesses some 
higher value than the preservation of per-
sonal integrity.
Many drug testing programs implemented 
within United States schools state that a 
refusal to submit to be tested results in the 
highest penalty available — total suspension 
from participation in all extracurricular activ-
ities. This is equivalent to the penalty handed 
out to someone who tests positive for drugs 
three times (McKeganey, 2005). 
The attachment of disciplinary measures for 
refusing to participate in a drug testing pro-
gram may be evidence of the need to gain 
consent through coercion. Further to this, 
in many school programs even if a student 
participates voluntarily, they are still sub-
ject to the same penalties for failure as a 
student who is asked to do a drug test ‘for 
cause’. The inconsistency of such a propo-
sition was discussed in Australian Railways 
Union of Workers, West Australian Branch 
and Others v Western Australian Government 
Railways Commission (1999). The Commis-
sioner stated that it was not ‘an employer’s 
role to operate as a law enforcement agency 
nor as the social conscience of the com-
munity’ and therefore considered that any 
drug and alcohol testing program designed 
as a means of improving worker safety and 
productivity should encourage the voluntary 
participation of employees by not penalis-
ing them.
Given the above, it is improbable that drug 
testing of a child could occur without their 
consent, or that of their parents. Moreover, 
failure to offer consent would be unlikely to 
be deemed an admission of guilt within the 
current Australian legal framework.
In 29 Marion’s case (Department of Health and Community Services v JWB and SMB, 1992) the 
parents of a 14-year-old severely disabled girl sought the court’s permission to have their 
daughter sterilised. The judgement of the court was needed due to the inability of the girl to 
consent to the medical procedure. In this case, the views of Lord Scarman in the English case 
of Gillick v West Norfolk and Wisbech Area Health Authority were approved and applied by the 
High Court. The High Court stated that even though the role and duties of parents were borne 
out of natural law, they were not ‘sovereign or beyond review and control’. In this respect, it was 
considered that ‘parental rights are derived from parental duties and exist only so long as they 
are needed for the protection of the person and property of the child’ (Gillick v West Norfolk and 
Wisbech Area Health Authority, 1986).
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5.2.2 Necessity
Necessity is determined by circumstance and 
fact in situations of medical emergency, and 
the status of a child to refuse medical treat-
ment is more complex. For example, a doctor 
may operate on an individual who is denying 
consent or who has been rendered incapable 
of giving consent by way of an accident or 
in an emergency situation without fear of 
being charged with assault or trespass. In the 
cases of DOCS [Department of Community 
Services] v Y (1999) and Minister for Health 
v AS & Anor (2004) the Court overruled the 
refusal to consent to medical treatment of 
both the parents and the child.30 In both 
cases, the views and wishes of the parents 
were not considered as being reflective of 
the best interests of the child.
It is interesting to note that in the cases of 
Earls and Vernonia the United States Supreme 
Court invoked the doctrine of necessity, 
thereby negating the requirement of children 
or their parents to consent to the proposed 
non-therapeutic medical intervention. How-
ever, it is unlikely that the doctrine of neces-
sity could be successfully invoked in Australia 
to override the rights of parents who might 
wish to prevent their child being drug-tested 
at school.
5.3 The rights of children
A central issue in drug testing, and a key 
area where there is significant difference in 
perspective and legal interpretation between 
Australia and the United States, is in rela-
tion to the rights of the child. The United 
States Supreme Court determined that chil-
dren were less entitled to the full ‘bundle of 
rights’ enjoyed by adults. This raises not only 
ethical concerns, but also welfare concerns. 
The status position of the child within the 
United States has led to the determination 
that children are less entitled to freedom 
from interference of the state. The applica-
tion in the United States of a lower standard 
of ‘reasonableness’ has resulted in children 
and teenagers being strip-searched, drug-
tested and, in one school, the FBI raided 
the school with sniffer dogs and pointed 
guns at the children’s heads (Alexander et 
al. v Goose Creek Police Department et al., 
2006; Stefkovich & Torres, 2003). Use of 
such tactics to control the behaviour of chil-
dren must be examined in light of the fact 
that it is now well accepted that children 
within an institutional environment are at 
increased risk of material harm to their per-
son. Significant harm has been, historically, 
brought about through the power imbalance 
that exists between pupil and teacher, and 
children and the state. By the time a case 
comes before the judiciary, an injury, whether 
physical or psychological, has already been 
sustained.31
In these cases both the child and their parents were refusing life-saving treatment endorsed by 30 
the doctors involved. Due to the urgent nature of the medical intervention needed (that is, the 
medical procedures in both cases were therapeutic as opposed to non-therapeutic), the Court 
exercised its inherent parens patriae jurisdiction and directed that the child should be placed 
under the care of the doctors who were able to treat the child as necessary.
Without commenting too much on the facts, in 31 New South Wales v Lepore (2003), a teacher 
under the guise of discipline would send students to a time-out room, ask them to strip and 
smack their body parts. While the teacher was found guilty of an assault, the State was held 
liable for the acts of the teacher.
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As illustrated below, Australian law interprets 
the rights of the child quite differently from 
United States law. For this reason (among 
others), it is not appropriate to extrapolate 
or generalise from legal determinations by 
United States courts to the Australian situ-
ation. Australia has acknowledged that chil-
dren are in special need of protection from 
the state through ratification of the interna-
tional treaty — Convention on the Rights of 
the Child (CROC). Unlike the United States 
Bill of Rights,32 the Convention on the Rights 
of the Child is a modern document, therefore 
its interpretation and intent are easier to dis-
cern according to modern values.
The Australian Law Reform Commission states 
that the medical profession has deferred to the 
theory of principalist ethics since the 1960s 
(Australian Law Reform Commission, 2003). 
In regard to medical testing,33 the full bundle 
of rights should be defined as reflective of the 
principalist theory of ethics which employs 
values such as:
respect for persons•	 : a commitment to treat-
ing people as autonomous agents, and to 
protecting those with diminished capacity 
for autonomy. This principle encompasses 
concepts of respect for the inherent dignity 
of persons, human rights and the promo-
tion of informed decision making
justice•	 : a commitment to ensure fair dis-
tribution of benefits and burdens and to 
avoid oppression of vulnerable groups
beneficence•	 : an obligation to maximise 
possible benefits and minimise possible 
harms (non-maleficence). 
(Australian Law Reform Commission, 2003)
In contrast, consequentialist ethics is ‘acting 
to achieve the best outcome’. It is a justifica-
tion that is based upon consequences, not 
principles (Australian Law Reform Commis-
sion, 2003). Arguably, due to the difference 
in the nature of the relationship that exists 
between a doctor and patient and the state 
and its citizens, legislators are concerned 
with consequentialist ethics as they seek 
to balance individual rights with issues of 
public safety. As such, ‘laws are norms that 
involve an evaluation of behaviour in terms 
of what it should be, an expectation as to 
what behaviour will be and particular reac-
tions to behaviour, including attempts to 
apply sanctions or induce a particular kind 
of conduct’ (Roach Anleu, 2000).
The recognition that children are ‘politically 
disabled’ (Harris, 1982) has led the Australian 
Law Reform Commission to warn that while 
‘age discrimination is an important process 
in law making so as to protect young peo-
ple vulnerable to exploitation, it should be 
recognised such distinctions may also be 
imposed in an arbitrary manner so as to 
streamline administrative processes without 
actually incurring any benefit on the young 
person affected’ (Australian Law Reform 
Commission, 1996).
In accordance with principles of interpretation, the United States Bill of Rights is often subjected 32 
to interpretation with reference to what the forefathers intended.
Drug testing was considered as being within the ambit of medical examinations by the United 33 
States Supreme Court in Vernonia, when it analogised that since the government required public 
school children to be vaccinated, the state exercised more control and supervision over children 
than it did over ‘free adults’.
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The Australian Constitution does not contain 
any express rights similar to the United States 
Bill of Rights. However, the rights of children 
are recognised within Australian law through 
Australia’s ratification of the Convention on 
the Rights of the Child as well as in the Family 
Law Act 1975 (Cth). The Convention on the 
Rights of the Child (CROC) was ratified by 
Australia in December 1990 and came into 
effect on 16 January 1991. The Convention 
on the Rights of the Child provides signifi-
cant guidance as to the responsibilities of 
the state vis-à-vis the child. Article 16 of 
CROC provides that:
no child shall be subjected to arbitrary or 
unlawful interference with his or her pri-
vacy, family, home or correspondence, nor 
to unlawful attacks on his or her honor 
or reputation. (Convention on the Rights 
of the Child, 1991)
While the Article refers generally to informa-
tion privacy, it has also been interpreted to 
cover physical privacy (Australian Law Reform 
Commission, 2006). Further to this, Article 
18 states that:
States Parties shall use their best efforts 
to ensure recognition of the principle that 
… Parents or, as the case may be, legal 
guardians, have the primary responsibility 
for the upbringing and development of 
the child. The best interests of the child 
will be their basic concern.
Articles 28 and 29 provide guidance as to 
the role of the state in providing education 
for children. It is written that States Parties 
should recognise the right of the child to 
education. The Convention obligates sig-
natories to ‘ensure that school discipline is 
administered in a manner consistent with the 
child’s human dignity’ as well as agree that, 
amongst other things, the education of the 
child shall be directed to:
the development of the child’s personality, •	
talents and mental and physical abilities 
to their fullest potential 
the development of respect for human •	
rights and fundamental freedoms, and for 
the principles enshrined in the Charter of 
the United Nations
the development of respect for the child’s •	
parents, his or her own cultural identity, 
language and values, for the national val-
ues of the country in which the child is 
living, the country from which he or she 
may originate, and for civilizations dif-
ferent from his or her own
the preparation of the child for responsible •	
life in a free society, in the spirit of un-
derstanding, peace, tolerance, equality of 
sexes, and friendship among all peoples, 
ethnic, national and religious groups and 
persons of indigenous origin (Convention 
on the Rights of the Child, 1991).
While an international treaty is not gener-
ally considered binding, any State or federal 
legislation, policy or practice may place 
Australia in breach of its international obli-
gations (Australian Law Reform Commission, 
2006). Further to this, the ‘best interests of 
the child’ test is enacted in the Family Law 
Act 1975 (Cth). This test has been assessed 
as paramount in that the ‘protection of the 
child should be elevated above all other 
interests, although those other interests are 
not completely disregarded’ (Minister for 
Health v AS & Anor, 2004).
In summary, Australia is a strong adherent to 
the principles set out in the Convention on 
the Rights of the Child. As such, Australian 
children are afforded special protection in 
terms of their right to privacy and protection 
from interference or acts that might nega-
tively impact their reputation. Drug testing, 
without cause, may be viewed as a threat 
to this right.
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5.4 Deterrence strategy
Drug testing of students is often proposed as 
a preventative strategy in various settings in 
the belief that it will operate as a deterrent. 
While the efficacy of random drug testing 
as an effective prevention strategy is hard to 
establish, a view is often held that drug test-
ing will act as a deterrent to drug use, or at 
least curb use at proscribed times.34
For example, targeted student drug testing 
was implemented in one school in Oregon in 
1995 (Vernonia School District 47J v Acton 
et al., 1995). The school stated that it had 
introduced a drug testing policy due to re-
ported drug use by the football team. It was 
a widely held belief within the community 
that the young people were rebelling due to 
the example set by the football team. The 
school argued that the implementation of a 
random drug testing policy would help deter 
the uptake of drug use and would therefore 
act as a possible preventive measure for drug 
use within the student community.
The policy was implemented as a prerequi-
site for participation in sports. However, one 
student and his parents refused to consent 
to the drug testing policy. Therefore, in ac-
cordance with the terms of the policy, the 
student was denied the opportunity to join 
the football team. The student then chal-
lenged the legality of the school’s drug test-
ing policy on the grounds that it violated his 
Fourth Amendment rights.35 Implicit within 
the construction of the Fourth Amendment 
is the determination that searches are lawful, 
if they are considered reasonable. Reasona-
bleness is determined by ‘balancing its intru-
sion on the individual’s Fourth Amendment 
interests against its promotion of legitimate 
governmental interests’ (Vernonia School Dis-
trict 47J v Acton et al., 1995). Further to this, 
it was considered that the protection of the 
Fourth Amendment extended to protecting 
only those rights that society regarded as 
legitimate (New Jersey v TLO, 1985).
The United States Supreme Court concluded 
that the drug testing policy was reasonable 
and in reaching this decision considered:
the relationship of the parties•	
the necessity of the drug testing policy, •	
and
whether any acts of ‘positive law’•	 36 regu-
lated the responsibilities and obligations 
of the parties.37
Implicit within this statement is the view that those who use drugs may be able to refrain from 34 
use while they are engaged in a proscribed activity. Road traffic laws are regulatory laws aimed 
at increasing road safety. Workplace codes and regulations are laws aimed at increasing worker 
safety and were introduced to ensure employers fulfilled their duty of care. However, a child’s 
compulsory attendance at school is required by statute.
The Fourth Amendment provides that people have ‘the right … to be secure in their persons, 35 
houses, papers, and effects, against unreasonable searches and seizures’.
Positive law is statutory law; that is, law that has been made according to formal rules of 36 
validity.
If acts of statutory law exist, the potential for a drug and alcohol policy to be given lawful 37 
authorisation is more favourable (Exxon Corp v Esso Workers’ Union, Inc., 1997).
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The relationship between schools and the 
federal government in the United States is 
distinctly different from the relationship that 
exists in Australia between schools and the 
Commonwealth or State governments. Since 
2001, the federal government of the United 
States has provided achievement bonuses 
to schools that attained educational targets 
and promoted a safe school environment. 
In the United States, federally funded pol-
icy directed at improving the educational 
outcomes of children and schools is located 
within its ‘No Child Left Behind’ policy; of 
which Title V: Safe Schools for the 21st Cen-
tury mandates the empowering of States and 
school districts in the education and preven-
tion of drug use and violence within schools 
and effectively extends the ‘war on drugs’ to 
children (Bush, 2001). In the deliverance of 
the Supreme Court judgements in Board of 
Education of Independent School Dist. No. 92 
of Pottawatomie County v Earls38 and Verno-
nia39 (detailed above), it was considered that 
in order to give efficacy to the concerns of 
the government and the school district, the 
random drug testing of students participat-
ing in extracurricular activities was not only 
reasonable, it was necessary.
The Supreme Court in Vernonia also consid-
ered that a student’s participation in extra-
curricular activities was a privilege, not a 
right. This contention was upheld by the 
Supreme Court in Earls where it was stated 
that ‘the only consequence of a failed drug 
test is to limit the student’s privilege of 
participating in extracurricular activities’ 
(Board of Education of Independent School 
Dist. No. 92 of Pottawatomie County v Earls, 
2002) ( author’s emphasis). The declaration 
by schools, federal and State governments 
and the judiciary in the United States that 
the penalties imposed are non-punitive is 
based upon the fact that the students are 
not excluded from academic activities.
However, the blurred line between academic 
and non-academic subjects was acknowl-
edged in the random student drug testing 
policy implemented at one school in the 
United States. The random student drug 
testing policy implemented at Electra Inde-
pendent School District in Texas states that 
if participation in the extracurricular activ-
ity was required to contribute to the stu-
dent’s grade point average, then the student 
may need to find another alternative. When 
United States drug testing policies refer to 
extracurricular activities, this also includes 
participation in and attendance at school 
events. For example, students who test posi-
tive for drug use are often unable to attend 
any school dances, fetes, school sporting 
events and other school celebrations. In 
 Arizona, the drug testing policy implemented 
by Chandler Unified School District No. 80 
prohibits students who have tested positive 
for drugs from even entering locker rooms 
and wearing the school colours. Potentially, a 
student at Chandler could be excluded from 
participating in school events and extracur-
ricular activities for up to six years.
This case involved the determination of whether it was reasonable to extend random drug 38 
testing to all students who participated in extracurricular activities.
At the time of 39 Vernonia, the Safe and Drug-Free Schools and Communities Act (SDFSCA) was 
Title IV, Part A of the Elementary and Secondary Education Act (ESEA). This Act was later 
reauthorised as the ‘No Child Left Behind’ Act 2001.
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The United States judiciary has drawn a line 
of demarcation between compulsory attend-
ance at school and choosing to participate 
in extracurricular activities. In the 2001 deci-
sion of Tannahill v Lockney, the United States 
Supreme Court found the drug testing policy 
implemented was too rigid and unreasonable. 
The school attempted to introduce man-
datory random testing for all its students, 
regardless of whether they participated in 
extracurricular activities or not. In this case, 
the Supreme Court stated that the policies 
were too coercive in nature and impinged on 
a student’s Fourth Amendment rights due 
to the fact that it was compulsory for chil-
dren to attend school (Tannahill v Lockney 
Independent School District, 2001). In this 
way, the courts drew a distinction between 
participating in an activity by choice and par-
ticipating in a statutorily required activity.
Australian children, like children in the United 
States, are required to attend school in most 
States until they are 16 (Hallfors et al., 2007). 
This is a compulsory, statutory requirement.40 
In fact, in New South Wales v Lepore the duty 
of a school to ensure that reasonable care 
is taken is said to derive from this statutory 
compulsion (New South Wales v Lepore, 2003). 
However, in the United States, an artificial 
demarcation exists between the statutory 
requirement to attend school and the choice 
of a student to actually participate within the 
school. As compulsory attendance at school 
usually ends when a child turns 16,41 therefore, 
according to the United States demarcation 
of activities, by choice, any child who attends 
school after this age could be subject to the 
random student drug testing program or, 
alternatively, be excluded from school.
In Australia, elective participation in subjects 
often commences in high school and many 
so-called elective subjects offer students the 
opportunity to enhance their future abil-
ity to contribute to society in a meaningful 
way through developing work-related and 
life skills. When drawing the line between 
compulsory attendance in academic subjects 
and elective participation in a subject, it is 
important to remember that many students 
choose subjects that reflect their strengths 
and enhance their feelings of individuality 
and self-esteem. Further to this, the par-
ticipation in many extracurricular activities 
could be considered an important part of 
promoting student health and wellbeing 
through the development of cultural, social 
and individual identity.
Relevant statutes in Australia are: 40 Education Act 2004 (ACT), s.9; Education Act 1990 (NSW), 
s.3(1); Education Act (NT), s.4(1); Education (General Provisions) Act 2006 (Qld), s.9; Education 
Act 1972 (SA), s.5(1); Education Act 1994 (Tas), s.4(1); Education Act 1958 (Vic), s.3; School 
Education Act 1999 (WA), s.6.
In some States, the age is 15 or upon completion of year 10.41 
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5.5 Similarities and 
differences between 
workplaces and schools
Similar reasoning in regard to the potential 
deterrent effect of drug testing has been 
applied in relation to the workplace. The 
effectiveness of drug testing as a preventative 
measure of harm was discussed in the work-
place drug testing case of BHP Iron Ore Pty 
Ltd v Construction, Mining, Energy, Timber-
yards, Sawmills and Woodworkers Union of 
Australia Western Australian Branch (1998) 
(‘BHP’). In BHP, the Commissioner referred to 
evidence tendered by Professor Ross Homel 
which stated ‘that random drug testing in 
all probability would act as a deterrent to 
the use of drugs in the workplace’. Profes-
sor Homel based his conclusion on data and 
experience with random breath testing in a 
road traffic environment.
In an Australian workplace drug testing 
case, the notion of choice was advanced 
by counsel for the employer in Perkins v 
Golden Plains Fodder Australia/Macpri Pty 
Ltd (2004). Perkins was an industrial rela-
tions case brought against an employer who 
had implemented a ‘zero tolerance’ random 
drug and alcohol testing policy.42 Counsel 
for the employer advanced that an employee 
when faced with the prospect of random 
drug testing could:
risk his job by continuing to smoke an •	
illicit drug, or
stop smoking marijuana altogether, or•	
look for another job.•	
The Commissioner, however, considered the 
options advanced as being overly harsh and 
not representative of community views. The 
random drug testing policy introduced in 
Perkins was described by the Commissioner 
as an employer’s document due to the rec-
ognition that the employer had simply im-
posed the document onto its employees 
without any negotiation and with very little 
regard to the consent of the employees. As 
such, the Commissioner in Perkins declared 
that the construction of the implemented 
policy should be interpreted in a manner 
less favourable to the employer (Perkins v 
Golden Plains Fodder Australia/Macpri Pty 
Ltd, 2004).
The test of reasonableness is a determining 
factor in Australian cases that have con-
sidered the application of workplace drug 
testing policies. Reasonableness is deter-
mined with consideration given to why the 
policy was implemented, whether the policy 
was fair and reasonable in its application, 
and whether the penalties implemented were 
consistent in meeting the stated objectives of 
the drug testing policy. The Australian judi-
ciary has also placed particular emphasis on 
the quality and nature of consent in regard 
to workplace drug testing policies. This is 
due to the recognition that ‘the introduction 
of a random alcohol and drug program can 
be counter-productive if there is overwhelm-
ing opposition to it’ (BHP Iron Ore Pty Ltd 
v Construction, Mining, Energy, Timberyards, 
Sawmills and Woodworkers Union of Aus-
tralia Western Australian Branch, 1998). In 
this regard, the amount of collective nego-
tiation in the implementation of, drafting of 
and consent to the proposed random drug 
testing policy is considered imperative to the 
The policy detailed that anyone who returned a positive drug test while at work would be 42 
dismissed immediately. Immediate dismissal resulted regardless of whether the test was conducted 
‘for cause’ or on a random basis. Further to this, the policy stated that if an employee refused to 
submit a sample, then they would be treated as returning a positive test and dismissed.
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consideration as to whether the program will 
achieve its desired outcome of prevention 
and deterrence (Australian Railways Union of 
Workers, West Australian Branch and Others 
v Western Australian Government Railways 
Commission, 1999; BHP Iron Ore Pty Ltd v 
Construction, Mining, Energy, Timberyards, 
Sawmills and Woodworkers Union of Aus-
tralia Western Australian Branch, 1998).
Due to the differences in legislative intent, 
the introduction of random drug testing of 
employees within Australia has been met 
with mixed reactions by the judiciary. Work-
places that have attempted to implement 
mandatory drug testing schemes often cite 
that the schemes are necessary in order to 
comply with occupational health and safety 
legislation and industry regulations aimed 
to increase worker wellbeing and safety.43 
However, the Australian judiciary has been 
reluctant to impose standards that essen-
tially speak to lifestyle issues rather than 
workplace conduct. This is due to the fact 
that, despite invading upon a person’s bod-
ily integrity, most drug testing methods 
are unable to determine impairment; they 
can determine use only. Impairment caused 
by drugs and alcohol is often the standard 
dictated by the legislature,44 as opposed to 
mere use. However, it was conceded by the 
Union in BHP Iron Ore Pty Ltd v Construction, 
Mining, Energy, Timberyards, Sawmills and 
Woodworkers Union of Australia Western 
Australian Branch (1998) that:
the current standards and expectations 
of the community concerning health and 
safety in the workplace, as evidenced by 
legislative prescriptions and judgements 
of courts and industrial tribunals, are such 
that there will, of necessity, be some con-
straints on the civil liberties at times and, 
in particular, an intrusion into the privacy 
of employees.
In regard to other Australian settings, work-
place commissioners have not only consid-
ered reasons why a workplace wished to 
implement a drug testing policy, but also 
the manner in which the workplace drug 
testing policy had been implemented (Aus-
tralian Railways Union of Workers, West 
Australian Branch and Others v Western 
Australian Government Railways Commis-
sion, 1999; BHP Iron Ore Pty Ltd v Construc-
tion, Mining,  Energy, Timberyards, Sawmills 
and Woodworkers Union of Australia West-
ern Australian Branch, 1998; Perkins v 
Golden Plains Fodder Australia/Macpri Pty 
Ltd, 2004; Public Service Association and 
Professional Officers’ Association Amalga-
mated Union of New South Wales (on behalf 
of Sandra Gay) and Department of Corrective 
Services, 2006).
See the cases of: 43 Perkins v Golden Plains Fodder Pty Ltd [2004] SAIRComm 5 (3 February 2004); 
BHP Iron Ore Pty Ltd v Construction, Mining, Energy, Timberyards, Sawmills and Woodworkers 
Union of Australia Western Australian Branch [1998] WAIRComm 130 (19 June 1998); Australian 
Railways Union of Workers, West Australian Branch and Others v Western Australian Government 
Railways Commission No. CR257 of 1998 [1999] WAIRComm 14 (20 January 1999); Public 
Service Association and Professional Officers’ Association Amalgamated Union of New South 
Wales (on behalf of Sandra Gay) and Department of Corrective Services [2006] NSWIRComm 147.
The statutory legislation which refers to the duty of employees is: 44 Occupational Health and 
Safety Act 1989 (ACT), s.40; Occupational Health and Safety Act 2000 (NSW), s.20; Workplace 
Health and Safety Act 1995 (Qld), s.36; Occupational Health, Safety and Welfare Act 1986 (SA), 
s.21(1b)(d); Workplace Health and Safety Act 1995 (Tas), s.16; Occupational Health and Safety 
Act 2004 (Vic), s.25; Occupational Safety and Health Act 1984 (WA), s.20; Occupational Health 
and Safety Act 1991 (Cth), s.21.
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Best practice in terms of workplace drug 
testing programs dictates that a process of 
consultation and consensus between work-
ers, management and unions be undertaken 
before any attempts are made to implement 
programs. Similar consultation processes 
would be expected in the school setting.
5.5.1 Compulsory and 
coercive testing
Consideration also needs to be given to situ-
ations in which compulsory or coercive test-
ing might be appropriate. In doing so, each 
case needs to be assessed in terms of the 
‘responsibilities imposed on … an employee 
and … on the employer’ (Perkins v Golden 
Plains Fodder Australia/Macpri Pty Ltd, 2004). 
In Perkins, it was considered by the Commis-
sioner that, as section 21 of the Occupational 
Health and Safety Act 1986 (SA) only requires 
an employee to attend work unimpaired by 
drugs or alcohol, a drug testing policy that 
could measure only use, not impairment, was 
disproportionate to the standard set by the 
legislature and therefore unreasonable. Even 
though the Commissioner in Perkins empa-
thised with the predicament of an employer in 
fulfilling its statutory duties, it was considered 
unreasonable for an employer to imple ment 
zero-tolerance random drug testing policies 
in the absence of any public policy reasons. 
This was due to the recognition that the pen-
alties imposed were not commensurate with 
the purpose of the policy. The Commissioner 
considered that, in the absence of public policy 
reasons, the only time that dismissal would 
be appropriate within the workplace for non-
compliance with a drug and alcohol policy 
would be if:
the employee was caught taking illicit •	
drugs on the premises
the employee had illicit drugs present on •	
the premises, and
the employee attended for work impaired •	
by illicit drugs.
In this regard, the Commissioner considered 
that the workplace in Perkins was not one 
that could be determined as being ‘safety 
sensitive’. As such, the Commissioner consid-
ered that the only recourse that the employer 
had in the event of a refusal to participate in 
the drug testing or in the event of a positive 
test result was a warning that the employee 
would be closely monitored for any sign of 
impairment and a recommendation that the 
employee undergo counselling.
The recommendation of counselling was 
considered an appropriate punishment due 
to the inability of testing methods to demon-
strate impairment and is consistent with the 
approach taken by the Australian National 
Drug Strategy (Ministerial Council on Drug 
Strategy, 2004).
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5.5.2 Safety-sensitive workplaces
In Australia, workplaces that have been 
deemed to be ‘safety sensitive’ or requir-
ing ‘special needs/public policy’ reasons 
have implemented zero-tolerance random 
drug testing policies as a means of improv-
ing worker safety and wellbeing, assisting in 
the prevention and deterrence of drug use 
within the workplace and for the protec-
tion of the public.45 Zero-tolerance policies 
mandate that both non-compliance and a 
positive test result will be subject to dis-
ciplinary measures. In Australia, workplace 
commissioners have been careful to distin-
guish these instances as ‘exceptional’ and 
have definitively stated that in the absence 
of any public policy reasons, they:
cannot see how, for a great majority 
of workers at least, fairness and reason 
(‘commonsense’) would allow a prohi-
bition extending to what a worker does 
in his or her own time well away from 
the workplace. (Perkins v Golden Plains 
 Fodder Australia/Macpri Pty Ltd, 2004; 
Public Service Association and Profes-
sional Officers’ Association Amalgamated 
Union of New South Wales (on behalf of 
Sandra Gay) and Department of Corrective 
Services, 2006)
An example of a workplace drug testing pol-
icy introduced for public policy reasons may 
be seen in Public Service Association and 
Professional Officers’ Association Amalga-
mated Union of New South Wales (on behalf 
of Sandra Gay) and Department of Correc-
tive Services (2006). Mandatory drug testing 
was introduced for all correctional services 
officers by the Crimes (Administration of 
Sentences) Act (NSW).46 The policy had been 
developed on the advice of the Independ-
ent Commission Against Corruption after it 
investigated an incident at the Metropolitan 
Remand and Reception Centre, Silverwater, 
New South Wales (Independent Commission 
Against Corruption, 2004).47 Even though it 
was considered important that the Depart-
ment was a law enforcement agency and its 
officers should be seen as upholding the law, 
the primary reason for the imposition of a 
zero-tolerance drug testing policy was that 
it was necessary in order for the Department 
to discharge its duty of care. Once again, the 
policy was implemented only after extensive 
negotiation and after collective consent was 
obtained through the relevant union, the 
Public Service Association.
See cases: 45 BHP Iron Ore Pty Ltd v Construction, Mining, Energy, Timberyards, Sawmills and 
Woodworkers Union of Australia Western Australian Branch, 1998; Exxon Corp v Esso Workers’ 
Union, Inc., 1997; Public Service Association and Professional Officers’ Association Amalgamated 
Union of New South Wales (on behalf of Sandra Gay) and Department of Corrective Services, 2006.
Division 5: Testing of Correctional Staff for Alcohol and Prohibited Drugs, of Part 11: Administration.46 
An officer, who admitted to having a drug habit, had been caught smuggling drugs and mobile 47 
phones into inmates. The officer admitted during questioning that his abuse of drugs had 
escalated due to his relationship with the prisoners and the prisoners’ ‘contacts’. In this regard, 
the introduction of a drug testing policy was considered necessary due to the recognition that 
officers who had problems with drugs and alcohol were a security risk to themselves, other staff, 
the prisoners and the public (Independent Commission Against Corruption, 2004).
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The difficulty with implementing zero toler-
ance policies within administrative systems 
such as workplaces and schools is that it is 
not the legislatures, but the managers and 
principals who determine what is reasonable 
in the circumstances. Laws are implemented 
on a continuum with formalised, institutional 
laws at one end of the spectrum and informal 
laws at the other end. The regulation and 
imposition of employer and employee work-
place safety standards, duties and obligations 
may be said to fit along the spectrum as a 
form of quasi-law. Arguably, the penalties 
applied in quasi-laws may be seen as more 
diffuse and less punitive than traditional 
legal sanctions. However, with the introduc-
tion of zero tolerance policies within some 
administrative systems, it may be argued that 
human dignities such as the right to individ-
ual autonomy and personal inviolability may 
be disregarded under the guise of increasing 
public safety and productivity.
There exists a primary difference between a 
workplace and a school environment; em-
ployment is reflective of a contractual rela-
tionship while a student’s requirement to 
attend school is a status relationship. Accord-
ingly, issues with collective negotiation and 
consent are substantially different within a 
workplace and a school environment. Chil-
dren and school teachers have a different 
relationship from employers and employees, 
and school environments often lack the av-
enues of redress and natural justice that are 
present within many workplaces. In the case 
of many workplaces, unions are often en-
listed to negotiate on behalf of workers and 
there is access to a judicial hearing if the 
need arises.
Workplaces that have implemented drug test-
ing policies have had a further responsibility to 
ensure that their employees were aware of the 
potential risks and penalties that may result 
from their workplace drug testing policy as 
well as to ensure that testing was conducted 
in a confidential, unobtrusive manner. Com-
missioners thought that, due to the limitations 
of available testing methods, review periods 
as well as a period in which the confidential 
information could be held by the employer 
were important considerations as to whether 
a policy was reasonable.
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5.6 Summary
The Australian and United States legal 1. 
perspectives differ greatly in regard to a 
number of key issues pertinent to drug 
testing. Hence, legal determinations by 
United States courts cannot be readily 
transferred to the Australian context.
Duty of care in Australia is considerably 2. 
more limited in its extent than in the 
United States. The duty of care of an 
Australian school does not normally ex-
tend to cover activities outside school 
hours and acknowledges the child’s right 
to privacy. On these grounds, it is unlikely 
that a case could be made that drug test-
ing would be necessitated or justified as 
part of the school’s duty of care.
It is improbable that drug testing of a 3. 
child could occur without their consent 
or that of their parents. Moreover, failure 
to offer consent would be unlikely to be 
deemed an admission of guilt within the 
current Australian legal framework.
The Australian legal perspective places 4. 
great(er) weight on the rights of the child 
(than does United States law) and affords 
the child significant rights to privacy and 
protection from interference especially 
where it may negatively impact their rep-
utation. Australian law is also sensitive 
to the lack of avenues for redress and 
natural justice available to children.
Best practice in workplace drug testing 5. 
recognises that testing is only one of a 
number of responses available to employ-
ers and consideration of testing involves 
extensive consultation processes with 
employees, management and unions to 
achieve consensus. Even then, it is con-
sidered reasonable only where specific 
workplaces are deemed safety-sensitive 
or special needs settings. Zero-tolerance 
random drug testing, in the absence of 
strong justification, has been judged to 
be unreasonable.
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6. Submissions — 
summary of comments
To assess the views of key stakeholders on 
drug detection and screening in schools, 
input was sought from representatives of par-
ent groups, teachers and principals, student 
groups (the latter groups included represen-
tation from private, state and non-secular 
schools), AOD experts (both researchers and 
clinicians), police and criminal justice work-
ers, youth services workers, legal experts and 
civil liberties commentators, policy advisers, 
politicians and health economists. Obtaining 
community views was considered essential, 
and the methods employed were designed 
to ensure maximum input from relevant 
community members. The results of the sub-
missions process are presented here.
6.1 Overview
A total of 33 submissions were received. Of 
these, 30 were from key stakeholder organi-
sations and three were from individuals. The 
list of stakeholders who made submissions 
can be found at Appendix E.
Two of the organisational submissions 
were from the United States, one of which 
appeared to be affiliated with one of the key 
informant organisations from Australia.
Table 31: Number of submissions received 
from each State/Territory/country
State/Territory/country
Number of 
submissions
South Australia 10
Victoria  7
Western Australia  5
New South Wales  3
Australian Capital Territory  2
Queensland  2
Tasmania  1
Northern Territory  1
Overseas (USA)  2
Total 33
Respondents were categorised by stakeholder 
group, nominated by the respondents (Table 
32). Some respondents belonged to more 
than one stakeholder group. Six respondents 
did not identify their stakeholder group(s).
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Table 32: Respondents categorised 
by stakeholder group
Stakeholder group Frequency
Policy maker
Education sector•	
Alcohol and other drugs •	
(AOD) sector
Crime prevention •	
12
 
4
 1
AOD worker/clinician/
agency/association  9
Parent  7
Teacher/principal/educator  6
Police  2
School student  2
Youth worker  1
Legal professional  1
Health professional  1
The average length of submissions was three 
to four pages. Four respondents elected for 
all parts of their submission to remain confi-
dential, while two requested that components 
of the submission remain confidential.
6.2 Summary of responses
The summary of responses from stakeholders 
is presented in accordance with the themes 
and questions in the submission pro-forma 
(see Appendix C).
6.2.1 Viability, effectiveness, 
impact and implications of drug 
detection and screening
In favour / not in favour of drug 
detection and screening in schools
The majority of key stakeholder respond-
ents (61%, n = 20) reported that they were 
not in favour of drug detection and screen-
ing measures in schools. These stakeholders 
included parent and school associations 
and various policy makers from the educa-
tion, legal, and drug and alcohol sectors. 
Nine stakeholders (27%) were in favour of 
drug detection and screening in schools, one 
stakeholder reported that they would require 
further information to make an informed 
decision, and three stakeholders did not 
expressly state their opinion in this regard.
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Advantages of drug detection and 
screening in schools
Among stakeholders who were in favour of 
drug detection and screening in schools, the 
most frequently cited advantages of imple-
menting such a system were that it would:
provide an opportunity for early detection •	
and intervention
act as a deterrent to drug use•	
provide a legitimate reason for young •	
people to refuse the offer of drugs and 
resist peer pressure.
Other advantages cited were that drug detec-
tion and screening measures could identify 
young people at risk and could benefit par-
ents and the community in general by the 
reduction of drug use.
Drug detection may reduce the incidence 
of drug trafficking in schools. It would 
assist in creating a safe environment for 
staff and students of the schools. It would 
also protect the public’s safety, and en-
hance parents’ confidence in the school. 
— Policy maker
Those who were not in favour of drug detec-
tion reported that the disadvantages of drug 
detection and screening in schools outweighed 
the advantages and that, to date, there was 
insufficient credible evidence on the effective-
ness, or lack thereof, of such measures.
The evidence collected to date (much of it 
from the USA) does not indicate any clear 
benefit in terms of a reduction in drug 
use… There seems to be no advantage 
for schools to engage in drug detection 
or screening procedures. — Organisation 
from the alcohol and other drug sector
Table 33: Frequency of responses 
for advantages of drug detection 
and screening in schools
Advantages Frequency
Provides early detection 7
Acts as a deterrence 6
Provides opportunity for 
early intervention
5
Provides a credible reason to 
say no to peer pressure
4
Identifies young people at risk 3
Benefits to parents
enhances confidence in •	
school system
parents involved •	
throughout the testing 
process
power and opportunity to •	
prevent child from self-
destructing
3
Creates safe environment 1
Reduces incidence of drug 
trafficking
1
Improves quality of education 1
Benefits the community 1
Note: Stakeholders could provide more than 
one response.
Subm
issions —
 sum
m
ary of com
m
ents
109
Disadvantages of drug detection and 
screening in schools
Stakeholders identified a range of social, eco-
nomic, ethical and legal disadvantages of 
school drug detection and screening. Social 
disadvantages included:
potential stigmatisation, discrimination •	
and alienation of students who are sub-
ject to screening and detection
creation of mistrust, suspicion and loss •	
of respect between teachers and students 
and/or parents and their children
disengagement of young people from •	
schools.
The high financial costs of drug screening 
measures were also noted, with some stake-
holders commenting that it would be more 
beneficial to direct funds towards the imple-
mentation of drug education and treatment 
programs. Ethical issues associated with drug 
detection and screening were also raised, 
particularly the infringement of students’ 
privacy and rights.
Drug testing can infuse an insidious sense 
of suspicion into the delicate student–
teacher relationship, which contributes to 
a hostile environment. This is of particu-
lar concern given the strong correlation 
between school connectedness and stu-
dent success. — Policy maker, education 
sector
if there were to be a proposal to introduce 
drug testing in schools which required the 
involvement of the NSWPF [New South 
Wales Police Force] there would be a 
number of ethical, logistical, legal and 
resourcing issues that would first need 
to be addressed. Furthermore, I would 
have significant concerns that any such 
proposal could undermine the good work 
currently undertaken by NSW Police in 
our schools which relies on developing 
a rapport between students and seeks 
to minimise the involvement of young 
people in the criminal justice system. 
—  Commissioner of Police
Further disadvantages of current drug test-
ing measures included the possibility that it 
could trigger a change of drug use to more 
harmful substances that are harder to detect 
or to substances that are not tested. 
Stakeholders also commented that drug tests 
did not provide sufficient information or a 
contextual basis for drug use. For example, 
tests are not able to distinguish between reg-
ular and experimental use or address prob-
lems underlying drug use. 
drug testing actually reveals very little 
about the circumstances of a student’s 
drug use. It does not show the extent of 
use, when or where the drug use occurred, 
nor the impairment caused by the use. 
— Policy maker, alcohol and other drug 
sector
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Stakeholders also referred to the potential in-
accuracy of drug testing tools and the scope 
for false positives to increase the legal liabil-
ity of schools and create a series of nega-
tive consequences for students inaccurately 
identified as using drugs.
Improper protocols, procedures and safe-
guards would give rise to allegations of 
discrimination against individuals, schools, 
school communities and school sectors. 
— Parent, teacher, policy maker
Also noted was the potential for long-term 
negative consequences for young people 
who were the recipients of punitive actions 
for their drug use. Stakeholders highlighted 
that if a student received a criminal charge or 
a negative school record as a result of their 
drug use, this may limit their education and 
employment opportunities in the future.
Some stakeholders provided counter-argu-
ments to these disadvantages. For example, 
it was reported that the relationship between 
teachers, parents and students would not be 
negatively affected if the drug detection/
screening program was seen as a measure 
to improve the school environment. Other 
stakeholders reported that there is no evi-
dence of unintended harmful consequences 
as a result of school drug testing and that 
there would be no disadvantages provided 
that the confidentiality and rights of students 
and parents were protected and opportuni-
ties for treatment were offered.
In our schools, students have responded 
positively to the idea of improving the 
school environment through drug test-
ing and testing has become a part of the 
school culture. We have found no evi-
dence of the erosion of trust in speaking 
to students and parents in our school 
community. – Principal (US)
Table 34: Frequency of responses for disadvantages of drug detection and screening in schools
Disadvantages Frequency
Economic
Costly to implement•	
Misdirection of funds (funds better spent on drug education/treatment •	
programs)
12
 
7
Legal 
Increases legal liability of school•	
No legislative guidelines/protocols exist•	
Hampers police efforts to minimise young people’s involvement in the •	
criminal justice system
5
2
 
1
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Disadvantages Frequency
Ethical
Invasion of privacy•	
Infringement of rights•	
10
7
Social
Stigmatises/discriminates/alienates students•	
Hampers relationship between teachers/school and students  •	
(e.g. creates mistrust, suspicion, loss of respect)
Increases disengagement/absenteeism in schools•	
Affects relationship between parents and children  •	
(e.g. promotes suspicion, undermines authority)
May offend cultural/religious beliefs•	
22
 
16
7
 
6
2
Psychological 
Trauma/humiliation/anxiety•	 4
Unreliability and other flaws of tests
Changing use to drugs that are harder to detect or using other •	
substances to mask effects
Provides no contextual basis for drug use / insufficient information •	
about drug use
Does not address underlying problem of drug use•	
Changing drug use to drugs that are not tested (e.g. alcohol)•	
 
9
 
8
5
4
Other implications/consequences of testing
Punitive consequences may exacerbate the problem•	
Affects quality of education / hampers role of providing education•	
Prevents students from actively seeking support/assistance for their •	
drug use
Makes school environment less supportive / more threatening•	
8
6
 
5
4
Note: Stakeholders could provide more than one response.
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6.2.1.1 Viability, effectiveness and 
appropriateness of drug detection and 
screening tools
Questionnaires
Stakeholders generally believed that ques-
tionnaires, although viable and appropriate 
to implement, were not very effective as they 
are usually based on self-report which is open 
to bias and subjective opinions and that stu-
dents would not necessarily be truthful when 
reporting their drug use behaviours.
Interviews and clinical observations
Stakeholders believed that the effective-
ness of interviews and clinical observations 
depended on the expertise and qualifica-
tions of the interviewer or clinician and the 
format of the interviews. Some stakeholders 
believed that it would be neither viable nor 
appropriate to implement this type of drug 
screening measure in schools.
Independent tests of body fluids/tissue
The majority of stakeholders believed that 
tests involving body fluid or tissue were not 
reliable, not feasible (too costly) and not 
acceptable (too invasive) to implement in 
schools. Other stakeholders believed that 
some tests were effective and appropriate if 
used with proper protocols or guidelines.
Non-invasive detection mechanisms
Most stakeholders reported that these forms 
of drug detection were not appropriate as 
they constituted a breach of privacy and 
that they were not very effective as inno-
cent students could potentially be accused 
if drugs were intentionally placed with their 
belongings.
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Table 35: Frequency of responses for viability, effectiveness and appropriateness 
of different types of drug detection and screening measures
Types 
of drug 
detection/
screening 
measures
Viable
Effective/reliable/
useful
Appropriate/
acceptable
Additional 
comments
Yes No Yes No Maybe Yes No Maybe
Question-
naires
4 1 1 12 4 7 3 0 Effectiveness 
depends on format, 
purpose of use
Interviews 
and clinical 
observations
2 5 0 5 11 3 7 1 Effectiveness 
depends on 
format, expertise 
of clinicians/
interviewers
Acceptable if 
conducted with 
informed consent
Independent 
tests of body 
fluids (e.g. 
saliva, urine, 
sweat, breath, 
blood)
4 9 4 11 3 5 16 0 Effective or appro-
priate if used with 
protocols/guidelines
Some tests more 
reliable/ expensive/
time-consuming/ 
invasive than others
Independent 
tests of body 
tissue (e.g. 
hair, skin, 
nails)
3 9 2 9 3 0 15 0 Effective if used 
with protocols/ 
guidelines
Non-invasive 
detection 
mechanisms 
(e.g. sniffer 
dogs, 
scanning 
equipment)
2 5 1 8 2 1 13 1 Breach of privacy, 
acceptable if 
ordered by the 
courts, innocent 
students can be 
framed
Note: Stakeholders could provide more than one response.
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6.2.1.2 Types of drug detection and 
screening measures that could be 
implemented in schools
More than half the stakeholders believed that 
no form of drug detection and screening 
should be implemented in schools (Table 36). 
The main reasons provided were that stu-
dents who had problems with drugs would 
exhibit a range of problematic behaviours 
that would be observable by teachers and 
other school staff (testing would therefore 
be unnecessary), and that current forms of 
drug detection and screening were unreliable 
and may be detrimental. Several stakehold-
ers reported a preference for saliva tests due 
to their higher levels of accuracy and effec-
tiveness. Other stakeholders maintained that 
any measure would do if conducted within 
proper legal guidelines and with consensus 
from the majority of school staff, parents 
and students.
Table 36: Frequency of responses for preferred drug detection/screening measure
Preferred drug detection/
screening measure Frequency Rationale
None 18 Testing is unnecessary as students with drug 
problems will exhibit detectable problematic 
behaviours
Tests are unreliable and may be detrimental
Preference for education and awareness 
programs
Saliva tests 3 Highly accurate and effective; not invasive 
(e.g. Oraline)
Independent tests of body 
fluids/tissues
2 Provides accurate results
Can be confidentially conducted
Questionnaires 2 Least invasive
Any tests 2 As long as conducted within proper legal 
framework
With consensus from majority of school staff, 
parents and students and development of 
proper guidelines
Random searches and 
sniffer dogs
1 Reinforces message that schools are public 
property where drugs are inappropriate 
without legitimate reasons
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6.2.1.3 Method of drug testing: 
random or targeted
Most stakeholders did not have a preference 
for either random or targeted drug testing as 
they were opposed to drug testing in schools 
in general. Several stakeholders reported a 
preference for random drug testing as only 
targeting certain groups for testing was seen 
as discriminatory, potentially leading to more 
social problems and distrust (Table 37).
6.2.1.4 Next steps taken once drug 
is detected
The majority of stakeholders recommended 
that some form of support and assistance 
should be provided to the student includ-
ing education, counselling and referrals for 
treatment where required (Table 38). A con-
sultative process with the student and their 
parents was suggested in many instances. 
Disciplinary actions were supported where 
considered appropriate. Police should be 
notified if the incidence was illegal.
Table 37: Frequency of responses for preferred method of drug testing
Method of drug 
testing
Supported
RationaleYes No
Random testing 7 17 Reasons against:
Inappropriate•	
Inaccurate testing devices•	
Will identify only a small sample of users•	
Reasons for:
Not discriminatory•	
Targeted testing 2 17 Reasons against:
Discriminatory•	
Leads to more social problems and distrust•	
Unethical•	
Inappropriate•	
Inaccurate testing devices•	
Reasons for:
Should be conducted only when it is part •	
of the rehabilitation process of an identified 
drug user
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Table 38: Frequency of responses for 
measures taken after drug detection
Next steps after detection Frequency
Assistance and support 
(e.g. education, counselling, 
referrals for treatment) 24
Communication with parents 12
Disciplinary actions taken 
where appropriate 7
Notify police where illegal 
incidences occur 6
No punitive measures should 
be taken 2
Students who test positive 
should be regularly 
tested thereafter 1
Note: Stakeholders could provide more than 
one response.
6.2.2 Viability, effectiveness, 
impact and implications of 
alternative measures
6.2.2.1 Alternatives to drug detection 
and screening
Most stakeholders suggested, as an alterna-
tive to drug detection and screening, the 
implementation of a well-developed drug 
education program that was evidence-based, 
comprehensive and part of a larger health 
and wellbeing program for schools (Table 39). 
Clearly articulated drug and alcohol policies 
and guidelines for schools were also suggested 
by several stakeholders as an alternative to 
drug detection and screening. Other strategies 
suggested include provision of counselling 
by qualified counsellors, options for early 
intervention and treatment programs, and 
programs and activities that focus on personal 
development, life skills, mentoring, peer sup-
port, and health.
In the context of a holistic approach to stu-
dent health, schools can provide evidence-
 based drug education programs that have 
realistic goals related to prevention, in-
tervention and harm reduction. Included 
in their approach should be the develop-
ment of policies that advocate for drug 
education as part of the health education 
program and provide specific guidelines 
that direct action, in the short, medium 
and longer term, when drug use incidents 
occur. — Drug education service provider
Drug education in schools must be linked 
to a comprehensive welfare, health and 
wellbeing strategy that offers students 
a range of supports to help them deal 
with problematic alcohol and/or drug use. 
— Policy maker, AOD sector
In contrast, a few stakeholders believed there 
were no viable alternatives available or that 
education programs and policies would be 
effective only if implemented in conjunction 
with drug detection and screening.
Unfortunately, we have reached a point 
in our society where the acceptance and 
use of illicit drugs amongst our youth 
[are] so prolific that mere education alone 
will not be enough to change this culture 
and prevent drug use. — Recovered drug 
users’ association
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Table 39: Frequency of responses for alternative measures to drug detection and screening
Alternative measures Frequency
Drug education — evidence-based, best practice, informative, 
awareness raising, part of health and wellbeing program 23
Drug and alcohol policy and guidelines — well communicated, 
comprehensive, clear 11
Provision of counselling / qualified counsellors 10
Options for treatment / early intervention programs 7
Personal development programs, health education, life skills 7
After-school programs, extracurricular activities 6
Mentoring / peer support programs 3
Family drug prevention programs 3
Increased commitment to student welfare 3
Increased support for disadvantaged / at-risk students 3
Teachers trained and resources to deal with problems 2
Education alone is insufficient, need to be combined with drug 
detection and screening 2
Good communication between schools, students and parents 2
No viable alternative to drug testing 2
Not sure 1
Other:
no evidence that drug use is problematic among school students•	
programs to support transition from primary to secondary schooling•	
1
1
Note: Stakeholders could provide more than one response.
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Advantages of alternatives to drug 
detection and screening
Stakeholders believed that the alternatives 
would maintain student engagement and 
retention in schools which have been iden-
tified as protective factors for reducing 
drug-related harms (Table 40). The alterna-
tive strategies would also not be invasive 
or infringe upon the rights and privacy of 
students. The relationship between school 
staff, students and parents would also be 
preserved or strengthened with the encour-
agement of open communication and trust 
evoked from the implementation of alterna-
tive strategies.
Other suggested advantages of alternative 
measures include:
They are cost-effective to implement.•	
They would address the underlying prob-•	
lems of drug use.
They provide prevention and early inter-•	
vention strategies.
Approaches which strengthen and en-
hance preventative school drug education 
programs and the management of drug 
related incidents are more likely to en-
able students to remain connected to the 
school setting, something universally ac-
cepted as an important protective  factor. 
— Policy maker, education sector
… in addressing drug use in schools it is 
paramount that students receive appropri-
ate support and early intervention, remain 
engaged with the school community and 
that any actions taken in response to illicit 
drug use do not cause more harm than 
the use of the drug itself. —  Commissioner 
of Police
Conversely, alternatives were seen by one 
respondent to have:
No advantage for children, parents or 
schools. Only for the drug traffickers who 
would continue to feast on the vulnerabil-
ity of young children. — Policy advocate, 
drug and alcohol sector (US)
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Table 40: Frequency of responses for advantages of alternative methods
Advantages Frequency
Connectedness/engagement/retention in school maintained — 
protective factor in reducing drug-related harms
12
Increased effectiveness in reducing drug use 6
No invasion of privacy/rights 4
Encourages honest communication and trust, builds positive 
relationships between young people, parents and schools
4
Provides prevention and early intervention strategies 4
Cost-effective 4
Addresses overall health and wellbeing of students 4
Addresses underlying issues around drug use 3
Increased awareness about the effects of drug use 2
No discrimination 2
Consistent with role/duty of care of schools 2
Maintains school environment as safe and supportive 2
Offers positive, constructive assistance 2
Note: Stakeholders could provide more than one response.
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Disadvantages of alternatives to drug 
detection and screening
Few stakeholders identified disadvantages 
to alternative strategies. Several respondents 
reported that there would be no disadvan-
tages, while others commented that there 
would be no certainty that these alternatives 
would guarantee a reduction in drug use. 
Some stakeholders stated that schools that 
did not adopt testing and/or detection meas-
ures may be perceived as ‘not doing enough’ 
or that they were ‘soft on drugs’, but that 
these impressions could be prevented via 
active promotion and communication of 
drug education programs and policies.
Table 41: Frequency of responses for 
disadvantages of alternative methods
Disadvantages Frequency
Cost 3
No guarantee that drug 
use will reduce / drug use 
will persist 2
Negative perception of 
schools — ‘soft on drugs’, 
not doing enough 2
Difficult if drug program not 
seen as a priority area 2
Teachers may not be 
confident/competent to deal 
with this area 2
Other:
Program may not be •	
targeted at current users
Those who do not attend •	
schools will not be able 
to participate
1
 
 
1
Note: Stakeholders could provide more than 
one response.
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6.2.2.2 Viability, effectiveness and 
appropriateness of alternative measures
Most stakeholders who responded to this 
question believed that alternatives were via-
ble, effective and appropriate to implement 
in schools (Table 42). Some reported that 
there was more credible evidence on alter-
native measures compared to the available 
evidence regarding the effectiveness of drug 
detection and screening tools. 
Other stakeholders commented that the effec-
tiveness of alternative programs would depend 
on how well they were designed, whether or 
not they were based on evidence, and the 
level of commitment and actual application 
of the strategies. A few stakeholders indicated 
the need for more research and evaluation 
of these programs. A small proportion of 
stakeholders thought alternative measures 
were neither viable nor effective.
Table 42: Frequency of responses for viability, effectiveness 
and appropriateness of alternative measures
Viability, effectiveness  
& appropriateness Frequency Additional comments
Viable 10
Effective 10 More evidence is available on the efficacy 
of alternatives than the efficacy of drug 
detection and screening
Appropriate 8
May be effective 5 Effectiveness depends on:
regularity of application•	
long-term commitment and dedication•	
use of evidence-based strategies•	
how well it is designed•	
Not sure 3 Requires more research and evaluation of 
effectiveness
Not effective 3
Not viable 2
Not appropriate 1
Note: Stakeholders could provide more than one response.
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7. Online survey results
To obtain the views of a wider range of the 
professional and general community, NCETA 
also administered an online survey to seek 
views about drug testing in the school set-
ting. The survey included eight questions 
addressing views about drug detection and 
screening in schools and alternatives to 
drug testing. The survey was developed by 
NCETA specifically for this project and was 
‘live’ on the NCETA website from 10 July 
until 24 August 2007. The survey was open 
to anyone via the NCETA website.
7.1 Number of surveys
A total of 304 online surveys were recorded 
in SurveyMonkey at the closing date. The 
final number of surveys included for analysis 
was 284, as 20 surveys were incomplete and 
therefore ineligible for analysis. The key find-
ings from the survey are presented below.
7.2 Demographics of 
respondents
The demographic characteristics of the re-
spondents are presented in Table 43. The 
majority of survey respondents were female 
(66%, n = 186), aged between 36 and 55 
years (54%, n = 153), married or living with 
a partner (61%, n = 171), with children (60%, 
n = 168), and employed (87%, n = 248). The 
majority of respondents worked in health care 
and social assistance (55%, n = 150) or in 
education and training (18%, n = 49) fields.
Respondents mainly resided in metropolitan 
locations (72%), in South Australia (28%), New 
South Wales (24%) and Queensland (21%).
The majority of respondents (n = 168) were 
parents or guardians (60% of respondents). 
Of these, 78 (46% of parents) had a child of 
primary school age or younger, 55 (33%) had 
a child in high school, and 77 (46%) had a 
child aged 18 years or over. These percent-
ages total more than 100 per cent as parents 
could select more than one category.
Table 43: Demographic characteristics of respondents
Demographic n (%)
Female
Male
186 (66%)
 95 (34%)
Age range
12–15 years
16–18 years
19–25 years
26–35 years
36–45 years
46–55 years
56–65 years
66 years or older
 1 (0.4%)
 4 (1%)
26 (9%)
63 (22%)
75 (27%)
78 (28%)
30 (11%)
 5 (2%)
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Demographic n (%)
Marital status
Married (including de facto, living with life partner)
Never married
Divorced/separated
Widowed
 171 (61%)
 77 (27%)
 31 (11%)
 3 (1%)
Parent/guardian
Yes
No
168 (60%)
114 (40%)
Employment status
Employed for wages, salary or payment in kind
Engaged in full-time/part-time study
Self-employed
Retired on a pension
Engaged in home duties
Unemployed and looking for work
Unable to work
Other
 247 (87%)
 15 (5%)
 7 (3%)
 4 (1%)
 2 (1%)
 1 (0.4%)
 0 (0%)
 8 (3%)
State/Territory
South Australia
New South Wales
Queensland
Victoria
Western Australia
Australian Capital Territory
Tasmania
Northern Territory
80 (28%)
67 (24%)
59 (21%)
36 (13%)
17 (6%)
15 (5%)
 8 (3%)
 1 (0.4%)
Geographic location
Metropolitan
Regional
Rural
Remote
202 (71%)
 50 (18%)
 32 (11%)
 0 (0%)
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7.3 Support for and opposition 
to school drug testing
Overall, 24 per cent (n = 66) of respondents 
supported drug testing in schools, while 71 per 
cent (n = 200) were opposed to it (see Table 
44). Very few respondents (only 3%) were 
neutral (i.e. neither opposed to it nor in sup-
port of it).
Support for and opposition to specific meth-
ods of drug testing in school are presented 
in Table 45. Support (‘support’ and ‘strongly 
support’ combined) was highest for question-
naires (47%) and for interviews and clinical 
observations (47%). Opposition (‘oppose’ and 
‘strongly oppose’ combined) was highest for 
sniffer dogs (85%) and nail analysis (85%).
Table 44: Support for and opposition 
to drug testing in schools
Response selected n (%)
Strongly oppose 132 (47%)
Oppose  68 (24%)
Neither oppose nor support  9 (3%)
Support  31 (11%)
Strongly support  35 (13%)
Don’t know enough to say  6 (2%)
Table 45: Number (and percentage) of respondents who oppose 
or support specific methods of drug testing in schools
Method of drug 
testing
Strongly 
oppose Oppose
Neither 
oppose nor 
support Support
Strongly 
support
Don’t know 
enough 
to say
Questionnaires  36 (13%) 47 (18%)  84 (31%) 76 (28%) 19 (7%) 7 (3%)
Interviews & clin-
ical observations  52 (20%) 48 (18%)  60 (23%)  82 (31%) 16 (6%) 9 (3%)
Sniffer dogs 182 (67%) 48 (18%) 10 (4%) 15 (6%) 15 (6%) 0 (0%)
Scanning 
equipment 162 (62%) 56 (21%) 16 (6%) 19 (7%)  8 (3%) 2 (1%)
Saliva test 162 (60%) 39 (14%) 14 (5%)  33 (12%) 19 (7%) 3 (1%)
Breath test 157 (60%) 40 (15%) 15 (6%)  36 (14%)  9 (3%) 4 (2%)
Sweat test 164 (63%) 39 (15%) 19 (7%) 18 (7%) 13 (5%) 7 (3%)
Blood test 182 (69%) 40 (15%) 17 (6%) 16 (6%)  9 (3%) 1 (0.4%)
Urine analysis 174 (66%) 44 (17%) 14 (5%) 21 (8%) 12 (5%) 0 (0%)
Hair analysis 170 (65%) 39 (15%) 12 (5%)  26 (10%)  9 (3%) 6 (2%)
Skin analysis 171 (66%) 44 (17%) 17 (7%) 12 (5%)  8 (3%) 8 (3%)
Nail analysis 171 (66%) 43 (17%) 16 (6%) 15 (6%)  8 (3%) 7 (3%)
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7.4 Advantages and 
disadvantages of school 
drug testing
Respondents’ perceptions of the advantages 
and disadvantages of school drug testing are 
shown in Table 46. Approximately half the 
respondents felt there were no advantages to 
drug testing in school (51%). The most com-
mon advantages cited were that ‘students who 
use drugs can be identified and treated’ (37%) 
and that ‘it would be a deterrent to drug use 
among students’ (27%). The most commonly 
cited disadvantages were that ‘it would lead 
to mistrust between students and school per-
sonnel’ (96%) and that ‘it would stigmatise 
students with drug problems’ (72%). Seven 
per cent of respondents thought there were no 
disadvantages to drug testing in schools.
The other advantages mentioned include re-
ducing drug dealing in schools and making 
students aware of their responsibilities. Other 
disadvantages mentioned include students 
switching to using less detectable drugs and 
fundamental human rights being eroded.
Advantages n (%)
It would be a deterrent to drug 
use among students
 77 
(27%)
It would reduce the existing 
prevalence of drug use among 
students
 54 
(19%)
It would help parents to 
monitor/manage their children
 51 
(18%)
It would assist overall behaviour 
and discipline in the school
 38 
(13%)
Students who use drugs can be 
identified and disciplined
22 
(8%)
Students who use drugs can be 
identified and treated
104 
(37%)
It would send out the right 
message about drug use
 51 
(18%)
It would improve public health  40 
(14%)
There would be no advantages 146 
(51%)
Other advantages 14 
(5%)
Disadvantages n (%)
It would be an invasion 
of privacy
187 
(66%)
It would lead to mistrust 
between students and 
school personnel
215 
(76%)
It would exacerbate drug use 
among students
59 
(21%)
It would stigmatise students 
with drug problems
204 
(72%)
Students who use drugs would 
leave school
184 
(65%)
It would be expensive to 
implement
158 
(56%)
Drug testing is unreliable and 
can produce inaccurate results
147 
(52%)
It would override the role 
of parents
102 
(36%)
There would be no 
disadvantages
20 
(7%)
Other disadvantages  44 
(15%)
Table 46: Respondents’ perceptions of the advantages and disadvantages of drug testing in schools
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7.5 Who should be tested 
if drug testing were 
implemented?
Participants were asked which students 
should be tested, if drug testing were imple-
mented in schools (see Table 47). Respond-
ents most commonly endorsed random drug 
testing (39%) in Years 7–9 (42%) and 10–12 
(61%).
Table 47: Support for and opposition 
to drug testing in schools
Which students 
should be tested n (%)
All students  84 (30%)
Tests should be done 
on a random basis 111 (39%)
Other  29 (10%)
Which year groups 
should be tested n (%)
Years 1–3  4 (1%)
Years 4–6  12 (4%)
Years 7–9 118 (42%)
Years 10–12 174 (61%)
All years  31 (11%)
The most common alternatives suggested 
under the ‘other’ (for which student should 
be tested) were students who had been iden-
tified as ‘problematic’ or ‘at risk’ (n = 8, 3%), 
and students who had evidenced intoxica-
tion or were suspected of using drugs during 
school (n = 11, 4%).
7.6 What next steps should 
be taken if a student tests 
positive to drugs?
Table 48 indicates respondents’ endorsement 
of the steps that should be taken next if a 
student tests positive to drugs. The most 
commonly endorsed steps were to provide 
referral for treatment (57%), provide vol-
untary counselling (51%), and inform the 
parents (51%).
Table 48: Number of respondents (and 
percentage) indicating which next steps should 
be taken if a student tests positive to drugs
Next step n (%)
Inform the parents 144 (51%)
Inform the police  24 (9%)
Issue a warning  45 (26%)
Give them detention  3 (1%)
Suspend them  9 (3%)
Expel them  6 (2%)
Provide voluntary 
counselling 144 (51%)
Provide compulsory 
counselling  93 (33%)
Provide referral for 
treatment 161 (57%)
Other  39 (14%)
Some of the alternative steps suggested in the 
‘other’ category include conducting follow-
up drug tests, responding on a case-by-case 
basis, providing the student with information/
education on drugs, and providing the student 
with support.
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7.7 Alternatives to school 
drug testing
Table 49 indicates which alternatives to drug 
testing in schools the respondents endorsed. 
The most commonly indicated alternatives 
include incorporating drug and alcohol edu-
cation programs into the school curriculum 
(80%) and providing drug and alcohol coun-
selling services (66%).
Table 49: Number of respondents 
(and percentage) endorsing 
alternatives to school drug testing
Strategy n (%)
Engage students in 
extracurricular activities 174 (61%)
Provide drug and alcohol 
counselling services 188 (66%)
Provide referrals to drug 
and alcohol treatment 
professionals 177 (62%)
Incorporate drug and 
alcohol education programs 
into school curriculum 227 (80%)
Implement drug and 
alcohol guidelines in 
school policy 178 (63%)
Improve parenting skills 174 (61%)
There are no alternatives 
that are as effective as 
drug testing  14 (5%)
Other  33 (12%)
Options mentioned in the ‘other’ category 
included providing alcohol and drug infor-
mation to parents, and building resilience 
among students.
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8. Alternatives to 
drug detection and 
screening in schools
Drug use by schoolchildren is influenced by 
a wide range of factors, and there is growing 
evidence of which drug preventive strategies 
are likely to be effective in the school set-
ting. In recent years, considerable national48 
and international research effort has been 
directed towards identifying the risk and 
protective factors associated with the devel-
opment of a range of potentially harmful 
adolescent behaviours, including drug use.
There have also been three Cochrane Collab-
oration reviews undertaken in recent years to 
identify which types of strategies provide best 
evidence of efficacy (Foxcroft, Ireland, Lowe 
& Breen, 2007; Faggiano, Vigna-Taglianti, 
Versino, Zambon, Borraccino & Lemma, 2005; 
Thomas & Perera, 2006). This has led to a 
strengthened knowledge base regarding the 
efficacy of various types of interventions in 
different settings, including schools.
In general, the research literature highlights 
the importance of addressing identified risk 
factors, while simultaneously enhancing pro-
tective factors associated with drug use by 
young people. These are areas where schools 
can play a variety of roles in the prevention 
of drug use and in the minimisation of drug 
harm among young people.
This section outlines a range of approaches49 
that can be taken to prevent and/or reduce 
school students’ alcohol or other drug use. 
The approaches outlined here are presented 
as alternatives to various forms of testing 
and screening as described earlier in this 
document.
The key types of school-based interventions 
applicable to the school setting are categor-
ised here according to one of four different 
broad approaches:
curriculum-based interventions conducted •	
in the classroom
whole-school interventions focused on the •	
school’s role as an institution of social-
isation
targeted interventions addressing high-•	
risk students
family strengthening programs.•	
8.1 Types of alternative 
programs
8.1.1 Four categories of school-
based interventions
The types of preventive strategies that are 
amenable to the school setting can be cat-
egorised according to one of four different 
broad approaches as shown in Table 50.
There have been a number of important projects undertaken in Australia to identify effective 48 
prevention strategies including: the Pathways to Prevention project (National Crime Prevention, 
1999), the work on the social determinants of drug use undertaken by Spooner and colleagues 
at the National Drug and Alcohol Research Centre (Spooner et al., 2001); and a large project 
reviewing the evidence on the prevention of substance use by the National Drug Research 
Institute (Loxley et al., 2004).
The range of approaches covered here is not exhaustive. The major areas of interest including 49 
those for which there is the strongest evidence base are addressed. Other strategies, such as 
peer education and peer mentoring, DARE programs and social norming approaches may be of 
interest to some readers but are not specifically addressed.
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While these four categories are not exhaustive 
or exclusive (i.e. they can be implemented in 
conjunction with one another), they nonethe-
less provide an overview of the range of possi-
ble approaches that can be undertaken within 
the school setting. These four approaches also 
operate in parallel to the three levels of drug 
prevention efforts that have been identified 
(Allen, Coombes &  Foxcroft, 2006), namely: 
universal prevention interventions, aimed •	
at the general population of families and 
young people who are not identified on 
the basis of individual risk factors
selective prevention interventions which •	
target individuals, families or groups that 
have increased risk of drug use problems, 
and
indicated prevention programs which are •	
targeted at the multiple and complex risk 
factors.
Each of these four broad approaches, and 
the levels at which they usually operate, have 
different strengths and weaknesses and dif-
ferent levels of efficacy and each is outlined 
below.
Table 50: Types of school-based preventive strategies and their levels of efficacy
Strategy Strategy descriptor Efficacy
Curriculum-
based
Curriculum-based school 
drug education (a universal 
prevention strategy)
A popular strategy with limited 
evidence to date of effective 
strategies that can be employed in 
the classroom situation
Schools as 
institutions of 
socialisation
Strategies that draw on 
the role of the school as 
an important institution of 
socialisation and which seek 
to enhance a student’s degree 
of connectedness to schools 
(a universal prevention strategy)
A strong national and international 
evidence base from longitudinal 
studies. Strategies designed to 
enhance levels of connectedness 
to the school have positive impacts 
across a wide array of behaviours 
and health areas
Interventions 
targeted at 
high-risk 
students 
Interventions targeted at 
students with identified risk 
factors for the development of 
drug use problems (selective or 
targeted prevention strategies)
A growing evidence base with novel 
approaches that combine the proven 
elements of brief motivational 
interventions with effective screening 
and selection tools targeting 
personality types prone to a range of 
antisocial behaviours including drug 
use. Again, the impact is positive for 
a range of behaviour problem areas
Programs to 
strengthen 
families
Programs designed to build 
the effective functioning of 
families
A good evidence base and a strategy 
that can work well in conjunction 
with 2 and 3 above. Recruitment of 
high-need families is a challenge
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8.2 Effectiveness of 
alternative programs
8.2.1 Curriculum-based approaches
Curriculum-based approaches form the group 
of interventions most often thought of when 
discussing school-based alcohol and drug pre-
vention strategies. They have strong intuitive 
appeal and popular support. School-based 
drug education programs, as conceptualised 
historically, concern the ways in which schools 
can transmit knowledge, information or skills 
to young people so as to prevent them using 
alcohol or other drugs (Roche, 2006). This 
might be termed ‘the drug education curricu-
lum approach’ to drug prevention in schools. 
This approach could, for example, involve 
drug-related themes, lessons and activities.
There are at least four categories of drug ed-
ucation programs (Allen et al., 2006). While 
these categories of programs are conceptu-
ally distinct from one another, in practice 
they are often employed together. Hence, 
young people may be exposed to a variety 
of approaches over time. These categories 
include:
Information models
Information models were some of the earli-
est drug education models, dating back to 
the 1960s. They sought to provide informa-
tion about drugs, drug use and drug misuse 
and were based on the assumption that 
logical choices are made by young people 
and that drug misuse occurred as a result 
of a lack of knowledge about drugs and, if 
appropriately informed, students would act 
appropriately. The information model was 
largely discredited by the late 1970s (Allen 
et al., 2006). A variation on this approach 
was use of scare tactics, predicated on the 
belief that such an approach would invoke 
fear arousal which would, in turn, result in 
reduced drug use. This approach has also 
been found to be ineffective (Midford & 
Munro, 2006).
Values/decision-making models
These models were based on the assumption 
that young people use drugs to compensate 
for personal or social deficits (Allen et al., 
2006). Therefore, the aim of this approach 
was to increase self-esteem, improve self-
understanding and clarify personal values. 
Assessments of these models found that they 
could have significant impacts on young 
people’s knowledge, but had no positive 
effect on behaviour.
Social competency models
Most current curriculum-based drug edu-
cation programs utilise these models, which 
are based on the premise that young people 
use drugs because of social pressure from a 
variety of sources such as media and peers. 
In order to resist these pressures, young peo-
ple are exposed to counter-arguments and 
trained in the skills necessary to carry out 
non-use choices (Allen et al., 2006). Evalu-
ations of these programs have had mixed 
results, with some indicating that better con-
ceptualised and more soundly implemented 
programs led to desirable behaviour changes, 
such as abstinence or delayed onset of drug 
use. On the other hand, other evaluations 
have reported very few long-term effects 
from this approach.
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Harm minimisation model
Hawthorne (2001), as cited in Allen et al. 
(2006), identified a further category of drug 
education program, the ‘harm minimisation’ 
or harm reduction model. These models are 
based on the assumption that, given the 
appropriate skills and knowledge, young 
people will become more discerning about 
their drug use, which will result in a reduc-
tion of drug-related harm. Coombes, Allen 
& Foxcroft (2006) reported a lack of evalua-
tions of this approach, making it difficult to 
draw conclusions about its effectiveness.
Curriculum-based approaches to drug pre-
vention have been popular for some time 
and have been subject to evaluation over 
a 30-year plus time span. However, evalu-
ations of classroom-based drug education 
have been consistently disappointing, with a 
few minor exceptions. In general, classroom-
based interventions have not demonstrated 
sustained behaviour change, although some 
programs have been associated with short-
term reductions in drug use.
Evaluating the effectiveness of curriculum-
based drug education programs is a chal-
lenging task. The methodological problems 
associated with designing and carrying out 
evaluations of drug education programs have 
resulted in very few programs having been 
subjected to rigorous evaluations involving 
experimental designs or multi-level analyses 
(Allen et al., 2006). In addition, the major-
ity of evaluations of drug education pro-
grams have taken place in the United States 
and have abstinence as their primary goal 
( Midford & Munro, 2006).
To date, three Cochrane reviews of the efficacy 
of classroom-based drug education have been 
undertaken (Foxcroft et al., 2007;  Faggiano 
et al., 2005; Thomas & Perera, 2006). Across 
these reviews there is little high- quality evi-
dence that classroom interventions can have 
any long-term effects (McCambridge, 2007). 
Moreover, the evidence base itself is limited 
and is characterised by significant methodo-
logical and inferential shortcomings. Crit-
ics of the classroom-based approaches, the 
underpinning evidence base and the over-
arching conceptual frame that shapes them, 
all highlight the need for a broadened concep-
tualisation of the nature of prevention which 
incorporates socioeconomic factors.
The Cochrane Collaboration review under-
taken by Faggiano et al. (2005) examined 
32 controlled studies of school-based drug 
prevention programs with the usual cur-
riculum. Programs that focused on improv-
ing students’ knowledge about drug use 
issues demonstrated some degree of suc-
cess but they did not impact on behaviour. 
Programs that focused on the development 
of social skills effectively increased levels 
of drug knowledge, decision-making skills, 
self- esteem, resistance to peer pressure and 
reduced illicit drug use, but only in the short 
term. In critiquing this finding, Coombes et 
al. (2006) pointed out that, although the 
social skills training programs resulted in 
statistically significant changes, it is ques-
tionable whether the achieved effects were 
meaningful in a public health or preven-
tion sense.
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Faggiano et al. (2005) also noted that meas-
ures of change were often made immedi-
ately after the intervention, with very little 
longer-term follow-up or investigation of 
peer influence, social context and involve-
ment of parents. Most of the trials examined 
were also conducted in the United States. 
Given that social context and broader drug 
policies have a significant influence on the 
effectiveness of the programs, the results of 
these evaluations may not be relevant to 
other countries.
In a cost–benefit analysis of soundly con-
ducted curriculum-based school drug preven-
tion programs in the United States, Caulkins, 
Pacula, Paddock and Chiesa (2002) reported 
societal returns of $840 in contrast to pro-
gram costs of $150 per student. Benefits ac-
crued from these programs came mostly from 
reduced tobacco, alcohol and cocaine use 
(39%, 28% and 20% of total benefits, re-
spectively). Caulkins et al. (2002) also noted 
that programs are not cost-effective because 
they reduce a large proportion of drug use 
(which they do not); rather, they are effective 
because they have modest impacts on drug 
use and related harms, and when widely im-
plemented, these small decreases can result 
in significant reductions in societal costs.
In summarising the evidence concerning 
the efficacy of school-based drug preven-
tion programs, Coombes et al. (2006) re-
ported that information models and values/
decision- making models have been shown to 
be ineffective. Certain social influence pro-
grams have been reported to delay the onset 
of drug use under optimum conditions.
Loxley et al. (2004), in their comprehensive 
examination of school drug education pro-
grams, concluded that short-term reductions 
in drug use and progression to frequent drug 
use may be achievable via this approach but 
prospects for longer-term behaviour change 
are unclear.
On the one hand, the empirical research does 
not give a ringing endorsement to any particu-
lar form of curriculum-based drug education. 
On the other hand, Midford (2006) main-
tains that the funding parameters applied to 
research in this area do not lend themselves to 
the kind of context-driven longitudinal evalu-
ations that would be necessary to demonstrate 
program effectiveness.
In summary, however, it is clear that there is 
not a strong empirical basis to demonstrate the 
effectiveness of curriculum-based school drug 
prevention programs in schools. Given this 
limitation, it is important to examine broader 
factors that impact on young people’s behav-
iour (Australian Government Department of 
Education, Science and Training, 2004):
We now know that the culture, relation-
ships and opportunities in schools contrib-
ute to young people’s social and academic 
outcomes and that these are relevant to a 
range of behaviours including drug use. 
Without reducing the role of drug edu-
cation programs, research is demanding a 
shift in focus so that curriculum and class-
room learning is seen as part of a broader 
and comprehensive approach to drug pre-
vention and minimising the harm for stu-
dents and the school community. (p.6)
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8.2.2 Schools as institutions 
of socialisation
An alternative role for schools in drug pre-
vention is in relation to their function as 
major institutions of socialisation. In this 
way, schools have an opportunity to be posi-
tive social institutions which nurture young 
people, create a sense of connectedness and 
belonging, enhance resilience, encourage 
optimism and promote healthy behaviours 
in a range of areas (such as alcohol and 
other drug use). This broader approach to 
prevention, without necessarily focusing 
on drug issues, seeks to create a nurturing 
school environment which addresses some 
of the risk and protective factors for drug 
use described earlier.
Historically, schools were viewed as conven-
ient conduits through which knowledge, skills 
and attitudes concerning drug use could be 
channelled to young people in the hope 
that this would lead to behaviour change. 
However, in recent years, there has been an 
important change in the way the role of 
schools in drug prevention has been concep-
tualised. Greater emphasis is now placed on 
the role of the school itself as a social insti-
tution that can have a positive influence on 
the socialisation of young people.
School-based programs that teach social and 
emotional competence, also termed social 
and emotional learning (SEL) programs, 
have been developed to address the over-
arching goal of schools not only to produce 
students who are culturally literate, intel-
lectually reflective and committed to life-
long learning, but also to encourage young 
people to ‘interact in socially skilled and 
respectful ways; to practice positive, safe, 
and healthy behaviors; to contribute ethically 
and responsibly to their peer group, fam-
ily, school and community; and to possess 
basic competencies, work habits, and val-
ues as a foundation for meaningful employ-
ment and engaged citizenship’ (Greenberg, 
Weissberg, O’Brien, Zins, Fredericks, Resnik 
et al., 2003). While SEL programs may differ 
in content and application across schools, 
they commonly encompass the following 
areas: (i) self- regulation and management 
of emotions; (ii) empathy for others; (iii) 
self-awareness and recognising emotions; 
(iv) motivation; (v) conflict resolution; (vi) 
problem solution; and (vii) general social 
competence. These programs also include 
establishment of a supportive culture within 
the school environment and often extend to 
engaging parents in the program in order to 
reinforce what is learned within the school to 
facilitate implementation of skills through-
out daily life.
Evidence from some studies suggests that 
participation in a SEL program develops atti-
tudes in children that are inconsistent with 
harmful behaviours, including substance use 
(Durlak, Taylor, Kawashima, Pachan, DuPre, 
Celio et al., 2007; Tobler & Stratton, 1997). 
In an evaluation of over 200 such programs, 
Tobler and Stratton concluded that programs 
with a highly interactive approach, includ-
ing social influences, comprehensive life skills 
and system-wide changes were more effec-
tive compared to more didactic models that 
focused on knowledge, attitudes, values and 
drug awareness resistance education (DARE)-
type programs. In addition, programs were 
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more likely to foster lasting benefits when 
they were conducted across successive years 
and comprised multiple components that 
were reinforced in the broader environment 
with peers, family members, community and 
health professionals (also see studies con-
ducted by Botvin and colleagues, which have 
been assessed in Cochrane reviews (Faggiano 
et al., 2005)).
This approach has gained considerable cur-
rency in recent years and focuses on the 
school as a whole addressing its role as an 
institution of socialisation. Such approaches 
are designed to make the school safer, more 
nurturing social institutions which enhance 
students’ sense of connectedness. Student 
connectedness to their school acts as a 
strong moderator of a range of risk factors 
including drug use. The quality of student-
to-student relationships, student–teacher 
relationships and ways in which students 
identify with the school as a social institu-
tion have been shown to be pivotal to drug 
prevention.
In addition to potentially providing a nurtur-
ing environment for young people, staying 
at school improves a young person’s chance 
of finding employment or entering tertiary 
education (Munro, 1997), as cited in Roche 
(2006). Schools can also provide a link to the 
community, increase students’ resilience to 
paths to addiction and provide them with 
an environment that continually challenges 
them to contemplate their future (Norden, 
2005).
This kind of school-based drug preven-
tive program is based on a social develop-
ment model (Hawkins, Catalano, Kosterman, 
 Abbott & Hill, 1999) whereby strong bonds 
to a school serve as protection against behav-
iours that violate socially accepted standards. 
Attachment (i.e. a positive emotional link) 
and commitment (i.e. a personal investment 
in the group) are the key elements of such 
bonds. When social groups produce strong 
bonds of attachment and commitment in 
members, and promote clear standards for 
behaviour, these groups increase their be-
haviour consistent with those standards and 
prevent behaviour that violates them.
There is strong evidence that the level of 
connectedness to family and to social insti-
tutions (such as schools) felt by young people 
profoundly impacts upon their quality of life 
and health-related behaviours, such as drug 
use. Recent Australian studies form an impor-
tant contribution to this evidence base.
Victoria’s Gatehouse Project was a multi-level, 
school-based intervention program designed 
to increase levels of emotional wellbeing and 
reduce rates of drug use problems associated 
with low levels of emotional wellbeing. The 
project sought to build a sense of security 
and trust within schools, increase skills and 
opportunities for effective communication, 
and build a sense of positive regard through 
valued participation in aspects of school life 
(Bond et al., 2004). Following the imple-
mentation of the intervention, there were 
significant differences between the inter-
vention group and the control group. The 
authors concluded that a broader focus on 
a student’s connectedness and school cli-
mate may be equally, if not more, effective 
in addressing health and problem behaviours 
than specific, single issue-focused educa-
tion packages.
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The Gatehouse Project followed on from ear-
lier work undertaken in the United States 
and elsewhere, which found similarly positive 
results for these types of interventions. For 
example, in a study of 12 118 adolescents in 
the United States, Resnick et al. (1997) found 
that adolescents’ sense of connectedness 
with their schools was associated with:
lower levels of emotional distress and sui-•	
cidal involvement among both younger 
and older adolescents
somewhat lower levels of violence•	
less frequent cigarette use•	
less frequent alcohol use•	
a delay in initiation of sexual activity•	
less frequent cannabis use.•	
The researchers concluded that parent–family 
connectedness and perceived school con-
nectedness were protective of a wide range 
of health risk behaviours examined.
Characteristics of schools that promote a 
sense of connectedness among students 
were identified in the United States National 
Longitudinal Study of Adolescent Health 
(McNeely, Nonnemaker & Blum, 2002). Data 
were drawn from 75 515 students across 
127 schools to examine the impact of school 
characteristics on cigarette smoking, drinking 
to intoxication, suicidal ideation or attempt, 
first sexual intercourse and weapon-related 
violence. Adolescents who perceived their 
teachers to be fair and cared about them 
were found to be less likely to initiate any of 
the health risk behaviours examined.
Using the same dataset as McNeely et al., 
further analysis was undertaken by Dorn-
bush, Erickson, Laird and Wong (2001). They 
reached similar conclusions about the influ-
ence of school and parental attachment on 
cigarette smoking, alcohol use, cannabis use, 
delinquency and violent behaviour, undif-
ferentiated by gender, ethnicity and their 
community’s level of economic deprivation. 
Adolescents’ attachment to family and school 
reduced the prevalence of health-harming 
behaviours and their intensity and overall 
frequency. There were no exceptions to this 
pattern across the different groups exam-
ined. Dornbush et al. (2001) found that high 
levels of connectedness to schools clearly 
reduced deviant behaviour. Once this behav-
iour had commenced, however, the relative 
influence of school connectedness tended 
to be weaker.
Bonny et al. (2000), in a study of approx-
imately 2000 adolescents in the United 
States, also reported that students who felt 
more connected to their schools reported 
better academic performance, required fewer 
school nurse visits and used fewer cigarettes 
and less alcohol.
The importance to young people of the 
level of connectedness they feel towards 
their schools has led to a number of inter-
ventions that have sought to increase this 
bonding. These programs have attempted to 
measure the impact of these interventions 
on various risky behaviours including drug 
use and to highlight the role that schools 
and social institutions can play in the pre-
vention of risky behaviours, of which drug 
use is but one.
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Catalano, Haggerty, Oesterle, Fleming and 
Hawkins (2004) summarised the findings of 
two projects, the Seattle Social Development 
Project (SSDP) and the Raising Healthy Chil-
dren (RHC) project. Data collected as part of 
the SSDP consistently showed that school 
bonding during the middle and high school 
years was significantly and negatively associ-
ated with substance use, delinquency, gang 
membership, violence, academic problems 
and sexual activity in adolescence and young 
adulthood. The SSDP was a multi- faceted 
program which sought to enhance the 
attachment of elementary students to their 
schools. Following the implementation of the 
program, when participants were followed up 
in twelfth grade, the intervention group had 
higher levels of school attachment and com-
mitment, and academic achievement, and 
lower levels of school problems, violence, 
alcohol misuse and risky sexual behaviour.
In the RHC project, Catalano et al. (2004) 
reported that, prior to implementation, level 
of school bonding was negatively associ-
ated with problem behaviour (measured by 
teachers and parents), substance use, ag-
gression, school problems and delinquency 
(measured by child self-report). Moreover, 
school bonding had a stronger protective 
effect for children whose parents reported 
involvement in illicit drug use, heavy alco-
hol use and domestic violence than for those 
children whose parents were not involved 
in these behaviours. They also found that 
school bonding had a positive association 
with later academic achievement. Like the 
SSDP, participation in the RHC program was 
associated with increased social and cog-
nitive competence, commitment to school 
and academic performance, and reduction 
in problem behaviours.
In summarising the findings of their research 
Catalano et al. (2004) indicated:
These longitudinal studies have demon-
strated the importance of school bonding 
in contributing to positive outcomes like 
academic performance and social compe-
tence. In addition, strong school bonding 
was associated with less tobacco, alco-
hol and drug use; criminal involvement; 
gang membership; and school dropout. 
(p.259)
Such approaches have also been found to be 
effective at the primary school level. Hawkins 
et al. (1999) undertook an evaluation of 
a package of interventions that trained 
teachers and parents to promote children’s 
academic competencies and bonding to 
school, and that developed children’s social 
competencies to resist health-compromising 
influences. The intervention took place dur-
ing elementary (primary) school grades. It 
resulted in less school misbehaviour and bet-
ter academic achievement six years after the 
intervention. The intervention seemed par-
ticularly effective in improving attachment 
to school, achievement and school behaviour 
of children from poorer families. In addition, 
the intervention reduced lifetime prevalence 
of violent criminal behaviour, heavy drinking, 
sexual intercourse and pregnancy. No effects 
were observed, however, for lifetime preva-
lence of use of cigarettes, alcohol, cannabis 
or other illicit drugs at 18 years.
Hawkins et al. (1999) reported that their 
findings:
suggest that early and continued inter-
vention in the elementary grades can help 
put children on a positive developmental 
course that is maintained through high 
school. The findings are consistent with 
our hypothesis that helping parents and 
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teachers to strengthen children’s commit-
ment and attachment to school in the 
elementary grades can produce lasting dif-
ferences in bonding to school that medi-
ate risk and prevent health-compromising 
behaviours in adolescence. (p.231)
The authors made a further interesting ob-
servation concerning the durability of the 
effects of their intervention, given that it 
occurred during the elementary grades with-
out any boosters or follow-up intervention 
in the following years. They stated:
this intervention focussed on increasing 
school bonding and achievement rather 
than on developing norms or skills spe-
cifically related to avoiding health-risk 
behaviours. Developing a strong com-
mitment to schooling in the elementary 
grades may set the children on a devel-
opmental path toward school completion 
and success that is naturally reinforced 
both by teachers being responsive to eager 
students and by the students’ own com-
mitment to schooling. (p.231)
There are close associations between the 
level of connectedness felt by students and 
the presence of health-harming behaviours 
such as drug use. Consequently, enhancing 
student bonding to schools has the potential 
to decrease these behaviours among young 
people. Critical to the successful imple-
mentation of these programs are measures 
that encourage students to bond with their 
schools as social institutions and to form 
trusting and nurturing relationships with 
staff and other students at the school. This 
represents one of the most important and 
empirically tested drug prevention strategies 
available to schools.
8.2.3 Interventions targeted 
at students
A third way of viewing the role of schools 
in drug prevention is the opportunity they 
afford to identify and intervene early in 
risk factors associated with the develop-
ment of drug problems. Schools represent 
an important opportunity to implement 
these selective or indicated preventive pro-
grams, because risk factors can come to the 
attention of teachers or be highlighted by 
various screening processes. As well, the links 
between schools, students and families can 
be used to channel intervention programs.
In addition to universal drug preventive ap-
proaches (such as illustrated through the role 
of schools as institutions of socialisation, see 
8.2.2 above), there is good evidence that 
selec tive and indicated programs can also be 
of benefit to schools. Where students have 
been identified as being at risk of develop-
ing drug use problems, there is a range of 
interventions that have shown some effi-
cacy in terms of moderating the effects of 
risk factors. Where students have personality 
traits that could predispose them to difficul-
ties with drug misuse, there is evidence that 
targeted interventions can reduce the poten-
tially negative effects of these traits.
Brief interventions for young people
An intervention strategy that has applicability 
in school combines early screening of ado-
lescent drug misuse with brief interventions 
aimed at encouraging behaviour change 
(Toumbourou et al., 2007). Brief motivational 
enhancement interventions using motiva-
tional interviewing principles have shown 
substantial promise in a range of spheres. 
Brief motivational and cognitive– behavioural 
interventions that are client-centred and 
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empathic are also known to be effective. 
Importantly, they focus on risk factors, rather 
than necessarily on problem behaviours. In 
this way, they provide an opportunity to 
intervene with the risk factors before they 
turn into problem behaviours, such as drug 
use. Motivational interviewing:
is a patient centred interviewing style with 
the goal of resolving conflicts regarding 
the pros and cons of change, enhanc-
ing motivation, and encouraging posi-
tive changes in behaviour. The interview 
style is characterised by empathy and 
acceptance, with an avoidance of direct 
confrontation… Motivational interview-
ing and other interventions that focus 
on resolving ambivalence (e.g. evaluat-
ing the pros and cons of change versus no 
change) might increase intrinsic motiva-
tion by allowing patients to explore their 
own values and how they may differ from 
actual behavioural choices. (p.1396)
As Toumbourou et al. (2007) noted, many 
adolescents who drink heavily or use other 
drugs tend to grow out of this behaviour 
as they enter adulthood. This occurs largely 
because the costs or problems associated 
with the drug use outweigh the benefits 
gained, and because the cognitive–control 
centre of the brain which deals with logic 
and self-regulation (i.e. the brain’s execu-
tive functions) becomes more fully activated. 
Motivational interviewing tends to sharpen 
the focus on the costs and benefits associ-
ated with problem behaviours, and provides 
an opportunity for change to occur earlier 
in drug use careers, rather than later.
Motivational interviewing has strong support 
from the scientific literature. Burke, Arkowitz 
and Menchola (2003), for example, con-
ducted a meta-analysis of 30 clinical trials 
of motivational interventions. Motivational 
interviewing50 was found to be at least as 
effective as other active treatments and more 
effective than no treatment and/or placebo 
in addressing problems involving alcohol and 
drug misuse, diet and exercise.
Although motivational interviewing-based 
brief interventions are well established with 
adults, the study of their use with young peo-
ple is a newer endeavour (Winters & Leitten, 
2007). Tevyaw and Monti (2004) reviewed 
several studies involving the use of motiva-
tional enhancement and other brief interven-
tions specifically for adolescent substance 
users. They found that these approaches 
resulted in decreases in substance-related 
negative consequences and problems, decre-
ments in substance use, and increased treat-
ment engagement. Results were particularly 
strong for those with heavier substance use 
patterns and/or less motivation to change.
Tait and Hulse (2003) examined 11 relevant 
studies involving 3734 adolescents and also 
reported that brief interventions confer ben-
efits to adolescent substance users across a 
diverse range of settings including schools, 
universities and substance misuse treatment 
centres. Brief interventions were found to 
have a small effect on alcohol consump-
tion, but a very substantial effect on users 
of multiple substances.
The study involved clinical trials of what the authors termed 50 adapted motivational interviewing 
because some of the interventions did not solely rely on motivational interviewing techniques.
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Of particular interest in the school context 
is the study by Winters and Leitten (2007). 
They randomly assigned 79 students between 
the ages of 13 and 17, who presented for 
a school chemical health assessment,51 to 
three groups. One group received assess-
ment only (the control group), one group 
received two sessions of brief intervention, 
and the third group received two sessions of 
brief intervention, plus one session involving 
the student and a parent. The researchers 
reported significant improvements for both 
intervention groups. In addition, the group 
that involved a session with a parent exhib-
ited greater and more consistent intervention 
effects compared with the adolescent-only 
intervention group.
An interesting development in brief inter-
ventions for young people has been that 
of interventions that target dimensions of 
personality associated with substance mis-
use. Conrod, Stewart, Comeau and Maclean 
(2006) identified a group of 297 Canadian 
high school students who had one of three 
groups of personality characteristics asso-
ciated with the development of substance 
misuse. These high-risk characteristics were 
anxiety sensitivity, hopelessness and sen-
sation seeking. Participants in the study 
were provided with cognitive–behavioural 
and motivational interventions tailored to 
the specific personality characteristics of 
each participant. When followed up at four 
months, the intervention group had a signifi-
cantly higher level of abstinence, reductions 
in the quantity of alcohol consumed and the 
frequency of binge drinking and other alco-
hol problems, compared with the controls.
The authors suggested the factors that may 
contribute to the efficacy and efficiency of 
this approach included:
targeting prospective risk factors rather •	
than early signs of problems
incorporating intervention techniques that •	
specifically target individual risk factors
making interventions personally relevant •	
and easy for students to engage with.
While there have not been a large number 
of studies of brief intervention among ado-
lescence, and still less in the school setting, 
this is an approach that offers considera-
ble promise. Client-centred and empathic 
approaches, which are central to motiva-
tional interviewing, are also consistent with 
research that points to the value of schools 
being nurturing and supportive environ-
ments for young people.
Students were required to present for a chemical health assessment if they were caught using 51 
drugs at school, were caught with drugs in their possession, or were referred by a teacher who 
was concerned that the student was using drugs.
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8.2.4 School-based approaches 
that strengthen families
Strategies that support families to reduce 
the risk factors for drug use are also impor-
tant options for schools.52 Indeed, some of 
the strongest supporting evidence for effec-
tive drug prevention programs comes from 
those that involve families. Given the impor-
tant role that families play in the prevention 
(and development) of drug problems, there is 
growing support for implementing programs 
that strengthen parent–child communication 
and relationships (Allen et al., 2006). How-
ever, one of the major problems with such 
programs is the difficulties associated with 
engaging parents in them; of particular con-
cern are the ‘hard-to-reach parents’, such as 
those from low income/socioeconomic status 
families, those experiencing divorce, unem-
ployment, social isolation or high levels of 
family conflict. Families with these charac-
teristics are more likely to have children with 
problem behaviours.
One of the most effective school-based fam-
ily drug prevention programs is the Strength-
ening Families Program (SFP) (Allen et al., 
2006). SFP is a multi-component, family 
skills training program that involves parent 
skills training, children skills training and 
family life-skills training. The Cochrane Col-
laboration examination of programs aimed at 
primary prevention of alcohol misuse among 
young people reported the SFP53 was one 
of the few drug preventive programs that 
showed promise as an effective universal in-
tervention over the longer term (greater than 
three years) (Foxcroft et al., 2007). Although 
the Cochrane Collaboration review focused 
on alcohol prevention efforts, prevention 
benefits for other drugs were also identified 
in the SFP evaluations (Allen et al., 2006).
Similarly, Spoth, Redmond and Shin (2001) 
recruited 667 sixth-grade students and their 
families into a trial of two types of brief in-
tervention compared with a control group. 
The first intervention was a five-session pro-
gram, Preparing for the Drug Free Years. The 
second was the seven-session Iowa Strength-
ening Families Program (ISFP). The interven-
tion groups demonstrated delayed initiation 
into drug use, and reductions in current 
and composite use of cannabis, alcohol 
and toba cco. The follow-up was conducted 
four years after the intervention, which was 
at a time when students were at high risk 
of substance misuse behaviours. There was a 
greater number of significant effects found 
for the relatively more intensive ISFP.
Given the important role that families play in 
the development of drug use problems, it is 
encouraging that programs that strengthen 
families can reduce drug problems. Schools 
may be a useful launching point for these 
programs.
In outlining the evidence base for interventions of this type, it is recognised that while the 52 
interventions recruited subjects from schools, they may not have been conducted in schools, 
or involved school personnel.
The version of the SFP reviewed in the Cochrane Collaboration project was SFP 10–14.53 
Alternatives to drug detection and screening in schools
141
8.2.5 Summary
Prevention research has consistently identi-
fied risk and protective factors associated 
with drug misuse as the primary targets for 
preventive intervention (Hawkins et al., 2002). 
Should a drug testing program be considered 
appropriate, it should not be implemented 
in isolation, but as only one of a range of 
options within a drug strategy. Further, a risk 
reduction / protection enhancement model is 
held to be the best available framework for 
addressing adolescent health and behaviour 
problems (Loxley et al., 2004; Spooner et al., 
2001). Moreover, interventions that reduce 
multiple risk factors in individuals, and the 
environments in which they socialise, hold 
promise for preventing multiple adolescent 
health and behaviour problems including 
tobacco and other substance misuse, risky 
sexual behaviour, violence, delinquency and 
school drop-out (Hawkins et al., 2002).
Three important school-based drug 
prevention strategies or approaches
The traditional forms of curriculum-based 
drug education have generally failed to 
yield the types of outcomes hoped for after 
30 years of concerted effort. Nevertheless, 
schools remain one of the most important 
settings for health promotion and pre-
ventive interventions among children and 
youth. Overall, the literature suggests that 
successful, safe negotiation through the 
adolescent–adult transition requires good 
regulatory capacity, including executive 
functioning and emotion regulation, and 
the opportunity to draw on social capital, 
such as connections or relationships with 
supportive adults, peers who have good reg-
ulatory capacity, and prosocial community 
organisations.
This review has identified four different 
approaches (briefly summarised below); of 
these, three are recommended as potentially 
useful ways in which schools can effectively 
work to prevent drug use problems among 
their student populations:
support and develop connectedness•	
brief interventions for high-risk youth•	
family interventions.•	
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8.3 Key findings
8.3.1 Curriculum-based 
interventions/programs
Curriculum-based approaches to drug pre-
vention have not demonstrated sustained 
behaviour change, although some programs 
have been associated with short-term reduc-
tions in drug use. This does not necessarily 
imply that issues concerning drug use should 
not be included in the curriculum but that 
appropriate drug use issues be included in 
much the same way as a range of other 
health-related issues form part of the school 
curriculum. However, addressing drug use 
issues via the curriculum is unlikely, of itself, 
to lead to the desired behaviour change.
8.3.2 School-wide interventions
A group of approaches that show consider-
able promise are those that result in schools 
becoming safe, nurturing social institutions 
to which students become connected. The 
evidence concerning the degree to which 
student connectedness to schools mediates 
other risk factors for drug use is very strong. 
Important in this regard is the quality of 
student-to-student relationships, student–
teacher relationships and ways in which the 
students identify with the school as a social 
institution.
8.3.3 At-risk individuals
For students exposed to a number of risk 
factors for developing substance misuse 
problems, there is a range of interventions 
that have shown some efficacy in terms of 
mediating the effects of these risk factors. 
Equally, where students have personality 
traits that predispose them to difficulties 
with substance use, targeted interventions 
using brief motivational and cognitive– 
behavioural interventions, which are client-
centred and empathic, can reduce the effects 
of these traits.
8.3.4 Families
Strategies that support families to reduce the 
risk factors for drug use that occur in their 
domain are also important. Indeed, some of 
the strongest supporting evidence for effec-
tive drug prevention programs comes from 
those that involve families.
The drug use behaviour of students is clearly 
influenced by a range of factors, many of 
which are beyond the scope of schools to 
influence. Implementation of drug preven-
tion programs in schools without considering 
the range of broader social influences on 
drug use is not likely to be effective. In con-
sidering the implementation of prevention 
programs, it is important to be clear about 
the aims of the program. For example, is the 
aim of the program to prevent all use of a 
substance/s or to reduce the harm associated 
with that use? No single strategy is likely to 
be effective in and of itself. A comprehensive 
suite of effective evidence-based strategies 
is proposed.
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A final issue that warrants consideration is 
that, by its very nature, research into school-
based drug prevention should not consider 
the efficacy of individual programs in isola-
tion from other factors (or programs) that 
might influence drug use. Wilson, Gottfredson 
and Najaka (2001) made the point that:
school-based prevention, in practice, is 
generally not a stand-alone curricular or 
other type of intervention. Rather, it is 
a mix of many different activities that 
schools implement. This suggests that at 
least as important as the question ‘Which 
program works?’ are questions such as 
‘Which combinations or sequences of strat-
egies work best?’ and ‘How can schools 
effectively design comprehensive packages 
of prevention strategies and implement 
them in a high quality fashion?’ (p.269, 
emphasis in original text)
In drawing all of this evidence together, 
it has been possible to develop a series of 
questions that should be asked in relation to 
any approach to drug prevention programs in 
schools. The answers to these questions will 
provide an insight into the extent to which 
any proposed drug prevention programs are 
evidence-based.
Which of the identified risk and protec-•	
tive factors for drug use does the program 
seek to address?
What evidence is there for the likelihood •	
of the program impacting positively on 
those risk and protective factors? 
How will the project enhance student con-•	
nectedness to schools and act to enhance 
trusting and nurturing relationships within 
the school environment?
How will the program identify those stu-•	
dents who have been exposed to a number 
of risk factors and are therefore at risk of 
developing substance misuse problems?
How will the program respond to at-risk •	
students in an empathic way which will 
mediate the effects of those risk factors? 
What evidence is there for the efficacy of 
this approach?
How will the program assist families that •	
have characteristics likely to enhance the 
risk profile of young people developing 
drug misuse problems? What evidence is 
there for the efficacy of this approach?
Clearly not all programs will seek to address 
all of these issues. Nevertheless, program 
proponents should be able to identify which 
issues they are seeking to address and the 
evidence base to support that approach.
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10. Appendices
10.1 Appendix A: Drug testing costs based 
on a 20 per cent positive POCT rate
Table A51: Cost estimates for the purchase of different test types, applied to 
different testing strategies (for a school population of 500 students)
Testing method Urine Saliva Sweat Hair1 
Strategy To
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Times tested p/a 1 3 3 1 1 3 3 1 1 3 3 1 1 3 3 1
POCT             
Laboratory 
screen1    
Quantity 500 50 25 10 500 50 25 10 500 50 25 10 500 50 25 10
Purchase cost $18 $18 $18 $18 $21 $21 $21 $21 $50 $50 $50 $50 $170 $170 $170 $170
Subtotal (a) $9000 $2700 $1350 $180 $10 500 $3150 $1575 $210 $25 000 $7500 $3750 $500 $85 000 $25 500 $12 750 $1700
Laboratory 
confirmation 
Quantity (20%) 100 10 8 5 100 10 8 5 100 10 8 5 100 10 8 5
Cost $55 $55 $55 $55 $80 $80 $80 $80 $45 $45 $45 $45 $200 $200 $200 $200
Subtotal (b) $5500 $1650 $1320 $275 $8000 $2400 $1920 $400 $4500 $1350 $1080 $225 $20 000 $6000 $4800 $1000
Total cost per 
school
Total (a + b) $14 500 $4350 $2670 $455 $18 500 $5550 $3495 $610 $29 500 $8850 $4830 $725 $105 000 $31 500 $17 550 $2700
Total student 
population 2006
Government 
schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost 
(govt schools) $65.2m $19.6m $12m $2.1m $83.2m $25m $15.7m $2.7m $132.6m $39.8m $21.7m $3.3m $472.1m $141.6m $78.9m $12.1m
Non-government 
schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost 
(non-govt 
schools) $32.5m $9.7m $6m $1m $41.4m $12.4m $7.8m $1.4m $66.1m $19.8m $9.8m $1.6m $235.2m $70.5m $39.3m $6m
Total cost 
(All schools) $97.7m $29.3m $18m $3.1m $124.6m $37.4m $23.5m $4.1m $198.7m $59.6m $31.5m $4.9m $707.3m $212.1m $118.2m $18.1m
Note: 1 POCT devices are unavailable for hair analysis.  
However, overseas laboratories can screen hair for drug use.
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Table A51: Cost estimates for the purchase of different test types, applied to 
different testing strategies (for a school population of 500 students)
Testing method Urine Saliva Sweat Hair1 
Strategy To
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Times tested p/a 1 3 3 1 1 3 3 1 1 3 3 1 1 3 3 1
POCT             
Laboratory 
screen1    
Quantity 500 50 25 10 500 50 25 10 500 50 25 10 500 50 25 10
Purchase cost $18 $18 $18 $18 $21 $21 $21 $21 $50 $50 $50 $50 $170 $170 $170 $170
Subtotal (a) $9000 $2700 $1350 $180 $10 500 $3150 $1575 $210 $25 000 $7500 $3750 $500 $85 000 $25 500 $12 750 $1700
Laboratory 
confirmation 
Quantity (20%) 100 10 8 5 100 10 8 5 100 10 8 5 100 10 8 5
Cost $55 $55 $55 $55 $80 $80 $80 $80 $45 $45 $45 $45 $200 $200 $200 $200
Subtotal (b) $5500 $1650 $1320 $275 $8000 $2400 $1920 $400 $4500 $1350 $1080 $225 $20 000 $6000 $4800 $1000
Total cost per 
school
Total (a + b) $14 500 $4350 $2670 $455 $18 500 $5550 $3495 $610 $29 500 $8850 $4830 $725 $105 000 $31 500 $17 550 $2700
Total student 
population 2006
Government 
schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost 
(govt schools) $65.2m $19.6m $12m $2.1m $83.2m $25m $15.7m $2.7m $132.6m $39.8m $21.7m $3.3m $472.1m $141.6m $78.9m $12.1m
Non-government 
schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost 
(non-govt 
schools) $32.5m $9.7m $6m $1m $41.4m $12.4m $7.8m $1.4m $66.1m $19.8m $9.8m $1.6m $235.2m $70.5m $39.3m $6m
Total cost 
(All schools) $97.7m $29.3m $18m $3.1m $124.6m $37.4m $23.5m $4.1m $198.7m $59.6m $31.5m $4.9m $707.3m $212.1m $118.2m $18.1m
Note: 1 POCT devices are unavailable for hair analysis.  
However, overseas laboratories can screen hair for drug use.
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Table A52: Cost estimates for the purchase of different test types plus additional on-costs, 
applied to different testing strategies (for a school population of 500 students)
Testing method Urine Saliva Sweat Hair1
Strategy To
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Times tested p/a 1 3 3 1 1 3 3 1 1 3 3 1 1 3 3 1
POCT             
Laboratory 
screen1    
Quantity 500 50 25 10 500 50 25 10 500 50 25 10 500 50 25 10
Purchase cost $18 $18 $18 $18 $21 $21 $21 $21 $50 $50 $50 $50 $170 $170 $170 $170
On-costs 
(+ $20) $38 $38 $38 $38 $41 $41 $41 $41 $70 $70 $70 $70 $190 $190 $190 $190
Subtotal (a) $19 000 $5700 $2850 $380 $20 500 $6150 $3075 $410 $35 000 $10 500 $5250 $700 $95 000 $28 500 $14 250 $1900
Laboratory 
confirmation 
Quantity (20%) 100 10 8 5 100 10 8 5 100 10 8 5 100 10 8 5
Cost $55 $55 $55 $55 $80 $80 $80 $80 $45 $45 $45 $45 $200 $200 $200 $200
On-costs (+ $20) $75 $75 $75 $75 $100 $100 $100 $100 $65 $65 $65 $65 $220 $220 $220 $220
Subtotal (b) $7500 $2250 $1800 $375 $10 000 $3000 $2400 $500 $6500 $1950 $1560 $325 $22 000 $6600 $5280 $1100
Total cost per 
school 
Total (a + b) $26 500 $7950 $4650 $755 $30 500 $9150 $5475 $910 $41 500 $12 450 $6810 $1025 $117 000 $35 100 $19 530 $3000
Total student 
population 
2006 
Government 
schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost 
(govt schools) $119 155 607 $35 746 698 $20 908 446 $3 394 782 $137 141 359 $41 142 426 $24 618 009 $4 091 724 $186 602 177 $55 980 678 $30 620 756 $4 608 810 $526 083 246 $157 825 044 $87 815 473 $13 489 200
Non-government 
schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost 
(non-govt 
schools) $59 349 771 $17 804 979 $10 414 140 $1 690 898 $68 308 227 $20 492 523 $12 261 810 $2 038 036 $92 943 981 $27 883 269 $15 251 676 $2 295 590 $262 034 838 $78 596 622 $43 739 388 $6 718 800
Total cost 
(All schools) $178 505 378 $53 551 677 $31 322 624 $5 085 680 $205 449 586 $61 634 949 $36 879 819 $6 129 760 $279 546 158 $83 863 947 $45 872 432 $6 904 400 $788 118 084 $236 421 666 $131 554 861 $20 208 000
Note: 1 POCT devices are unavailable for hair analysis.  
However, overseas laboratories can screen hair for drug use.
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Table A52: Cost estimates for the purchase of different test types plus additional on-costs, 
applied to different testing strategies (for a school population of 500 students)
Testing method Urine Saliva Sweat Hair1
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Times tested p/a 1 3 3 1 1 3 3 1 1 3 3 1 1 3 3 1
POCT             
Laboratory 
screen1    
Quantity 500 50 25 10 500 50 25 10 500 50 25 10 500 50 25 10
Purchase cost $18 $18 $18 $18 $21 $21 $21 $21 $50 $50 $50 $50 $170 $170 $170 $170
On-costs 
(+ $20) $38 $38 $38 $38 $41 $41 $41 $41 $70 $70 $70 $70 $190 $190 $190 $190
Subtotal (a) $19 000 $5700 $2850 $380 $20 500 $6150 $3075 $410 $35 000 $10 500 $5250 $700 $95 000 $28 500 $14 250 $1900
Laboratory 
confirmation 
Quantity (20%) 100 10 8 5 100 10 8 5 100 10 8 5 100 10 8 5
Cost $55 $55 $55 $55 $80 $80 $80 $80 $45 $45 $45 $45 $200 $200 $200 $200
On-costs (+ $20) $75 $75 $75 $75 $100 $100 $100 $100 $65 $65 $65 $65 $220 $220 $220 $220
Subtotal (b) $7500 $2250 $1800 $375 $10 000 $3000 $2400 $500 $6500 $1950 $1560 $325 $22 000 $6600 $5280 $1100
Total cost per 
school 
Total (a + b) $26 500 $7950 $4650 $755 $30 500 $9150 $5475 $910 $41 500 $12 450 $6810 $1025 $117 000 $35 100 $19 530 $3000
Total student 
population 
2006 
Government 
schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost 
(govt schools) $119 155 607 $35 746 698 $20 908 446 $3 394 782 $137 141 359 $41 142 426 $24 618 009 $4 091 724 $186 602 177 $55 980 678 $30 620 756 $4 608 810 $526 083 246 $157 825 044 $87 815 473 $13 489 200
Non-government 
schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost 
(non-govt 
schools) $59 349 771 $17 804 979 $10 414 140 $1 690 898 $68 308 227 $20 492 523 $12 261 810 $2 038 036 $92 943 981 $27 883 269 $15 251 676 $2 295 590 $262 034 838 $78 596 622 $43 739 388 $6 718 800
Total cost 
(All schools) $178 505 378 $53 551 677 $31 322 624 $5 085 680 $205 449 586 $61 634 949 $36 879 819 $6 129 760 $279 546 158 $83 863 947 $45 872 432 $6 904 400 $788 118 084 $236 421 666 $131 554 861 $20 208 000
Note: 1 POCT devices are unavailable for hair analysis.  
However, overseas laboratories can screen hair for drug use.
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Table A53: Cost estimates for the provision of testing services at an hourly rate, 
applied to different testing strategies (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups For cause3
Total school 
population Random sample Targeted groups For cause3
Quantity tested 500 50 25 10 500 50 25 10
Tests p/hr 8 8 8 8 8 8 8 8
Hours needed 63 6 3 4 63 6 3 4
Hourly rate1 $80 $80 $80 $80 $80 $80 $80 $80
Times tested p/a 1 3 3 1 1 3 3 1
Subtotal (a) $5000 $1500 $750 $320 $5000 $1500 $750 $320
POCT cost $9000 $2700 $1350 $180 $10 500 $3150 $1575 $210
Lab confirmation cost $5500 $1650 $3795 $275 $8000 $2400 $5520 $400
Subtotal (b)2 $14 500 $4350 $5145 $455 $18 500 $5550 $7095 $610
Total cost per school
Total (a)+(b) $19 500 $5850 $5895 $775 $23 500 $7050 $7845 $930
Total student 
population 2006 
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $87 680 541 $26 304 174 $26 506 514 $3 484 710 $105 666 293 $31 699 902 $35 274 572 $4 181 652
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost  
(non-govt schools) $43 672 473 $13 101 777 $13 202 442 $1 735 690 $52 630 929 $15 789 321 $17 569 662 $2 082 828
Total cost (All schools) $131 353 014 $39 405 951 $39 708 956 $5 220 400 $158 297 222 $47 489 223 $52 844 234 $6 264 480
Notes:
1 The hourly rate is costed on the lowest price of $80 per hour and calculated on the assumption 
that eight tests can be performed in one hour.
2 As the lower hourly rates quoted by service providers do not include POCT devices and laboratory 
confirmations, these costs are added.
3 As ‘for cause’ testing involves only one hour of testing, it is likely that a minimum service fee of 
four hours would be charged.
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Table A53: Cost estimates for the provision of testing services at an hourly rate, 
applied to different testing strategies (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups For cause3
Total school 
population Random sample Targeted groups For cause3
Quantity tested 500 50 25 10 500 50 25 10
Tests p/hr 8 8 8 8 8 8 8 8
Hours needed 63 6 3 4 63 6 3 4
Hourly rate1 $80 $80 $80 $80 $80 $80 $80 $80
Times tested p/a 1 3 3 1 1 3 3 1
Subtotal (a) $5000 $1500 $750 $320 $5000 $1500 $750 $320
POCT cost $9000 $2700 $1350 $180 $10 500 $3150 $1575 $210
Lab confirmation cost $5500 $1650 $3795 $275 $8000 $2400 $5520 $400
Subtotal (b)2 $14 500 $4350 $5145 $455 $18 500 $5550 $7095 $610
Total cost per school
Total (a)+(b) $19 500 $5850 $5895 $775 $23 500 $7050 $7845 $930
Total student 
population 2006 
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $87 680 541 $26 304 174 $26 506 514 $3 484 710 $105 666 293 $31 699 902 $35 274 572 $4 181 652
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost  
(non-govt schools) $43 672 473 $13 101 777 $13 202 442 $1 735 690 $52 630 929 $15 789 321 $17 569 662 $2 082 828
Total cost (All schools) $131 353 014 $39 405 951 $39 708 956 $5 220 400 $158 297 222 $47 489 223 $52 844 234 $6 264 480
Notes:
1 The hourly rate is costed on the lowest price of $80 per hour and calculated on the assumption 
that eight tests can be performed in one hour.
2 As the lower hourly rates quoted by service providers do not include POCT devices and laboratory 
confirmations, these costs are added.
3 As ‘for cause’ testing involves only one hour of testing, it is likely that a minimum service fee of 
four hours would be charged.
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Table A54: Cost estimates for the provision of testing services 
at a fixed fee per test (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups For cause
Total school 
population Random sample Targeted groups For cause
Times tested p/a 1 3 3 1 1 3 3 1
POCT
Quantity 500 50 25 10 500 50 25 10
Service fee $48 $48 $48 $80 $62 $62 $62 $115
Subtotal (a) $24 000 $7200 $3600 $800 $31 000 $9300 $4650 $1150
Laboratory confirmation
Quantity (20%) 100 10 8 5 100 10 8 5
Service fee $55 $55 $55 $55 $80 $80 $80 $80
Subtotal (b) $5500 $1650 $1320 $275 $8000 $2400 $1920 $400
Total cost per school
Total (a + b) $29 500 $8850 $4920 $1075 $39 000 $11 700 $6570 $1550
Total student 
population 2006
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $132 644 921 $39 793 494 $22 122 485 $4 833 630 $175 361 082 $52 608 348 $29 541 611 $6 969 420
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost  
(non-govt schools) $66 068 613 $19 820 637 $11 018 832 $2 407 570 $87 344 946 $26 203 554 $14 714 172 $3 471 380
Total cost (All schools) $198 713 534 $59 614 131 $33 141 317 $7 241 200 $262 706 028 $78 811 902 $44 255 783 $10 440 800
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Table A54: Cost estimates for the provision of testing services 
at a fixed fee per test (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups For cause
Total school 
population Random sample Targeted groups For cause
Times tested p/a 1 3 3 1 1 3 3 1
POCT
Quantity 500 50 25 10 500 50 25 10
Service fee $48 $48 $48 $80 $62 $62 $62 $115
Subtotal (a) $24 000 $7200 $3600 $800 $31 000 $9300 $4650 $1150
Laboratory confirmation
Quantity (20%) 100 10 8 5 100 10 8 5
Service fee $55 $55 $55 $55 $80 $80 $80 $80
Subtotal (b) $5500 $1650 $1320 $275 $8000 $2400 $1920 $400
Total cost per school
Total (a + b) $29 500 $8850 $4920 $1075 $39 000 $11 700 $6570 $1550
Total student 
population 2006
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $132 644 921 $39 793 494 $22 122 485 $4 833 630 $175 361 082 $52 608 348 $29 541 611 $6 969 420
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost  
(non-govt schools) $66 068 613 $19 820 637 $11 018 832 $2 407 570 $87 344 946 $26 203 554 $14 714 172 $3 471 380
Total cost (All schools) $198 713 534 $59 614 131 $33 141 317 $7 241 200 $262 706 028 $78 811 902 $44 255 783 $10 440 800
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Table A55: Cost estimates for the provision of testing services at a fixed fee 
per test plus on-costs and the purchase of POCT devices, applied to different 
testing strategies (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups For cause
Total school 
population Random sample Targeted groups For cause
Times tested p/a 1 3 3 1 1 3 3 1
POCT
Quantity 500 50 25 10 500 50 25 10
Service fee $48 $48 $48 $80 $62 $62 $62 $115
POCT device cost $18 $18 $18 $18 $21 $21 $21 $21
Subtotal (a) $43 000 $12 900 $6540 $1180 $51 500 $15 450 $7725 $1560
On-costs ($20/test) $20 $20 $20 $20 $20 $20 $20 $20
Laboratory confirmation
Quantity (20%) 100 10 8 5 100 10 8 5
Service fee $55 $55 $55 $55 $80 $80 $80 $80
Test cost $55 $55 $55 $55 $80 $80 $80 $80
Subtotal (b) $11 000 $3300 $2640 $550 $16 000 $4800 $3840 $800
Total cost per school
Total (a + b) $53 000 $16 200 $9180 $1730 $67 500 $20 250 $11 565 $2360
Total student 
population 2006
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $238 311 214 $72 842 328 $40 917 604 $7 778 772 $303 509 565 $91 052 910 $52 001 328 $10 611 504
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost  
(non-govt schools) $118 699 542 $36 281 844 $20 380 360 $3 874 508 $151 173 945 $45 352 305 $25 900 974 $5 285 456
Total cost (All schools) $357 010 756 $109 124 172 $61 297 964 $11 653 280 $454 683 510 $136 405 215 $77 902 302 $15 896 960
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Table A55: Cost estimates for the provision of testing services at a fixed fee 
per test plus on-costs and the purchase of POCT devices, applied to different 
testing strategies (for a school population of 500 students)
Testing method Urine Saliva
Strategy
Total school 
population
Random 
sample
Targeted 
groups For cause
Total school 
population Random sample Targeted groups For cause
Times tested p/a 1 3 3 1 1 3 3 1
POCT
Quantity 500 50 25 10 500 50 25 10
Service fee $48 $48 $48 $80 $62 $62 $62 $115
POCT device cost $18 $18 $18 $18 $21 $21 $21 $21
Subtotal (a) $43 000 $12 900 $6540 $1180 $51 500 $15 450 $7725 $1560
On-costs ($20/test) $20 $20 $20 $20 $20 $20 $20 $20
Laboratory confirmation
Quantity (20%) 100 10 8 5 100 10 8 5
Service fee $55 $55 $55 $55 $80 $80 $80 $80
Test cost $55 $55 $55 $55 $80 $80 $80 $80
Subtotal (b) $11 000 $3300 $2640 $550 $16 000 $4800 $3840 $800
Total cost per school
Total (a + b) $53 000 $16 200 $9180 $1730 $67 500 $20 250 $11 565 $2360
Total student 
population 2006
Government schools 2 248 219 224 822 112 411 44 964 2 248 219 224 822 112 411 44 964
Total cost (govt schools) $238 311 214 $72 842 328 $40 917 604 $7 778 772 $303 509 565 $91 052 910 $52 001 328 $10 611 504
Non-government schools 1 119 807 111 981 55 990 22 396 1 119 807 111 981 55 990 22 396
Total cost  
(non-govt schools) $118 699 542 $36 281 844 $20 380 360 $3 874 508 $151 173 945 $45 352 305 $25 900 974 $5 285 456
Total cost (All schools) $357 010 756 $109 124 172 $61 297 964 $11 653 280 $454 683 510 $136 405 215 $77 902 302 $15 896 960
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10.2 Appendix B: List of 
organisations invited to 
forward a submission
ACT Health 
GPO Box 825 
Canberra City ACT 2601 
Phone: 132 281  
Email: HealthACT@act.gov
Alcohol and Other Drugs Program  
Ms Joanne Townsend, Director 
Phone: 08 8999 2780 
Fax: 08 8999 242 
http://www.nt.gov.au/health/
healthdev/aodp/aodp.shtml
Alcohol Education and Rehabilitation 
Foundation 
Mr Daryl Smeaton, Chief Executive Officer 
PO Box 19 
Deakin West ACT 2600 
Phone: 02 6122 8600 
www.aerf.com.au
Alcohol, Tobacco and Other Drugs Service 
GPO Box 8161 
Brisbane QLD 4001 
Phone: 07 3837 5989 
(Brisbane and interstate)
Association of Principals of Catholic 
Secondary Schools 
Ms Mary Ciccarelli, Executive Officer 
PO Box 971 
Cottesloe WA 6911 
Phone: 08 9335 4835 
Fax: 08 9335 4836 
Email: opd@iinet.net.au 
http://www.apcssa.edu.au/
Australian Anglican Schools Network 
Mrs Lynne Thomson, President 
GPO Box 421 
Brisbane QLD 4001 
Phone: 07 3839 0882 
Fax: 07 3839 0879 
Email: dandersen@aso.qld.edu.au 
http://www.aasn.edu.au/
Australian Association of Christian Schools 
Mr Robert Johnston, Executive Officer 
PO Box 252 
Springwood NSW 2777 
Phone: 02 4751 9815
Australian Bar Association 
Stephen Estcourt QC, ABA President  
Level 5, Inns of Court 
North Quay Brisbane QLD 4001 
Phone: 07 3238 5100 
Fax: 07 3236 1180 
Email: mail@austbar.asn.au 
http://www.austbar.asn.au/
Australian Catholic Primary 
Principals Association 
Mr Brian Lacey, President 
St Mary’s Central School  
PO Box 363 
Wellington NSW 2820 
Phone: 02 6845 1822  
Fax: 02 6845 1339  
Email: blacey@smcs.org.au
Australian College of Educators 
Ms Cheryl O’Connor, 
Chief Executive Officer 
PO Box 323 
Deakin West ACT 2600 
Phone: 02 6281 1677  
Fax: 02 6285 1262 
Free call: 1800 208 586 
Email: ace@austcolled.com.au  
Website: http://www.austcolled.com.au
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Australian Council of Social Service 
Lin Hatfield Dodds, President  
Locked Bag 4777 
Strawberry Hills NSW 2012 
Phone: 02 9310 4844 
Fax: 02 9310 4822 
Email: info@acoss.org.au
Australian Council of State School 
Organisations 
Ms Jennifer Branch, President 
PO Box 323 
Curtin ACT 2605  
Phone: 02 6282 5150 
Email: acsso@acsso.org.au 
http://www.acsso.org.au/
Alcohol and other Drugs Council 
of Australia 
Ms Donna Bull, Chief Executive Officer 
PO Box 269 
Woden ACT 2606 
Phone: 02 6281 0686 
Fax: 02 6281 0995 
Email: adca@adca.org.au 
List-serve: update@adca-lists.org.au
Australian Drug Foundation 
Mr Bill Stronach,  
Chief Executive Officer & 
Director, Information Services  
PO Box 818 
North Melbourne VIC 3051 
Phone: 03 9278 8100 
Fax: 03 9328 3008 
Email: adf@adf.org.au
Australian Education Union  
Australian Capital Territory Branch 
Mr Clive Haggar 
PO Box 3042 
Manuka ACT 2603
Australian Education Union 
Federal Office 
Ms Pat Byrne, Federal President 
120 Clarendon Street  
Southbank VIC 3006 
Phone: 03 9693 1800 
Email: aeu@aeufederal.org.au 
http://www.aeufederal.org.au/
Australian Education Union 
Northern Territory Branch  
Ms Nadine Williams, Branch Secretary 
PO Box 41863 
Casuarina NT 0811
Australian Education Union 
South Australian Branch 
Mr Andrew Gohl, State President  
163 Greenhill Rd 
Parkside SA 5063
Australian Education Union  
Tasmanian Branch 
Ms Jean Walker, State President 
PO Box 117  
North Hobart TAS 7002
Australian Education Union 
Victorian Branch 
Mary Bluett, Branch President 
112 Trenerry Crescent 
Abbotsford VIC 3067
Australian Federal Police 
Commissioner M Keelty 
GPO Box 401 
Canberra ACT 2601
Australian Institute of Criminology 
Dr Toni Makkai, Director 
GPO Box 2944  
Canberra ACT 2601  
Phone: 02 6260 9200 
http://www.aic.gov.au
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Australian Joint Council of Professional 
Teacher Associations  
Ms Anne Tumak, President 
PO Box 1096 
Leichhardt NSW 2040 
http://www.ajcpta.edu.au/
Australian National Council on Drugs 
Dr John Herron, Chairman 
PO Box 1552 
Canberra ACT 2601 
Ph: 02 6279 1650 
Fax: 02 6279 1610 
Email: ancd@ancd.org.au 
http://www.ancd.org.au
Australian Primary Principals Association 
Ms Leonie Trimper, President  
Education Development Centre 
Milner Street 
Hindmarsh SA 5007 
http://www.appa.asn.au/contact/ 
?IntCatId=15
Australian Professional Society on Alcohol 
and Other Drugs 
Dr Ingrid Van Beek, President 
PO Box 73 
Surry Hills NSW 2010 
Ph: 02 9331 7747/48 
Fax: 02 9331 7789 
Email: admin.officer@apsad.org.au 
http://www.apsad.org.au 
Australian Secondary Principals Association 
Peter Martin, Executive Officer 
No mail address available 
Phone & Fax: 03 5358 4943 (Home) 
Phone: 03 9326 8077 & 
Fax: 03 9326 8147 (Work) 
http://aspa.asn.au/index.
php?option=com_frontpage&Itemid=1
Catholic Education Commission of Victoria 
Dr Teresa Angelico, 
Acting Chief Executive Officer 
PO Box 3 
East Melbourne VIC 8002 
Email: tangelico@ceo.melb.catholic.edu.au
Civil Liberties Australia 
Mr Bill Rowlings 
PO Box 7438 
Fisher ACT 2611 
http://www.claact.org.au/
Council of Education Associations 
of South Australia 
Mr Ian Smyth, Executive Director 
Level 2, Education Development Centre 
Milner Street  
Hindmarsh SA 5007 
Phone: 08 8463 5875 
http://www.ceasa.asn.au/index.html
Department of Education, Tasmania 
Mr John Smyth, Secretary 
GPO Box 169 
Hobart TAS 7001 
Phone: 1300 135 513 
Fax: 03 6231 1576 
Email: ServiceCentre@education.tas.gov.au 
http://www.education.tas.gov.au
Department of Education, Victoria 
Prof. Peter Dawkins, Secretary 
GPO Box 4367 
Melbourne VIC 3001 
Phone: 03 9637 2000
Department of Education and Children’s 
Services, South Australia 
Mr Christopher Robinson, 
Chief Executive Officer 
GPO Box 1152  
Adelaide SA 5001 
Phone: 08 8226 1000  
Free call: 1800 088 158  
Email: decscustomers@saugov.sa.gov.au 
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Department of Education, Science and 
Technology, Australian Government 
Ms Lisa Paul, Secretary 
PO Box 9880 
Canberra City ACT 2601 
DEST General Enquiries: 1300 363 079 
Canberra Switchboard: 02 6240 8111
Department of Education and Training, 
New South Wales 
Mr Michael Coutts-Trotter, 
Director-General 
GPO Box 33  
Sydney NSW 2001 
Phone: 02 9561 8000
Department of Education and Training, 
Western Australia 
Ms Sharyn O’Neill, A/Director-General 
151 Royal Street,  
East Perth WA 6004  
Phone: 08 9264 4111 
Fax: 08 9264 5005 
http://www.det.wa.edu.au
Department of Education, Training and 
the Arts, Queensland 
Ms Rachel Hunter, Director-General 
PO Box 15033 
City East QLD 4002 
Phone: 07 3237 0111
Department of Employment, Education 
and Training, Northern Territory 
Ms Margaret Banks, Chief Executive 
PO Box 4821 
Darwin NT 0801 
Phone: 08 8999 5659 
Email: infocentre.deet@nt.gov.au
Drug and Alcohol Nurses of Australasia 
Via ‘contact us’ form: 
http://www.danaonline.org//
index.php?option=com_
contact&catid=27&Itemid=14
Drug and Alcohol Office  
PO Box 126 
Mt Lawley WA 6150 
Phone: 08 9370 0333 
Fax: 08 9272 6605 
Email: DAO@health.wa.gov.au
Drug and Alcohol Services, South Australia  
Ms Marina Bowshall 
161 Greenhill Road 
Parkside SA 5063 
Phone: 08 8274 3333 
Fax: 08 8274 3399 
http://www.dassa.sa.gov.au
Drug Free Australia 
Mr Craig Thompson, National President 
PO Box 497 
Elizabeth SA 5112 
Phone: 08 8287 6815
Drugs Policy and Services Branch,  
Department of Human Services, Victoria 
Mr Paul Smith, 
Director, Mental Health & Drugs Division 
50 Lonsdale Street 
Melbourne VIC 3000 
Phone: 03 9096 5238
Education Network Australia 
Greg Black, Chief Executive Officer 
Level One, 182 Fullarton Road 
Dulwich SA 5065  
Phone: 08 8334 3210 
Email: inform@educationau.edu.au 
http://www.educationau.edu.au/
Independent Schools Council of Australia 
Mr Bill Daniels, Executive Director 
PO Box 324  
Deakin West ACT 2600 
Phone: 02 6282 3488  
Fax: 02 6285 2926 
Email: isca@isca.edu.au 
http://www.isca.edu.au/
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Intergovernmental Committee on Drugs 
Chair 
http://www.ancd.org.au/about/ndsf.htm
Law Council of Australia 
Mr Tim Bugg, President 
GPO Box 1989 
Canberra ACT 2601 
Phone: 02 6246 3788 
Email: mail@lawcouncil.asn.au 
http://www.lawcouncil.asn.au/
Life Education 
Mr Jay Bacik, Chief Executive Officer 
Life Education National Office 
Level 7, 280 Pitt Street 
Sydney NSW 2000  
Phone: 02 8262 4300  
Fax: 02 8262 4333  
Email: national@lifeeducation.org.au
Lutheran Education Australia 
Dr Adrienne Jericho, Executive Director  
197 Archer Street 
North Adelaide SA 5006 
Phone: 08 8267 7318 
Fax: 08 8267 7320 
Email: lea@lca.org.au 
http://www.lea.org.au
Lutheran Schools Association of SA, 
WA & NT 
Mr Barry Kahl, Director 
197 Archer Street 
North Adelaide SA 5006 
Email: lsa@sa.lca.org.au 
http://www.lea.org.au/sa/
Ministerial Council on Drug Strategy 
Kay McNiece, MCDS Secretariat 
Media Liaison 
Phone: 0412 132 585 
http://www.nationaldrugstrategy.
gov.au/internet/drugstrategy/
publishing.nsf/Content/mcds-lp
Ministerial Council on Education, 
Employment, Training and Youth Affairs 
The Hon. Paul Henderson MLA, Chair 
PO Box 202 
Carlton South VIC 3053  
Phone: 03 9639 0588  
Fax: 03 9639 1790  
Email: enquiries@mceetya.edu.au  
http://www.mceetya.edu.au
Multicultural Communities Council of SA Inc 
Dr Tony Cocchiaro AM MBBS, President 
113 Gilbert Street 
Adelaide SA 5000 
Ph: 08 8410 0300 
Fax: 08 8410 0311 
Email: mccsa@mccsa.org.au 
http://www.multiwebsa.org.au/
National Catholic Education Commission 
Ms Joan Warhurst, Chief Executive Officer  
GPO Box 3046 
Canberra City ACT 2601 
Phone: 02 6201 9830 
Fax: 02 6257 7395 
Email: ncec@ncec.catholic.edu.au
National Drug and Alcohol Research Centre 
Professor Richard Mattick 
University of New South Wales 
Randwick Campus 
22–32 King Street 
Randwick NSW 2031 
Phone: 02 9385 0333 
Fax: 02 9385 0222
National Drug Research Institute 
Professor Steve Allsop 
Curtin University  
GPO Box U1987 
Perth WA 6845 
Building 901, Level 2, 10 Selby Street 
Shenton Park WA 6008 
Phone: 08 9266 1600 
Fax: 08 9266 1611 
Email: enquiries@ndri.curtin.edu.au
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National Union of Students Inc  
Michael Nguyen, President 
Suite 64, Trades Hall 
54 Victoria Street 
Carlton South VIC 3053 
Ph: 03 9650 8908 
Fax: 03 9650 8906 
Email: nus@nus.asn.au
National Youth Roundtable 
Department of Families, Community 
Services and Indigenous Affairs, 
Australian Government 
Box 7788 
Canberra Mail Centre ACT 2610 
Email: theeditor@thesource.gov.au
New South Wales Network of Alcohol and 
Other Drug Agencies  
Mr Larry Pierce, Executive Director 
PO Box 2345 
Strawberry Hills NSW 2012 
Phone: 02 96988669  
Fax: 02 96900727 
Email: admin@nada.org.au
New South Wales Police Force 
Commissioner Ken Moroney 
Locked Bag 5102 
Parramatta NSW 2124 
Phone: 1800 622 571 
http://www.police.nsw.gov.au
New South Wales Teachers’ Federation 
Ms Maree O’Halloran, President  
Locked Bag 3010 
Darlinghurst NSW 1300
Northern Territory Police 
Commissioner Paul White 
PO Box 39764 
Winnellie NT 0821  
http://www.police.nt.gov.au
Odyssey House
New South Wales 
Drug and Alcohol Rehabilitation Program 
Mr James Pitts, Chief Executive Officer 
Odyssey House NSW 
PO Box 459  
Campbelltown NSW 2560 
Phone: 02 9281 5144
Victoria 
Community Services / Admissions 
Mr David Crosbie, Chief Executive officer 
Odyssey House Victoria 
660 Bridge Road 
Richmond VIC 3121 
Phone: 03 9420 7610
Residential 
Lower Plenty 
28 Bonds Road 
Lower Plenty VIC 3092 
Phone: 03 9430 1800
Benalla 
PO Box 671 
Benalla VIC 3672 
Phone: 03 5766 6399 
Institute of Studies 
660 Bridge Road 
Richmond VIC 3121 
Phone: 03 9420 7600
O@SYS Youth Service 
22 Lt Chapel St 
Prahran VIC 3181 
Phone: 03 9521 4366
Shepparton 
PO Box 74 
Shepparton East VIC 3631 
Phone: 03 5821 6501
Odyssey Peninsula Short Term 
Engagement (OPSTEP) 
1/404 Nepean Hwy 
Frankston VIC 3199 
Phone: 03 9770 0822
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Office for Children and Youth 
Ms Fiona Lander, Acting Executive Director 
Level 7, Dumas House 
2 Havelock Street 
West Perth WA 
Phone: 08 6217 8400 or 1800 281 116  
Fax: 08 9481 3074 
Email: youngpeople@dcd.wa.gov.au
Office for Children, Youth and 
Family Support 
Youth InterACT 
Ms Lou Denley, Executive Director 
GPO Box 158 
Canberra ACT 2601 
Phone: 02 6205 0632
Office for Youth 
Dr Tahnya Donaghy, Director 
GPO Box 320 
Adelaide SA 5001 
Phone: 08 8207 0660 
Fax: 08 8207 0600
Office for Youth 
PO Box 10817, Adelaide Street 
Brisbane QLD 4000 
Phone: 07 3405 5812 
Fax: 07 3405 5801 
Email: enquiries@generate.qld.gov.au
Office of Youth Affairs 
Debra Zupp, Manager 
GPO Box 4396 
Darwin NT 0801 
Free call: 1800 652 736 
Fax: 08 8999 3722 
Email: oya@nt.gov.au
Office of Youth Affairs 
GPO Box 169 
Hobart TAS 7001 
Phone: 03 6233 7329 
Email: OYA@education.tas.gov.au 
http://www.youthaffairs.tas.gov.au
Queensland Alcohol and Drug Research 
and Education Centre  
Professor Jake Najman, Director  
School of Population Health 
Level 1, Public Health Building 
University of Queensland 
Herston QLD 4006 
Phone: 07 3365 5189  
Email: qadrec@sph.uq.edu.au
Queensland Police Service 
Commissioner Bob Atkinson 
GPO Box 1440 
Brisbane QLD 4001 
Phone: 07 3364 6464 
http://www.police.qld.gov.au
Queensland Teachers’ Union 
Mr Steve Ryan, President 
PO Box 1750 
Milton BC QLD 4064
SA Association of School Parents’ Clubs Inc 
Ms Jenice Zerna 
GPO Box 2126  
Adelaide SA 5001 
Phone: 1800 724 640 
Email: saparent@arcom.com.au 
http://www.saaspc.org.au/
SA Network of Drug and Alcohol Service  
Ms Lesley Edwards, 
Acting Executive Officer 
218 Wright Street 
Adelaide SA 5000 
Phone: 08 8231 8818 
Fax: 08 8231 8860 
Email: info@sandas.com.au
Social Inclusion Initiative 
Social Inclusion Board 
Monsignor David Cappo, 
Social Inclusion Commissioner 
GPO Box 2343 
Adelaide SA 5001 
Email: socialinclusion@saugov.sa.gov.au 
http://www.socialinclusion.sa.gov.au/
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South Australian Police  
Commissioner Mal Hyde 
GPO Box 1539 
Adelaide SA 5001
State School Teachers’ Union of WA Inc 
Mr Mike Keely, President 
PO Box 6140 
East Perth WA 6892
Tasmanian Alcohol and Drug Service 
North — Launceston (Regional Office) 
13 Mulgrave Street, Launceston TAS 
Phone: 03 6336 5577 
Fax: 03 6336 5567
North West — Ulverstone Office 
11 Grove Street, Ulverstone TAS 
Phone: 03 6429 8555 
Fax: 03 6429 8599
South — Hobart (Regional Office) 
Clive Hamilton Building 
St Johns Park, New Town TAS 
Phone: 03 6230 7901 
Fax: 03 6230 7922
Tasmania Police 
Commissioner Richard McCreadie 
GPO Box 308C 
Hobart TAS 7001 
Phone: 03 6230 2111 
Email: tasmania.police@police.tas.gov.au 
http://www.police.tas.gov.au
Turning Point Alcohol and Drug Centre 
Professor Nick Crofts, Director 
54–62 Gertrude Street 
Fitzroy VIC 3065  
Phone: 03 8413 8413 
Fax: 03 9416 3420 
Email: info@turningpoint.org.au 
http://www.turningpoint.org.au
Victorian Alcohol and Drug Association  
211 Victoria Parade 
Collingwood VIC 3066 
Phone: 03 9416 0899 
Fax: 03 9416 2085 
Email: vaada@infoxchange.net.au
Victoria Police 
Chief Commissioner Christine Nixon 
Victoria Police Centre 
637 Flinders Street 
Melbourne VIC 3005 
Phone: 03 9247 6666 
http://www.police.vic.gov.au
Western Australian Network of Alcohol 
and Other Drug Agencies 
Ms Jill Rundle, Executive Director 
City West Lotteries House 
2 Delhi Street 
West Perth WA 6005 
Phone: 08 9420 7236 
Fax: 08 9486 7988 
Email: drugpeak@wanada.org.au
Western Australia Police 
Commissioner K O’Callaghan 
2 Adelaide Terrace  
East Perth WA 6004 
Phone: 08 9351 0699 
http://www.police.wa.gov.au
Youth Central 
Office for Youth 
Department for Victorian Communities 
GPO Box 2392 
Melbourne VIC 3001 
Email: youthwebsite@dvc.vic.gov.au
Youth NSW 
Department of Community Services, 
Communities Division 
Locked Bag 28 
Ashfield NSW 1800 
Phone: 02 9716 2871 
Email: youth@community.nsw.gov.au
Of Substance 
Research Pulse 
Australian Policy Online 
Email: admin@apo.org.au 
http://www.apo.org.au/
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10.3 Appendix C: 
Submission package
Call for submissions
Drug detection and screening 
in schools
Drug use among school students has been a 
matter of increasing concern in recent years. 
To examine the effectiveness and impact of 
drug detection and screening measures in 
schools, the National Centre for Education 
and Training in Australia (NCETA), Flinders 
University, has been contracted by the Aus-
tralian National Council on Drugs (ANCD) to 
undertake an independent, comprehensive 
and critical review of the issues. 
The review has two key objectives:
To examine the positive and negative 1. 
impacts and implications of the range of 
drug detection and screening measures 
currently available for schools in Aus-
tralia; and
To assess the viability and effective-2. 
ness of alternatives to drug detection 
and screening programs for schools in 
Australia.
Public Submissions
As part of this review, input is sought from 
relevant stakeholders in the community such 
as parents, teachers and principals, students, 
alcohol and other drug experts (researchers 
and clinicians), police, criminal justice work-
ers, youth services workers, legal experts, civil 
liberties commentators, policy advisors, poli-
ticians, and health economists.
NCETA would like to invite interested par-
ties to submit their views on these issues. 
Submissions should address the key themes/
questions in the submission pro-forma and 
follow the guidelines for submissions.
An electronic version of the submission forms 
can be downloaded from the NCETA website: 
www.nceta.flinders.edu.au
Submissions must be received by 
5.00pm EST, Friday, 27th July 2007.
Submissions can be emailed (preferred 
method) or posted to:
Drug Detection & Screening in Schools 
National Centre for Education and 
Training on Addiction (NCETA) 
Flinders University 
GPO Box 2100 
Adelaide 
South Australia 5001
Ph: 08 8201 7535 
Fax: 08 8201 7550 
Email: nceta@flinders.edu.au
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Guidelines for Preparing Submissions
Submissions should be brief, up to 4 1. 
pages and should address the key issues 
in the submission pro-forma.
Electronic submissions are preferred. 2. 
They must be saved as an MS Word doc-
ument and emailed to nceta@flinders.
edu.au. Written submissions should be 
typed or written clearly in black or blue 
ink on A4 paper.
The Submission Coversheet (see attached) 3. 
must be completed and forwarded with 
your submission. 
Unless there is a request for confidential-4. 
ity, your submission may be made public 
and may be published. If you wish for all 
or part of your submission to be treated 
as confidential, please indicate this on 
the coversheet and highlight the relevant 
sections in your submission.
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Drug Detection and Screening 
in Schools
Submission Pro-forma
Cover Sheet (next page)
Please complete the coversheet and forward 
with your submission to the review.
Instructions
Please address the key themes and ques-
tions below in your submission, providing 
comments or examples where relevant / 
applicable.
Theme 1: Drug Detection and Screening 
— Viability, Effectiveness, Impact 
and Implications (Social, Economical, 
Psychological, Ethical, Legal Perspectives)
Are you in favour / not in favour of drug 1. 
detection and screening in schools?
What do you believe would be the advan-2. 
tages of implementing drug detection 
and screening measures in schools?
What would be the disadvantages (in-3. 
cluding potential unintended harmful 
consequences) of implementing drug 
detection and screening measures in 
schools?
How viable, effective and appropriate are 4. 
the following types of drug testing or 
screening for schools?
Questionnaires (pen and pencil / i. 
online screening forms)
Interviews and clinical observations ii. 
(e.g. those used in a clinical interview 
assessment)
Independent tests of body fluids iii. 
(e.g. saliva, sweat, urine, breath or 
blood)
Independent tests of body tissue iv. 
(e.g. hair, skin or nails)
Non-invasive detection mechanisms v. 
(e.g. sniffer dogs, scanning equip-
ment)
Which type(s) of drug testing or screening 5. 
do you believe should be implemented 
in schools? Please provide reasons for 
your response.
In your opinion, should drug testing 6. 
be randomly conducted or targeted at 
selected groups? Please provide reasons 
for your response.
If drug usage is detected, what do you 7. 
think the next steps should be to address 
the problem?
(Note: Questions on alternative measures 
continued on next page)
Theme 2: Other Alternatives — Viability, 
Effectiveness, Impact and Implications 
(Social, Economical, Psychological, 
Ethical, Legal Perspectives)
What alternatives to drug detection 8. 
and screening programs do you believe 
would address drug use among school 
students? 
What would be the advantages of imple-9. 
menting these alternatives?
What would be the disadvantages of 10. 
implementing these alternatives?
How viable, effective and appropriate are 11. 
these alternatives?
Additional Comments
Are there any other issues on drug detec-12. 
tion and screening in schools that you 
would like to address?
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Submission Coversheet
Type of submission (tick one):
 Individual
 Organisational 
 Other (please specify)
Title (Dr/Prof/Mr/Mrs/Ms/Miss):
Name:
Name of organisation (if applicable):
Contact person (if applicable): Authorised by (if applicable):
Postal address:
Contact number: E-mail address:
Is all or part of your individual or organisational submission to be kept confidential?
 No
 Yes — all 
 Yes — part (indicate in submission which part) 
Which stakeholder group do you belong to or are writing on behalf of?
 School student  Parent  Researcher
 Tertiary student  Teacher / Principal / Educator  Policymaker
 Other (please specify)
Please forward this form with your submission to nceta@flinders.edu.au
Thank you.
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10.4 Appendix D: Online survey
Appendices
179
D
ru
g 
te
st
in
g 
in
 s
ch
oo
ls
: 
ev
id
en
ce
, i
m
pa
ct
s 
an
d 
al
te
rn
at
iv
es
180
Appendices
181
D
ru
g 
te
st
in
g 
in
 s
ch
oo
ls
: 
ev
id
en
ce
, i
m
pa
ct
s 
an
d 
al
te
rn
at
iv
es
182
Appendices
183
D
ru
g 
te
st
in
g 
in
 s
ch
oo
ls
: 
ev
id
en
ce
, i
m
pa
ct
s 
an
d 
al
te
rn
at
iv
es
184
10.5 Appendix E: List of submissions
Submission 
number Individual/organisation
State/
Territory/
country
1 Mr Jurgen Hemmerling VIC
2 CONFIDENTIAL
3 Pequannock Township Public Schools, New Jersey USA
4 Office of Crime Prevention WA
5 South Australia Police SA
6 Ms Deborah Felton NSW
7 Department of Education Victoria VIC
8 Mr Robert Rands TAS
9 Australian Drug Foundation VIC
10 School Drug Education and Road Aware WA
11 Lutheran Education Australia SA
12 Victorian Alcohol and Drug Association Inc VIC
13 CONFIDENTIAL
14 Alcohol and Other Drugs Council of Australia (ADCA) ACT
15 Drug Free Australia (DFA) SA
16 National Institute of Citizen Anti-Drug Policy (NICAP) USA
17 South Australian Parents and Friends Against Drugs 
(SAPFAD)
SA
18 Department of Education and Training Western Australia WA
19 Recovered Drug Users League of South Australia (RDULSA) SA
20 Department of Education, Training and Arts Queensland QLD
21 CONFIDENTIAL
22 Drug and Alcohol Office WA
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Submission 
number Individual/organisation
State/
Territory/
country
23 Australian Council for Health, Physical Education and 
Recreation, SA Branch Inc (ACHPER)
SA
24 Odyssey House VIC
25 South Australian Association of School Parents Clubs Inc SA
26 Department of Education, Science and Training (DEST) ACT
27 Uniting Care Moreland Hall VIC
28 Legal Aid Queensland QLD
29 Catholic Education Commission of Victoria Ltd (CECV) VIC
30 South Australian Department of Education and Children’s 
Services (DECS)
SA
31 New South Wales Department of Education and Training NSW
32 CONFIDENTIAL
33 New South Wales Police NSW
